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Abstract
Although all the cells in an organism posses the same genome, the regulatory mech-
anisms lead to highly specific cell types. Elucidating these regulatory mechanisms is
a great challenge in systems biology research. Nonetheless, it is known that a large
fraction of our genome is comprised of regulatory elements, the precise mechanisms
by which different combinations of regulatory elements are involved in controlling
gene expression and cell identity are poorly understood.
This thesis describes algorithms and approaches for modeling and analysis of
different modes of gene regulation. We present POSTIT a novel algorithm for mod-
eling and inferring transcript isoform regulation from transcriptomics and epige-
nomics data. POSTIT uses multi-task learning with structured-sparsity inducing
regularizer to share the regulatory information between isoforms of a gene, which is
shown to lead to accurate isoform expression prediction and inference of regulators.
Furthermore, it can use isoform expression level and annotation as informative pri-
ors for gene expression prediction. Hence, it constitute a novel accurate approach
applicable to gene or transcript isoform centric analysis using expression data. In
an application to microRNA (miRNA) target prioritization, we demonstrate that it
out-competes classical gene centric methods. Moreover, pinpoints important tran-
scription factors and miRNAs that regulate differentially expressed isoforms in any
biological system.
Competing endogenous RNA (ceRNA) interactions mediated by miRNAs were
postulated as an important cellular regulatory network, in which cross-talk between
different transcripts involves competition for joint regulators. We developed a novel
statistical method, called SPONGE, for large-scale inference of ceRNA networks. In
this framework, we designed an efficient empirical p-value computation approach,
by sampling from derived null models, which addresses important confounding
factors such as sample size, number of involved regulators and strength of corre-
lation. In an application to a large pan-cancer dataset with 31 cancers we discovered
protein-coding and non-coding RNAs that are generic ceRNAs in cancer.
Finally, we present an integrative analysis of miRNA and protein-based post-
transcriptional regulation. We postulate a competitive regulation of the RNA-
binding protein IMP2 with miRNAs binding the same RNAs using expression and
RNA binding data. This function of IMP2 is relevant in the contribution to disease
in the context of adult cellular metabolism. As a summary, in this thesis we have
presented a number of different novel approaches for inference and the integrative




Obwohl jede Zelle eines Organismus das gleiche Genom beinhaltet, führen regula-
torische Mechanismen zu hoch spezialisierten Zelltypen. Die Aufdeckung dieser
regulatorischen Mechanismen ist eine große Herausforderung für Forschung in
der Systembiologie. Obwohl ein Großteil unseres Genoms aus regulatorischen
Elementen besteht, sind die genauen Mechanismen, durch die verschiedene reg-
ulatorische Elemente miteinander kombiniert Genexpression und Zellidentität
bestimmen, bislang noch unbekannt.
Diese Arbeit beschreibt Algorithmen und Ansätze zur Modellierung und
Analyse verschiedener Aspekte der Genregulation. Wir stellen POSTIT als einen
neuen Algorithmus zur Modellierung und Vorhersage der Regulierung von
Transkript-Isoformen basierend auf Transcriptomics- und Epigenomics-Daten vor.
POSTIT verwendet multi-task learning mit Regularisierung auf Grundlage der
Transkriptannotation, um Information zwischen Isoformen des gleichen Gens zu
teilen. Dies führt zur besseren Vorhersage der Isoformexpression, sowie der Detek-
tierung von Regulatoren. Außerdem können Isoform-expression und -annotation
als informativer Prior zur Genexpressionsvorhersage verwendet werden. Daher
stellt es einen neuen, genaueren Ansatz dar, der zur Gen- oder Transkriptisoform-
abhängigen Analyse von Genexpressiondaten verwendbar ist. In einer Anwendung
auf miRNA target prioritization zeigen wir, dass es die Genauigkeit der Vorhersage
durch das klassische genabhängige Modell übertrifft. Zusätzlich werden wichtige
Transkriptionsfaktoren und miRNAs, die differentiell exprimierte Genisoformen in
Krebs regulieren, erkannt.
Competing endogeneous RNA (ceRNA) Interaktionen, die durch miRNAs
mediiert werden, bilden ein wichtiges regulatorischen Netzwerk, in welchem ein
Wettkampf um die gemeinsame Regulation verschiedener Transkripte entsteht.
Dafür entwickelten wir eine neue statistische Methode, SPONGE, zur Vorhersage
großer ceRNA Netzwerke. Im Zuge dessen leiteten wir einen Ansatz ab, der em-
pirische p-Werte durch mehrmaliges Ziehen von Stichproben aus einem abgeleiteten
Nullmodell efizient berechnen kann. Dadurch können wichtige fehlleitende Fak-
toren, wie Stichprobengröße, Anzahl der Regulatoren oder Stärke der Korrelation
adressiert werden. Es handelt sich hierbei um einen einheitlichen, schnellen Ansatz,
der Koregulation verschiedener miRNAs betrachtet. Durch die Anwendung auf
einen Krebsdatensatz mit 31 Krebstypen detektierten wir proteinkodierende und
nicht-proteinkodierende RNAs, die generische ceRNAs in Krebs darstellen.
Abschließend präsentieren wir eine integrative Analyse von miRNAs und
protein-basierter posttranslationaler Regulation. Wir postulieren eine kompeti-
tive Regulation des RNA-bindenden Proteins IMP2 mit miRNAs, die die selbe
RNA binden. Diese Funktion von IMP2 ist insbesondere für die Beteiligung an
Krankheiten des adulten zellulären Metabolismus relevant. Zusammenfassend
präsentieren wir hier verschiedene neuartige Ansätze zur integrativen Analyse reg-
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The twenty-first century is an exciting time for molecular biology. The DNA se-
quencing of the human genome and many other model organisms in early 2000 gen-
erated renewed hopes for novel therapeutics and treatments, but also left many fun-
damental questions unanswered. For example, what are the regulatory interactions
that determine cell identity? Given that different cells have the same DNA sequence,
how do they traverse different developmental trajectories with intricate spatial and
temporal precision? How does the cell decide when to respond to an external stim-
ulus? What are the changes in regulatory layers in different diseases prevent them
from being appropriately decoded and executed?
Our body comprises a huge atlas of cells with different functions and pheno-
types. All the cells possess the same set of genes, and how they are used determines
cell fate. Orchestrating combinatorial usage of the genes at the precise time and loca-
tion demands a vast amount of regulatory options. Hence, it is not surprising large
fraction of our genome consists of regulatory regions. International consortia like
the Encyclopedia of DNA Elements (ENCODE) consortium have assigned regula-
tory functions for around 80% of our genome (Roy et al., 2010).
1.1 Thesis scope
Learning new biological insights on gene regulation mechanisms from large-scale
high-throughput data set is a grand challenge in systems biology. In this thesis, we
focus on developing methods for modeling and analysis of different modes of gene
regulation. We develop and apply methods for transcriptional and post-transcriptional
regulatory network inference from epigenomics, transcriptomics data sets and demon-
strate their value for gene regulation and gene expression prediction. We formulate
the network inference problem in a supervised learning framework to predict the
regulatory edges by integrating chromatin accessibility, transcription factor binding,
sequence motifs, miRNA, and transcript isoform expression profiles.
1.1.1 Contributions
The key contributions of this thesis are as follows:
• POSTIT- a novel computational method for modeling and inferring transcript
isoform regulatory networks from transcriptomics and epigenomics data. This
method is based on multi-task learning, which encodes isoform annotation
for inferring isoform regulatory networks. Moreover, it implements a scalable
proximal gradient descent algorithm to solve the multi-task regression formu-
lation for the entire human transcriptome.
2 Chapter 1. Introduction
Contributions: All method development and data analysis of this project was
done by me, supervised by Marcel Schulz.
• SPONGE- a novel method for large-scale inference of competing endogeneous
RNA networks. SPONGE uses multiple sensitivity correlation, a newly defined
measure for which we can estimate a distribution under a null hypothesis.
SPONGE can accurately quantify the contribution of multiple miRNAs to a
ceRNA interaction with a probabilistic model that addresses previously ne-
glected confounding factors and allows fast p-value calculation.
Contributions: I had a major contribution to the design and development of
the algorithm. I implemented the miRNA target prediction module, made all
the derivations for the null model simulation, implemented the first working
version of the algorithm and designed the simulation experiments. Further-
more, I contributed to data analysis, interpretation and writing the manuscript.
Dennis Kostka suggested the idea of using the Schur complement for covari-
ance matrix simulation. Moreover, he helped to derive the null model simu-
lation for the case microRNA = 1. Markus List led the data analysis, wrote
the Bioconductor package, and contributed to writing the manuscript. Marcel
Schulz supervised the project and contributed to writing the manuscript.
• We present an integrative analysis of miRNA and protein-based post-
transcriptional regulation. We postulate a competitive regulation of the RNA-
binding protein IMP2 with miRNAs binding the same RNAs using expression
and RNA binding data. This function of IMP2 is relevant in the contribution
to disease in the context of adult cellular metabolism.
Contributions: I did the miRNA and IMP2 target prediction and the inte-
grative analysis of IMP2 and miRNA data. Moreover, I contributed to data
analysis, interpretation and writing of the manuscript. Finally, I supervised
Pathmanaban Ramasamy for miRNA expression quantification and differen-
tial expression analysis. Marina Wierz prepared all sequence libraries and was
involved in data interpretation. Karl Nordström was involved in primary data
generation. Sonja Kessler prepared the mice and was invovled in data inter-
pretation and paper writing. Martin Simon and Marcel Schulz were involved
in data analysis and paper writing.
1.1.2 Thesis outline
The remaining chapters of this thesis are summarized as follows:
• Chapter 2: Establishes the biological background of gene regulation. It pro-
vides a general overview of the different levels of gene regulation. Moreover,
it introduces technologies used to profile the transcriptome, chromatin acces-
sibility, and genome-wide binding occupancy of regulatory proteins.
• Chapter 3: Establishes the computational background on the methods that are
used in this thesis. The first part provides a primer on convex optimization
and describes a method for solving non-smooth convex functions. The second
part provides a theoretical background on supervised learning and different
types of sparsity-inducing norms. Finally, we review methods for modeling
gene expression and regulation.
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• Chapter 4: We present an integrative analysis of miRNA and protein-based
post-transcriptional regulation. We show that overexpression of the RNA-
binding protein IMP2 alters the regulatory capacity of miRNAs by competition
for binding sites.
• Chapter 5: Presents a new paradigm for modeling and inference of gene
regulation by incorporating transcript isoforms in a multi-task regression
formulation. Moreover, it describes an efficient optimization framework for
solving a multi-task learning approach for the entire human transcriptome.
Finally, we discuss the biological insights that we learned from analyzing the
transcript isoform regulatory network in cancer.
• Chapter 6: Presents a scalable algorithm for inferring large ceRNA regulatory
networks. A statistical framework for significance analysis of multiple sen-
sitivity correlation is described, in which confounding factors are addressed.
Finally, a pan-cancer analyis of ceRNAs is presented as a use-case for the
developed Bioconductor package. Chapter 6 will appear at processing of
ISMB-ECCB 2019 conference.





This chapter introduces the basic aspects of the gene regulation.
2.1 Chromatin organization
The human genome consists of 3× 109 bases, organized into 23 chromosomes, ac-
counting for a total length of 2 m DNA (Allis et al., 2007). Hence, it needs to be
compressed about 104-folds to fit into a cell’s nucleus (Figure 2.1). Histone proteins
provide a smart solution to this packing problem. The DNA wrapped around his-
tone proteins gives rise to a flexible polymer known as chromatin. Chromatin has a
compact organization, where most of the genetic material is inaccessible, and, hence
functionally inactive.
Histone tails are extensively post-translationally modified. These modifications
often correlate with the functional activity of the specific genomics region. The com-
bination of different histone modifications in a specific genomic region defines chro-
matin state. Chromatin state can be interpreated as the genome’s indexing system. It
serves as an efficient indexing platform, which it facilitates dynamic accessibility of
a specific genomic region in a particular time and location (Allis et al., 2007). Chro-
matin does not have a uniform structure; it comes in different flavours from a less
condensed region, euchromatin, to a more condensed one called heterochromatin. The
irreducible subunit of the chromatin is the nucleosome, which contains about 200 base
pairs of DNA, organized by an octomer of histone proteins. Regulatory codes (hi-
stone modifications) on the histone tails are involved in signaling the opening and
compaction of the DNA. Moreover, the histone code cues the recruitment of cellular
machinery to read and execute the genome (Allis et al., 2007).
2.2 Basic principles of gene regulation
Gene regulation refers to the mechanisms contributing to gene expression control.
Regulation of gene expression is a complex process, and a diverse set of regulatory
elements directs the regulatory controls at different levels. These regulatory levels
include: (1) When and where a gene is transcribed, (2) How RNA is spliced or pro-
cessed, (3) Which RNAs are transported to cytoplasm, (4) Which RNAs are stabilized
or degraded by post-transcriptional regulators, (5) Which mRNAs are translated into
protein, and (6) How proteins are post-translationally modified.
First, we describe the basic elements involved in gene regulation, then briefly
review its mechanisms.

















FIGURE 2.1: Different level of DNA compaction in the genome. 1) The nucleo-
some is the first level of compaction, which decreases the size sixfold over naked
DNA. 2) The second level of compaction is the interaction between different nucle-
osomes, leading to a condensed nanofiber of chromatin, with approximately 30 nm
in diameter. Linker histones stabilize the interaction between nucleosomes. The
final level of compaction requires the folding of the chromatin fiber into 3D struc-
tures, which leads to 1,000-fold linear compaction in euchromatin. This structure is
exchangeable with packing into mitotic chromosomes, which results into 10,0000-
folds compaction. This figure is based on (Allis et al., 2007)
2.2.1 Gene regulatory elements
Regulatory elements are sequence motifs, which are involved in regulating gene ex-
pression. They serve as a landing pad for different regulators. They are usually
6-8 nucleotide (nt) and, sometimes, are degenerate. Motifs are scattered all around
the genome. A collection of motifs constructs the regulatory element; combinatorial
usage of regulatory motifs encodes specific regulatory functions for regulatory ele-
ments. These elements are also overlaid with epigenomic marks, which increase the
regulatory capacity of the regulatory elements.
There are different types of gene regulatory elements including promoter, enhancer,
silencer, insulator (Chatterjee and Ahituv, 2017).
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Promoters are regulatory elements that are located close to the transcription start
site (TSS) of a gene and act as landing pad for assembling the core trancriptional ma-
chinery.
Enhancers are so-called "promoters of the promoter" controlling when, where,
and to what level expresses the gene. Enhancers can be located in the cis, or trans
of the target gene. Multiple enhancers can target a single promoter, and a single
enhancer can target many promoters. Enhancers are activated by the binding of se-
quence specific transcription factors (TFs) and co-activators. Active enhancers are
characterized by p300 protein occupancy, DNaseI hypersensitivity, and H3K4me1,
H3K4me2, and H3K27ac histone marks (Ong and Corces, 2011). Each enhancer can
have a different sequence, and hence, different activities across different cell types.
Enhancers specify tissue-specific gene expression.
Insulators are modular short sequence sets that act as a boundaries to define a
region that most regulatory elements reside. They are generally marked by CTCF
occupancy and function as barriers for chromatin interactions, hence preventing the
propagation of epigenomics marks from one genomic region to another (Ong and
Corces, 2014; Phillips and Corces, 2009).
Silencers act as negative regulators of the target promoters and suppress the
target gene activity (Lanzuolo et al., 2007). The precise regulatory mechanisms of
silencers have not yet beeen understood. It is hypothesized that they interact with
the target promoter and establish repressive chromatin marks (Harris, Mostecki, and
Rothman, 2005). Moreover, they may compete with the core promoter to sequester
TFs (Li et al., 2004).
The interplay between different regulatory elements at a specific time and lo-
cation creates complex regulatory circuitry that modulates gene expression at the
transcriptional and post-transcriptional levels. It is not surprising that the precise
understanding of regulatory circuitry is still limited.
5’-UTR 3’-UTR
Enhancer region Promoter motifs Splicing motifs Motifs at RNA-lvel
FIGURE 2.2: Different types of regulatory elements. They can be thousands of base
pair away from the target gene like enhancer, or can reside within or in the proxim-
ity of the gene like proximal promoters, splicing codes, and 3’-UTR.
2.2.2 Regulatory factors
Gene expression level can be modulated by the regulatory molecules, which directly
bind to a regulatory element at the DNA or RNA level. There are three main classes
of regulatory molecules: TFs, RNA-binding proteins (RBPs), and regulatory RNAs.
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FIGURE 2.3: A typical prototype of TFs. TFs have a very modular structure. They
have DNA binding doamins that interact with DNA in a sequence-specific way
with one of the grooves of the DNA. They also typically contain domains, which
have repression or activation function, and interact with other proteins. This figure
is based on (Lambert et al., 2018).
Transcription factors are defined as DNA-binding proteins capable of binding to
DNA in a sequence-specific manner, and modulating the chromatin and transcrip-
tion (Figure 2.3). They are the working horses of the cell reading genome. TFs have
modular structures and bind different motifs comprising 5-12 nt of DNA with dif-
ferent degrees of specificity (Spitz and Furlong, 2012). Many TFs recognize similar
binding motifs, which leads to the definition of TF families. TFs selectively read a
subset of regulatory elements and exert control over processes that specify cell types
and developmental patterns (Lee and Young, 2013).
The functions of TFs are determined based on the target genes. From a functional
perspective, TFs can be categorized into four distinct classes (Pope and Medzhitov,
2018).
• Class-A TFs target house keeping genes. Hence, these TFs are expressed in
most of the cell types. Examples of this class include SP1, YY1, and NRF-1.
• Class-B TFs are broadly expressed, but inactive inside the cell, waiting for spe-
cific signals to become active. Examples of these TFs include STATs, SMADs,
NF-kB, and p53. Usually, these TFs interact with the proteins involved in sig-
naling pathways, or have allosteric binding sites for specific ligands (e.g., lipids
and steroid hormones).
• Class-C TFs are inactive inside the cell. Their expression induced by class-B
TFs. Examples of class-C TFs include FosB, JunB, and E2F.
• Class-D TFs are the lineage-specific TFs. They usually target cell type specific
genes, and regulate cell differentiation. They usually bind to the enhancer
regions and keep the cell-type-specific genes active. Moreover, they facilitate
binding of class-B and class-C TFs to cell-type-specific enhancers.
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RNA-binding proteins
RNA-binding proteins (RBP) bind to single or double-strand RNA (dsRNA) through
one or multiple RNA-binding domains (RBDs), and modulate the fate or function of
the target RNAs (Hentze et al., 2018). Approximately 800 distinct RBDs are known.
RBPs have modular structures, and possess various structural motifs, such as dsRNA-
binding domain and RNA recognition motifs. Multiple domains enable RBPs to
recognize the target RNA sequences with different degrees of specificity and affin-
ity (Lunde, Moore, and Varani, 2007). Recent reports suggest that the human genome
contains between 1,072 and 1,540 RBP genes. Binding motifs for RBPs are usually
6-7 nt and very degenerate and, hence, they can target hundreds of mRNA.
RBPs have emerged as a key regulator of gene expression at co-translational and
post-transcriptional levels. They can bind to exon, intron, or 3’-UTR sequences. The
functional impact of RBP depend on where it binds. Usually, they control the lo-
calization, degredation, and translation of mRNA. Moreover, RBPs regulate the spa-
tiotemporal rate of RNA splicing, ployadenlaytion, and stability (Keene, 2007). A
recent study has shown that some RBPs have chromatin association properties, and
may couple the transcription and co-transcriptional splicing mechanisms (Van Nos-
trand et al., 2018).
Non-coding RNA
Since the discovery of non-coding RNAs (ncRNA) and their genes, such as rRNA
and tRNA, in the 1950s, new classes are constantly being discovered. Systemati-
cally focused efforts such as the ENCODE and modeENCOFE projects have revealed
that around 70% of the eukaryotic genome is transcribed (Pennisi, 2012; Roy et al.,
2010). This includes transcription from centromeres, telomeres, coding and non-
coding strands of the gene regions, and the regions between the genes (lincRNA).
More surprisingly, promoter (prRNAs) and enhancer (eRNAs) regions are also tran-
scribed.
Different classes of ncRNAs have very similar regulatory functions, and path-
ways, and employ similar molecular machinery, which makes it difficult to assign
them a distinct function and definition. Hence, they are generally are classified ac-
cording to their size into large (rRNA size), medium (tRNA size), and microRNA
sizes.
ncRNAs are used as a powerful system to modulate gene expression level on
the transcriptional or post-transcriptional levels (Morris and Mattick, 2014; Guttman
and Rinn, 2012). This regulation can be direct or indirect. The direct regulation oc-
curs by interference with RNA polymerase or by forming an RNA-duplex of anti-
sense RNA with the authentic gene transcript. The indirect regulation happens by
changing the local chromatin signature of the gene and even nuclear organization of
the gene in the nucleus.
Small RNAs have a length of less than 200 nt and are involved in RNA inter-
ference (RNAi) pathways that modulate gene expression via post-transcriptional
gene silencing (PTGS) and chromatin-dependent gene silencing (CDGS) (Morris and
Mattick, 2014). Although there are many classes of small RNA, based on their origin,
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structure, and biological role they are classified into three main categories: miRNAs,
small interfering RNAs (siRNA) and piRNAs (Farazi, Juranek, and Tuschl, 2008).
siRNAs have been primarily studied in plant and fungi. Their biogenesis is involved
in processing from double-strand RNA via Dicer enzymes and loading into a silenc-
ing complex, which is transported into the cytoplasm. They cleave the target mRNA
by complete sequence complementarity, thus have high target specificity. In the ma-
ture form, they are around 21-22 nt in length. piRNAs are germ-cell-specific small
RNAs named according to their interactions with Piwi clade of Argonaute proteins.
They have been associated with the epigenetic and post-transcriptional silencing of
transposons (Siomi et al., 2011).
MicroRNA are small RNAs that are found in almost all eukaryotes. They are
processed from longer transcripts, pre-RNA, that fold back and form hairpin struc-
tures. miRNAs play a central role in gene regulation, both at transcriptional and
post-transcriptional levels. It has been shown that miRNAs regulate around 90% of
genes. The human genome encodes around 1500 miRNAs. The primary transcript
comes in three different forms: i) Only one hairpin made from a gene, ii) three dis-
tinct hairpins from polycistronic mRNA or iii) from the intronic region of the gene
after splicing of pre-mRNA. Figure 2.4 shows the general miRNA biogenesis path-
way. After the miRNA duplex is produced in the cytoplasm, one of the strands
is loaded into the silencing complex. Then miRNA guides the silencing complex
to the target transcript. Many microRNA are conserved across different species.
Moreover, our genome contains hundreds of non-conserved microRNA expressed
at a low level compared to conserved miRNAs. microRNAs regulate gene expres-
sion both at the transcriptional and post-transcriptional levels (Morris and Mattick,
2014). It has been reported that miRNAs affect transcription initiation by binding
to the gene promoters (Place et al., 2008; Zhang et al., 2014), or promote heterochro-
matin formation.
Lewis et al. (Lewis, Burge, and Bartel, 2005) have reported that the evolutionary
conservation of the miRNA seed target sequence is a strong indicator of miRNA tar-
get site functionality, and that methods that consider evolutionary selection of the
target sites demonstrate better performance. Another factor that contributes to the
functionality of the miRNA target site is the location along the mRNA. Generally,
miRNA target sites at the beginning and end of the 3’-UTR are under strong evolu-
tionary selection pressure, and the sequence around these target sites is optimized
during evolution to enable efficient targeting by miRNAs. Moreover, miRNA bind-
ing sites in the coding region of the transcript have smaller effects on mRNA stability
than those in the 3’-UTR (Gaidatzis et al., 2007). Recently, Meijer et al. (Meijer et al.,
2013) have suggested that the distribution of the miRNA binding sites across the
transcriptome is not random, and interaction between different regulatory subunits
might dictate additional constraints on the spatial positioning of the miRNA target
sites.
Long Noncoding RNAs (lncRNAs) are usually longer than 200 nt, and are classi-
fied according to their genomic contexts, i.e., from where in the genome these RNAs
are transcribed. This classification includes stand-alone lncRNA which are distinct
transcription units, antisense transcripts contrary to the sense DNA strands of anno-
tated transcription units, pseudogenes, long intronic ncRNAs, promoter-associated
transcripts, and enhancer RNAs. They add up to 9,200 lncRNAs, the gene for some
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FIGURE 2.4: miRNA biogenesis. miRNA is transcribed by POL II. It is recognized
by Pasha and Drosha enzymes at the nucleus. Drosha cleaves the primary tran-
script by one helical turn far from the hairpin. The pre-miRNA further processed
by the Dicer enzyme at the cytoplasm and removes the loop, giving rise to the
miRNA-duplex. Finally, one of the strands of the duplex is loaded into Argonaute
protein and makes the silencing complex.
spans several kilobases and contain introns (Derrien et al., 2012). From the func-
tional perspective, lncRNAs have been involved in an extraordinary number of reg-
ulatory processes. They have been shown to influence gene regulation at a different
level. They can interact with epigenetic modifiers like DNMTs, PRC2, and trithorax
complexes. They also act as a scaffold to recruit protein complexes to facilitate co-
ordination of multiple layers of chromatin modifications. A prominent example the
crucial role of lncRNA in development includes the XIST lncRNA. Xist coats inactive
X-chromosome in females and acts as a major effector of the X inactivation process
by recruiting an epigenetic silencing complex (Kung, Colognori, and Lee, 2013). In
addition to the regulatory function of lncRNA at the epigenomics level, they can
affect transcription as well. Some act as a sponge for TFs and change their cellular
localization. Others may affect RNA processing, through interaction with splicing
factors. Moreover, depending on the shared microRNA recognition elements be-
tween lncRNAs, they can compete with each other to sequester shared miRNAs and
hence protect other transcripts from microRNA regulation (Kung, Colognori, and
Lee, 2013).
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2.2.3 Transcriptional gene regulation
Transcription is the process by which a particular segment of DNA is translated into
RNA. The RNA polymerase (RNAP) enzyme binds to the accessible core promoter,
opens up the double-strand DNA, and, while sliding along the DNA, synthesizes an
RNA copy of the gene. To initiate transcription in eukaryotes, hundreds of proteins
and subunits need to act in concert to assemble the transcriptional machinery at core
promoters (Figure 2.5). The rate of recruitment of RNAP to specific genomic regions
is modulated by TFs that bind to enhancer regions. These TFs recruit a series of gen-
eral transcription factors (GTFs). GTFs enable RNAP to recognize the core promoter
and form the transcription pre-initiation complex (PIC). After that, transcription be-
ings.
The basic transcriptional machinery is similar in higher eukaryotes. Regulation
at the transcriptional level is the most important step, because this ensures no other
unnecessary intermediate products are synthesized. For this reason, many levels of
regulatory control exist. Many of these regulatory control are mediated by epigenet-

















FIGURE 2.5: Transcriptional gene regulation. Transcriptional regulatory elements
work together to control the expression of a eukaryotic gene. The core promoter
consists of regulatory elements that provide landing pads for the general transcrip-
tion factor. These TFs helps RNA POL II to recognize the promoter and initiate
transcription.
Initiation of the transcription in eukaryotic cells depends on the chromatin struc-
ture. DNA is packed into nucleosome; and the core promoter sequence might not
be accessible to the transcriptional machinery. For a gene to be transcribed it should
have an active structure-, in other words, active promoters are associated with nucleosome-
depleted regions (NDRs). The Epigenetic state controls the active or inactive structure
of a gene. Hence, the expression of a gene is linked to the structure of the chromatin
both locally (at the promoter) and in the surrounding regions (Krebs, Goldstein, and
Kilpatrick, 2017). Acquisition of NDRs is the first step in transcription initiation.
This raises an important question regarding the transcription initiation. Given that
DNA is wrapped around nucleosomes, how are individual genes in a condensed
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chromatin region recognized and targeted for activation? It has been shown that
some TFs can bind to their DNA target sequence in closed chromatin (Spitz and Fur-
long, 2012). These activator proteins recruit chromatin complexes and histone mod-
ifiers to start removing or sliding nucleosomes and clearing the promoter, which
makes a gene potentially ready to be transcribed (Krebs, Goldstein, and Kilpatrick,
2017; Spitz and Furlong, 2012).
Epigenetic codes mark the regulatory region of the genome. Active promoters
are usually characterized by the H3K4me3 histone mark and a low level of DNA
methylation. Moreover, DNA methylation and the H3K36me3 mark in the gene
body are associated with transcription elongation (Allis et al., 2007).
The basal transcriptional apparatus has very low efficiency and, in most cases,
the activity of a promoter is increased by the presence of distal regulatory elements,
mainly enhancers. Enhancers have a variable distance to the core promoter, some
are located hundreds of kilobases from the core promoter, while others may lie quite
close to it. The proximal enhancer might be located upstream, downstream, or in the
intronic regions of the target gene. Active enhancers are characterized by p300 pro-
tein occupancy, DNaseI hypersensitivity, and H3K4me1, H3K4me2, and H3K27ac
histone marks (Ong and Corces, 2011).
An enhancer might have binding sites for both activator or repressor transcrip-
tion factors. Hence, depending on the cellular state at any given time, it will have
a mixture of transcription factors that bind to an enhancer. If more repressors bind
than activators, then this regulatory element will be a silencer (Krebs, Goldstein, and
Kilpatrick, 2017).
Enhancer interact with the basal transcriptional machinery at the core promoter
and usually exert their function by increasing the concentration of activator TFs near
the core promoter. The mediator complex and cohesin stabilize this interaction. Of-
ten, there is no one-to-one relationship between an enhancer and a target gene. An
enhancer can target multiple genes, and multiple enhancers can target a single gene
in a context-specific manner. It has been shown that an enhancer also is transcribed
into enhancer RNA, and is correlated with target gene expression level.
In a broad perspective, dynamic modification of histones and DNA, and its com-
bination with nucleosome positioning, plays a key role in transcriptional gene regu-
lation.
2.2.4 Post-transcriptional gene regulation
Post-transcriptional gene regulation refers to all the processes that start from RNA
transcriptions and end at RNA translation and stability. These processes are mainly
coordinated by miRNA and RBPs. While most of the processes for differential gene
expression are achieved at the transcriptional level, there are still numerous post-
transcriptional events that also regulate context-specific expression patterns (Cor-
bett, 2018). The main post-transcriptional processes include splicing, 5’-capping,
RNA editing and Polyadenylation.
Splicing is a form of RNA processing, in which introns of a primary transcript
are spliced, and exons are joined together. This process is mainly catalyzed by the
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spliceosome, a complex of small nuclear ribonucleoproteins (snRNPs). Introns usually
contain splicing regulatory signals. Combinatorial usage of these splicing signals
leads to alternative splicing. Alternative splicing enables cells to generate more than
one isoform from a single gene, hence expanding the post-transcriptional regulation
and proteome complexity. Alternative splicing can generate isoforms which can dif-
fer in their 3’-UTR sequence, coding sequence, and intron retention pattern (Baralle
and Giudice, 2017). These differences contribute to mRNA stability, localization, or
translation. Alternative splicing contributes to cell differentiation, identity, devel-
opment, and tissue-identity acquisition (Wang et al., 2008a). Moreover, mutations in
splicing signals is associated with tissue-specific diseases (Scotti and Swanson, 2016)
Polyadenylation is another RNA processing mechanism, in which a 3’ end of
nascent RNA is cleaved, followed by synthesis of a polyA tail on the 3’ end. The
cleavage happens around a well-conserved regulatory sequence called a polyadeny-
lation site(PAS). A transcript can have multiple PASs; differential usage of these sites
enables cells to produce distinct mRNA isoforms. This process is called alternative
polyadenylation(APA). Most APA sites reside in 3-UTRs. APA is a pervasive mech-
anism to expand transcriptome diversity and regulation. Recent reports show that
around 70% of mammalian mRNA-encoding genes express APA isoforms and fre-
quently accrue in the 3’-UTR (Hoque et al., 2012; Derti et al., 2012). As 3’-UTRs
contain regulatory elements that determine the fate of isoforms, 3’-UTR-APA can
considerably affect post-transcriptional isoform regulation in different aspects, in-
cluding regulating stabilization, localization, and export(Tian and Manley, 2017). A
3’-UTR sequence contains a high density of miRNA binding sites. The well-known
consequence of 3’-UTR-APA is differential targeting of 3-UTR-APA isoforms by miR-
NAs (Mayr and Bartel, 2009).
microRNA target reconition The seed region of the miRNAs is the most impor-
tant factor for a miRNA to recognize its target. Structural studies of argonaut (AGO)
with miRNA in complex revealed that the bases 2-6 of the miRNA are exposed for
nucleating the interaction between miRNA and the target. Plant miRNAs seed se-
quences have perfect sequence complementarity with their target site but, in ani-
mals, partial sequence complementarity is often sufficient to regulate target genes (Wang
et al., 2008b). Grimson et al. (Grimson et al., 2007) have reported that the higher the
sequence complementarity of the seed region with the target site, the stronger the
response of the target miRNA level to miRNA expression level changes. However,
it is still not clear how many mismatches can be tolerated between the miRNA and
the target sequence.
Consequence of microRNA target interaction Post-transcriptional gene repres-
sion is the most-studied consequence of miRNA target interactions, which leads to
a decrease in the encoded protein level. One of the main targets of miRNAs are
transcription factors (Hornstein and Shomron, 2006). In gene regulatory networks,
miRNAs and transcription factors interact. One such example is the feedforward
loop (FFL), where a miRNA and a transcription factor regulate a common target, and
transcription of the miRNA is regulated by the same transcription factor. Through
this regulatory module, miRNA counteract “leaky” transcription. These kinds of
networks are believed to be effective in noise buffering (Hornstein and Shomron,
2006). Re et al. have identified hundreds of such network motifs in humans and
hypothesized that one of the main activities of the miRNAs on a subset of their tar-
gets is to buffer transcriptional noise via FFLs and increase gene expression level
precision (Re et al., 2009). Other consequences of the miRNA target interaction
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are the competing endogenous RNA (ceRNA) effect. The ceRNA hypothesis sug-
gests that mRNAs with similar binding sites compete for shared miRNAs. Hence,
a ceRNA with high abundance sponges the shared miRNA and decrease miRNA
ability to suppress other targets (Arvey et al., 2010a). The advance of new experi-
mental methods to measure miRNA and mRNA expression levels in single cells, as
well as measuring their interaction affinities and rate of RNA-dependent responses,
opens a new horizon to study their dynamic regulation in more details (Hausser and
Zavolan, 2014).
2.3 Genomics data and high-throughput technologies
In recent years, significant progress has been made in the development of through-
put technologies for studying various aspects of gene regulation. These technologies
provide us the opportunity to reveal underlying biological mechanisms that con-
tribute to a specific phenotype. We describe the high-throughput technologies used
in the projects presented in this thesis.
2.3.1 Methods for genome-wide measurement of large and small RNA
The ability to measure the RNA expression level of thousands of genes simultane-
ously revolutionized biological research. RNA-seq is a next-generation sequencing
technology that allows sequencing of the entire transcriptome of an organism, pro-
ducing millions of small sequence reads per sequencing experiment (Torres et al.,
2008; Marioni et al., 2008). It has several advantages over microarray technology, in-
cluding very low background noise, high dynamic range of quantification, sensitiv-
ity to the genes with low and high expression levels, accurate estimation of expres-
sion levels, and a high level of reproducibility of results in biological and technical
replicates (Wang, Gerstein, and Snyder, 2009).
Figure 2.6 shows a typical workflow for an RNA-seq experiment. In RNA-seq,
the RNA molecules are first converted to cDNA fragments using RT-PCR. Then,
short adaptor molecules are ligated to one or both ends of these cDNA molecules.
The molecules are immobilized on the surface of the sequencer cell (in case of Illu-
mina sequencing) and further amplified after immobilization. Each molecule is se-
quenced in parallel in a high-throughput manner [26]. Depending on the technology
used, the sequencing can be done from one (single-end sequencing) or both ends of
the cDNA fragments (paired-end sequencing). The length of the reads depends on
the sequencing technology used, and is usually between 40-400 bp (Holt and Jones,
2008). In general, RNA-seq provides the opportunity to study the transcriptome of
an organism at single base resolution, quantify the expression levels of transcripts,
discover new genes and transcripts, and quantitatively examine the alternative splic-
ing diversity of the transcriptome. To achieve these goals, RNA-seq technology faces
three bioinformatic challenges: (i) read mapping, (ii) transcriptome reconstruction,
and (iii) expression quantification (Garber et al., 2011). One of the main steps in
RNA-seq data analysis is the mapping and alignment of the short RNA-seq reads,
either to the reference transcriptome or the genome of the organism. RNA-seq read
alignment is challenging because they are short, contain sequencing errors, and span
exon junctions.
















FIGURE 2.6: A typical RNA-seq workflow. Long RNAs are first fragmented and
converted to cDNA. Sequencing adaptors (blue) are ligated to cDNA fragments.
The using next generation sequencing technology, short reads are obtained. The
sequencing reads are aligned to reference genome, transcriptome or loci, and used
to estimate expression profiles.
2.3.2 Determining TF occupancy
Genome-wide mapping of regulator occupancy at regulatory sites is the essential
step to fully understand the regulatory mechanisms of gene regulation. The method
for genome-wide profiling of protein-DNA binding events is chromatin immunopre-
cipitation sequencing (ChIP-Seq) (Johnson et al., 2007). Binding events are estimated
from the fraction of the DNA that is bound to a specific protein. To this end, using
formaldehyde, all the proteins are cross-linked, and chromatin is sheared into frag-
ments of size 100-300 bp. Subsequently, these cross-linked fragments are selectively
enriched with factor specific antibodies by immunoprecipitation. Finally, the cross
linking is reversed and the purified DNA is subjected to library preparation and
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high-throughput sequencing. The performance of ChIP-Seq depends on the quality
of the antibody (sensitivity and specificity). For this reason, sensible quality control
measures have been established.
The resulting short sequencing reads can be mapped to the reference genome us-
ing standard genome alignment tools such as STAR. In the end, we obtain sequence
tag intensity for the whole genome, which represents the enrichment signal for the
respective factor. This signal is normalized using the sequence tags derived from
the same procedures omitting the immunoprecipitation step. Finally, standard peak
calling softwares can be used to identify true factor binding sites.
2.3.3 Determining RBP occupancy
To profile the regulatory occupancy at the transcriptome, an analogous technology to
ChIP-Seq has been developed. Photoactivatable ribonucleoside-enhanced crosslink-
ing and immunoprecipitation (PAR-CLIP) is a high-throughput method for profiling
the binding sites of RBPS (Hafner et al., 2010). The steps are very similar to ChIP-
Seq, with two main differences: First, UV-light induces cross-linking, and second,
isolated RNA is converted into a cDNA library before deep sequencing.
2.3.4 Characterizing chromatin accessibility
Chromatin accessibility provides another useful lens to look at the genome from the
gene regulatory perspective. Gene regulation requires access to regulatory elements.
Hence, identifying accessible DNA in open chromatin is a crucial step in elucidating
regulatory factor-binding events and other regulatory processes. DNaseI-Seq (Song
and Crawford, 2010) is one of the assays for characterizing open segments of the
genome. It is based on preferential cleavage of the accessible DNA compared to
the condensed region by a nuclease enzyme. DNaseI cuts the DNA in locations
where the DNA is open. Subsequently, DNaseI-digested fragments are collected, se-
quenced, and aligned to the reference genome. Quantifying the aligned sequencing
reads allows for accurate and high resolution profiling of active regulatory sites and
accessible DNA regions.
The DNaseI-Seq experiment provides more information beyond chromatin ac-
cessibility. Open chromatin regions frequently coincide with regulator occupancy.
Moreover, each protein has its own particular profile of protection in the DNaseI-
Seq experiment, and is reflected as small dips in the peaks. This enables elucidation






The essence of most machine learning algorithms is optimization where, the goal
is to optimize an objective function with respect to some constraints. There is an
intricate interplay between optimization and machine learning. In the age of big
data, scalability of learning algorithms are of paramount importance and, hence,
there is a demand for constant design and efficient implementation of optimization
algorithms. There are two main lines of research in this area (Bennett and Parrado-
Hernández, 2006). The first is to design or extend current optimization algorithms
for solving new learning models. The second is to solve existing machine learning
algorithms more efficiently by exploiting learning model structure. Moreover, ma-
chine learning and optimization communities have different quality criteria of good
optimization algorithms (Bennett and Parrado-Hernández, 2006). In the machine
learning community, generalization, scalability, and fast convergence to the approx-
imate solution of the model are the main factors. However, in the optimization com-
munity, accuracy of the solution, speed ,and numerical stability are the characteris-
tics of good algorithms.
For the methods developed in this thesis, we make use of ideas and concepts from
convex optimization. In this chapter, we review basic concepts of optimization based
on (Boyd and Vandenberghe, 2004).




subject to gi(x) ≤ bi, i = 1, . . . , m,
(3.1)
where the x ∈ Rd is the decision variable or optimization variable of the program.
f : Rd 7→ R is the objective function, gi : Rd 7→ R, i = 1, ...m are the constraints,
and b1, ..., bm are bounds of the constraints. The goal is to find x, which minimize
f (x) while satisfying the constraints. In other words, the optimum solution, x∗,
minimizes the function among all other feasible solutions to the program. The sim-
plest interpretation of Eq.3.1 is that x represents a decision or action, and constraints
impose limits on the actions.
Optimization arises everywhere, but the challenge is that most of the optimization
problems are intractable, in other words, we can not solve them efficiently. For-
tunately, for a subclass of optimization problems, convex functions, efficient algo-
rithms and methods have been developed to solve them with polynomial complex-
ity. Convex optimization has broad applicability in different fields, for example,
machine learning, combinatorial optimization, finance, etc.
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3.1.1 Convexity
We start with the definition of convex set and convex function. A set C is convex if
any point in the set can be written as a convex combination of any other points in
the set, which means that for any θ ∈ [0, 1], they satisfy
θx + (1− θ)y ∈ C.
In other words, a set is convex if any line segments that connect any pairs of points
in the set lies in the set C (Figure 3.1). In convex function, both the objective and the
FIGURE 3.1: Simple convex and non-convex sets. Left. The round shaped which
includes its boundary is a convex set. Right. The kidney-shaped set is not a convex
set since a line segment that connects two points lies outside of the set.
constraint functions are convex. This means that, they satisfy the inequality:
f (θx + (1− θ)y) ≤ θ f (x) + (1− θ) f (y),
for all x, y ∈ Rd and for all scalars θ ∈ [0, 1]. A simple geometric interpretation of
this inequality is that a line segment between (x, f (x)) and (y, f (y) must entirely lie
above (or on) the graph of the function f (Figure 3.2). Reformulating problems as
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property of convex functions is that every local minimum is the global opti-
mum. In general, convex problems are easily tractable both theoretically and
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FIGURE 3.2: Graph of a convex function. A line segment α f (x) + (1− α) f (y) al-
ways lies above the function value f (αx + (1− α)y).
convex optimization not only makes them attractive from the theoretical perspective
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but also makes them actionable, which means we can solve them numerically.
Quadratic programs (QP) are one of the common optimization problem in ma-
chine learning. They consist of a quadratic objective and linear constraint. QPs play
a central role in regularized risk minimization in machine learning. A QP can be





xTPx + qT + r
subject to Gx ≤ h
Ax = b,
where P ∈ Sn+ is in the cone of positive semi definite matrices , G ∈ Rm×n, and
A ∈ Rp×n.
In QP, we minimize a quadratic function over polyhedron, where the intersection of
QP constraints forms a polyhedron (Figure 3.3).
nodes that have a high influence on the network. For example, in the context
of social media can help us to find good broadcasters.
Beside of looking at the degree centrality, sometimes it is important to pin-
point the nodes controls most of the information flow in the network. In other
word, we want to identify which nodes act as bridge between other nodes in the
network. Betweennes centrally capture this idea.
Definition 7. (betweenness centrality) Let G = (V, E) be an undirected graph.






where  st is the total number of shortest path between node s and t and  st( )
is the number of shortest path goes through node  
Betweenness centrality is very useful to analyze communication dynamics in
the network. For example, it can help us to identify nodes that control collab-
oration between clusters in the network.
Eigenvector centrality idea first proposed by Philip Bonacich [3] and states
that centrality value of a node is directly depends on the centrality value of the
connected neighbors.
Definition 8. (eigenvector centrality) Given a strongly connected graph G =
(V, E) and A the adjacency matrix for G. The eigen vector centrality correspond
to the eignevector Ceiv of the largest eigenvalue  max of following equation
 Ceiv = ACeiv
In order to make the eigenvector centralies non-negative, we can select the
eigen-vector correspond to principal component A high eigenvector value for
n de  i means that, it is connected to many nodes who themselves are connected
to many others. Hence, this centrality measure takes into account the direct
and indirect interactions between the nodes. This centrality score are very
well suited for understanding the information propagation in the network. We
encourage reader to read about centrality measure at [15]
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FIGURE 3.3: A quadratic program with two variables. The dashed curves represent
contour lines of the objective function. The polyhedron defines the feasible solution
region. The optimum value of the objective function is obtained at point x∗.
3.1.2 Optimality condition for contrained convex functions




where f : Rd → R is a convex objective function and twice continuously differen-
tiable. A necessary and sufficient condition for x∗ to be the mimimizer of f is:
∇ f (x∗) = 0. (3.3)
Optimizing equation (3.2) is the same as finding the solution of (3.3). Except for a
few cases where we can find the solution of (3.3) analytically, usually, the problem
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must be solved by an iterative algorithm.




subject to gi(x) ≤ bi, i = 1, . . . , m.
We can convert it into an unconstrained convex problem by writing its associated
Lagrangian function as follows:





The non-negative weight λi > 0 is the Lagrangian multiplier, and it imposes a
penalty whenever constraints gi(x) < 0 are violated. Roughly speaking, Lagrangian
provides us with a tool to solve constrained optimization problems by reducing
them to an unconstrained optimization problem. According to the theory of La-
grangian duality, there exist an optimal vector λ∗ such that the optimum value of f
is a vector that minimizes the Lagrangian function of f . More specifically,
f ∗ = minimize
x∈R
L(x; λ∗)). (3.5)
To this end, any minimizer of equation (3.1) not only should satisfy the constraints
but should also be a zero gradient of Lagrangian, and hence, it should satisfy the
equation





3.1.3 Non-smooth functions and subgradients
Many interesting problems that occur in machine learning and statistics are con-
vex but non-smooth and, hence, nondifferentiable. For example, `1-norm is convex
but nondifferentiable at any point where at least one of the variables are zero. For
this class of problems, the optimality conditions that we described for differentiable
functions are not directly applicable. However, we can generalize the notion of the
gradient to a non-differentiable function using a subgradient.
Definition 1. (Subgradients). Given a convex function f : Rd 7→ R and a vector β ∈ Rd
, the subdifferential of f at β is defined as :
∂ f (β) := {z ∈ Rd| f (β) + zT(β́− β) ≤ f (β) f or all vectors β́ ∈ Rd}. (3.7)
Each element of ∂ f (β) is a subgradient of g at β.
A geomeric interpration of Eq. 3.7 is that any subgradient z in ∂g(β) defines a
linear function β́ 7→ f (β) +T (β́− β), which is tangent to the graph of f (Figure 3.4).
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Subdiferentials are very useful for studying non-smooth convex functions because
of the following property.
Proposition 1 (Subgradients at Optimality). For any convex function f : Rd 7→ R, a
point β ∈ Rd is a global minimum of f if and only if the condition 0 ∈ ∂ f (β) holds.
This concept is mainly useful for nonsmooth functions. When f is differentiable,
then 0 ∈ ∂ f (β) reduces to first order optimality condition ∇ f (β) = 0.Gradient and sub-gradient of smooth and non-smooth function
nodes that have a high influence on the network. For example, in the context
of social media can help us to find good broadcasters.
Beside of looking at the degree centrality, sometimes it is important to pin-
point the nodes controls most of the information flow in the network. In other
word, we want to identify which nodes act as bridge between other nodes in the
network. Betweennes centrally capture this idea.
Definition 7. (betweenness centrality) Let G = (V, E) be an undirected graph.
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Betweenness centrality is very useful to analyze communication dynamics in
the network. For example, it can help us to identify nodes that control collab-
oration between clusters in the network.
Eigenvector centrality idea first proposed by Philip Bonacich [3] and states
that centrality value of a node is directly depends on the centrality value of the
connected neighbors.
Definition 8. (eigenvector centrality) Given a strongly connected graph G =
(V, E) and A the adjacency matrix for G. The eigen vector centrality correspond
to the eignevector Ceiv of the largest eigenvalue  max of following equation
 Ceiv = ACeiv
In order to make the eigenvector centralies non-negative, we can select the
eigen-vector correspond to principal component A high eigenvector value for
node  i means that, it is connected to many nodes who themselves are connected
to many others. Hence, this centrality measure takes into account the direct
and indirect interactions between the nodes. This centrality score are very
well suited for understanding the information propagation in the network. We
encourage reader to read about centrality measure at [15]
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FIGURE 3.4: (a) Red curve represents the non-smooth convex function that is not
differentialble at point β∗. Blue linear functions represent subgradients of the func-
tion f at point β∗. (b) Red curve represents smooth function and linear function f
represents the gradient of f at point β∗.
3.1.4 Descent methods
Algorithms for solving convex functions can be categorized into two classes, namely
first order methods and second order methods. A first order method is any numerical
algorithm that requires the first gradient of the objective function. A second or-
der method beyond of using first gradient information also leverage second gra-
dient (Hessian) of the function. Hessian matrix provides information regarding
the curvature of the function, but computing Hessian can be computationally pro-
hibitive for large scale problems. For this reason, first order methods have become
very popular in machine learning, since they only use gradient information; hence,
they are scalable to large scale problems.
We have briefly reviewed optimality conditions for different types of convex func-
tions. Now, we briefly review basic principles for two first order methods, gradient
descent and proximal gradient descent, for solving convex functions.
Gradient descent algorithms solve an unconstrained objective function with pro-
ducing a minimizing sequence of {βt}∞t=1 via the update
βt+1 = βt − st∇ f (βt) f or t = 0, 1, 2, . . . , (3.8)
where st > 0 is the step size. Intuitively, by computing the gradient, we choose the
direction of steepest descent − f (β), and we descend in this direction for a certain
24 Chapter 3. Computational background
amount determined by st. A gradient descent algorithm is granted to converge to a
local minimum with a rate of O( 1k ), where the k is the number of iterations. Since
for convex functions, all local minima are a global minimum, convergence to global
minimum is granted. Nevertheless, several extensions improve the convergence rate
of the gradient descent (Qian, 1999; Kim and Fessler, 2016; Nesterov, 1983). In 1986,
Yurii Nesterov developed an accelerated gradient descent that improves the conver-
gence rate of gradient descent toO( 1k2 ) (Nesterov, 1983). Moreover, gradient descent
has been tailored to solve certain constrained optimization problems as well (Cala-
mai and Moré, 1987). Gradient descent is easily applicable to differentiable func-
tions, but it get ill-posed when it encountered with non-smooth function.
Proximal gradient descent Gradient descent is a widely used algorithm for smooth
convex optimization but is limited when it comes to non-smooth convex functions.
Many interesting problems in machine learning translate into non-smooth convex
functions. We often deal with these non-smooth functions as regularizers in ma-
chine learning, statistics, signal processing, etc. Now we review an algorithm, proxi-
mal gradient descent, that extends the ability of gradient descent to solve a subclass of
non-smooth convex functions for large scale problems.
Proximal methods (forward-backward splitting methods) are a class of algorithms
that uses the proximal operators of objective terms for solving a convex optimization
problem.
We first define a basic element of proximal algorithms. Proximal operator of a func-






||u− w||22 + µg(w). (3.9)
It compromises between minimizing g(w) and being close to point u , and µ controls
a trade-off between these terms. For this reason, proxg(w) : is called a proximal point
of u with respect to function g. Under some assumptions (Parikh and Boyd, 2014),
the proximal operator of function g can be viewed as a gradient step for g
Prox(u) = v−∇g(v). (3.10)
We now consider minimizing a non-smooth convex function `(x), which we can
decompose into a sum of two functions:
minimize f (x) + Ω(x), (3.11)
where the f is smooth and differentiable with Lipschitz-continuous gradient, and
Ω(x) is non-smooth and non-differentiable, for example an `1-norm. This decompo-
sition may not be unique, and different decomposition can lead to a different imple-
mentation of the proximal gradient descent for the `(x).
Proximal gradient descent defined as
xk+1 := ProxkλΩ(x
k − λk∇ f (xk)), (3.12)
where the k is the k-ith iteration of the algorithm. If we look carefully at equa-
tion 3.12, we realize that the proximal gradient descent algorithm consists of two
main steps. First, xk − λk∇ f (xk) is a computing gradient descent step k on f (x),
and the second step is to evaluate the proximal operator of the Ω(x) on the solution
that we get from the gradient descent step of f (x). These two steps iterate until the
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algorithm converges.
Proximal algorithms generalize the notion of projecting a point into convex sets and
are somewhat related to projected gradient descent algorithms. Generally, finding
a proximal operator for the non-smooth part is equivalent to solving another opti-
mization problem, but it turns out that, the proximal operator for many interesting
problems, often accepts a closed formula solution or can be solved quickly with stan-
dard approaches. Proximal algorithms are practical when all the relevant proximal
operators can be computed efficiently. Proximal methods are very suitable for solv-
ing non-smooth convex functions because of their convergence rate and their ability
to deal with large-scale non-smooth functions. There are several extensions of prox-
imal gradient descent that improve the convergence rate. For example, when it is
coupled with Nesterov’s acceleration method, we can achieve a convergence rate of
O( 1k2 ). Moreover, since it allows a warm start, we can solve the objective function
along the entire regularization path.
3.2 Supervised learning
Now we move on to introduce the basics of learning from data. We are given a
sample of observations T = (Xi, Yi)ni=1, coming from unknown probability measure
P(x, y). Also, we assume that data points are i.i.d, that means that they are drawn
independently and identically distributed. Xi is the input feature vector, and Yi is
the output variable. Our goal is to learn a function fn : X 7→ Y from a function class
F = { f | f : X 7→ Y}, such that a specific objective function is minimized. More
specifically, we assume that there is a function f which maps the input features to
the output variable as follow:
y = f (x) + ε, (3.13)
where ε is an irreducible error and may contain unmeasurable variables that contain
information about the output variable. However, the true underlying function is un-
known, and our goal is to learn f from training data. More specifically, we want to
fit a model to training data and make a prediction as accurate as possible on unseen
data that comes from the same unknown probability distribution. In other words,
given training data and a loss function L(Y, f (X), we want to learn a function f which
is as close to the optimum function f ∗ as possible. The term “closeness” is defined
as the difference between the risk of the function f and the smallest possible risk.
Below, we discuss two frameworks for learning where almost all (semi) supervised
learning algorithms can be formulated in one of these frameworks. This formula-
tion creates a unified point of view on supervised learning algorithms, where the
resulting learning algorithms has three main components: the loss function, the reg-
ularizer, and the employed function class.
3.2.1 Risk minimization
Recall that our goal is to select a function from a class of functions that, given a new
input feature vector Xi, it best approximates the corresponding yi value under the
assumption that the data comes from the same but unknown underlying distribu-
tion. This raises an important question as to how we should select our function.
Essentially, the task of finding the “best” prediction function boils down to the task
of finding a function that minimizes the “expected risk” or “generalization error” as
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follows:
R( f ) = E[L( f (x), y)] =
∫
L( f (x), y)dP(x, y). (3.14)
The loss function, L(y, f (x)), quantifies the discrepancy between prediction output
f (x) and true output y. The expected risk measures the expectation of loss concern-
ing an infinite number of samples drawn from distribution P(x, y).
Empirical risk minimization Unfortunately, in the real world, we almost never
have the true probability distribution, P(x, y). This makes it difficult (almost impos-
sible) to compute the true value of the risk for a given loss function. Instead, we
try to approximate P(x,y) using a given finite sample D, called training data. We as-
sume to have i.i.d sample (Xi, Yi)ni=1 input/output pairs drawn from data generating
probability p(x, y). The empirical loss is defined as






L(Yi, f (xi)). (3.15)
Given a function class F , emprical risk minimization is defined as
Remp( f ) = min
f∈F






L(Yi, f (Xi)). (3.16)
The most often used loss function for regression is square loss. Given a function
class F , the optimization problem for the empirical risk minimization is defined as:







(Yi − f (Xi))2. (3.17)
The standard function class F for linear regression is defined as
F = { f (x) = 〈 β, X〉| β ∈ Rd}. (3.18)
If we choose a large functional class F , we might get a very small empirical risk
value. Necessarily, this does not mean that we have found a function f that will per-
form well on the unseen data. This means that we might overfit the data. For this
reason, empirical risk underestimates the true risk, i.e., Remp ≤ R generally holds.
Regularized empirical risk minimization (RERM) The main problem of empir-
ical risk minimization is that it is more likely to overfit the data. There are two main
strategies to overcome overfitting. The first solution is to restrict ourselves to a small
function class F , e.g., linear functions. But this creates another problem called un-
derfitting, meaning that if the true underlying function is more complex than what
our function class can model, we are always far from the best possible solution, irre-
spective of the size of the training data.
The other solution is to use regularization while allowing to have a large functional
class. A regularization functional captures the complexity of the function. Hence,
adding a regularization functional to the objective function of optimization prob-
lems creates a trade-off between fitting data and the complexity of the function. This
form of regularization was developed by Tikhonov and is known as Tikhonov reg-
ularization.
Definition 2. Given a training sample (Xi, Yi)ni=1, a loss function L(Y, f (X)), a class of
functions F , and the regularization functional Ω : F 7→ R+, the regularized empirical
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L(Yi, f (Xi)) + λΩ( f ). (3.19)
Another advantage of adding a regularization functional to the objective func-
tion of optimization problem is that it makes the problem often easy to optimize,
since it makes the problem well posed. This regularization term is also connected to
the concept of bias-variance trade-off in statistical learning (Geman, Bienenstock, and
Doursat, 1992). Shortly, regularization leads to a biased estimator, while unbiased
estimator might suffer from high variance and, hence, poor generalization. Cur-








FIGURE 3.5: Behaviour of error for supervised learning models depending on the
model’s complexity. The training error shows a monotonic decrease with respect to
the complexity of the model due to ability of the model to better model the training
data. This can have a destructive effect on the test error, as the model shows poor
generalization performance on unseen data.
The Bias-Variance Trade-Off The empirical solution βn that we get by optimizing a
RERM optimization function is an approximation to the optimal weight vector β∗.
This approximation depends on the training sample (Xi, Yi)ni=1 size n; hence, it can
be random. Since our samples are i.i.d and come from same but unknown probabil-
ity distribution P(x, y), this raises two important questions about an estimator.
The first question is, if we compute βn over all possible training samples size n, does
E[βn] = β∗? This is called bias and it is the systematic error we make when we do
approximate the true underlying function.
The second question is, how much βn will fluctuate around its expected value over
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all possible training samples of size n? This quantity is called variance. If an estima-
tor has high variance, then small changes in the training data sets can lead to large
changes in f .
It turns out that we can decompose the expected loss into
E[R( fn)] = Var( fn(x)) + (Bias( fn(x)))2. (3.20)
There is an interesting interplay between bias-variance decomposition and overfitting-
underfitting ( Figure 3.5). If we choose to have large a function class F , it is more
likely that our bias will be close to zero; however, the variance of our estimator will
be large, since we need a large amount of data to learn the large model. On the
other hand, if we choose a very small function class F , we will have a large bias,
because the model cannot fit well to the data (i.e., true underlying data generating
models may be extremely complicated), but this will lead to low variance, since the
fitted function does not vary much given different training data sets. Eq. (3.20) tells
us that in order to minimize an expected test error, we need to have an optimum
trade-off between the bias and variance of our model.
3.2.2 Regularized linear regression
Regularized linear regression is a very simple, yet powerful, class of methods for
learning model p(yi|xi). In high dimentional regression problems, our goal is to
predict the output variable y from input vector x ∈ Rp. This allows us to estimate
parameters describing the dependence of output variable yi on input features xi.
Regularization enforces a preference over regression parameters, which can help us
to address the issue of bias-variance trade-off, especially in very high dimensional
data.
Given training sample (xi, yi)ni=1, the lq regularized estimator can be obtained by







`(yi, f (xi)) + Ω(β), (3.21)
where the loss ` : Rp 7→ R is assumed to be a smooth convex function with Lipschitz
continuous gradient, and the regularizer Ω(β) is convex, typically non-smooth and
non-Euclidean norm.
A typical example of loss function for linear regression is squared loss.
`(yi, f (xi)) = (yi − βTxi)2, (3.22)
where parameters β j describe magnitude and direction of jth feature on the target
variable y.
Regularization not only addresses the issue of bias-variance trade-off but also is one
of the practical frameworks to impose prior knowledge on the support of the pre-
dictor. For this reason, design and application of different sparsity-inducing norms
is an active research field.
3.2.3 Sparsity inducing norms
The principle of parsimony, which states that the most straightforward description
of a given phenomenon should be favored over more complicated ones, is central to
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different fields of science. In the context of learning, this translates into feature se-
lection which has two main implications. First, make the model more interpretable
or computationally efficient to use, even if the true underlying model is not sparse.
Second, sparsity can be viewed as prior knowledge that our model should be sparse.
We can achieve parsimony in a linear model by penalizing the empirical risk mini-
mization or log-likelihood function by the size of the non-zero entries of the coeffi-
cient vector. However, reducing parsimony to the problem of learning a model with
the lowest cardinality turns out to be insufficient and hence, structured parsimony
has been emerged as an extension of it (Jenatton, Obozinski, and Bach, 2010; Jacob,
Obozinski, and Vert, 2009).
Sparsity through `1 norm
In the last decade, numerous approaches have been developed to study `1 penalized
regression from a theoretical perspective to efficient implementation (Zhao and Yu,
2006; Wainwright, 2009; Bickel, Ritov, and Tsybakov, 2009). When we know a pri-
ori that the optimum solution β∗ for Eq. (3.21) should have a few non-zero entries,
then `1 norm, i.e., Ω(β) = ∑
p
i=1 |βi| norm, is typical choice for Ω(β). Depending
on the loss function, this penalization can lead to lasso (Tibshirani, 1996) or basis
pursuit (Chen, Donoho, and Saunders, 2001). Regularization with `1 norm leads to
a sparse solution meaning that, depending on the value of the regularizer, a number
of coefficients β∗ will be exactly equal to zero.
Elastic net
However standard Lasso penalty is a simple yet powerful regularizer for sparse
learning, but it comes with limitations. For the case of high dimensional data p n,
it selects at most n variables before it saturates. Moreover, if there are any struc-
tured patterns in the input features (group structure or correlated variables), Lasso
tends to be somewhat indifferent in selecting among a set of strong structured fea-
tures. One of the ways to overcome this problem is to use a convex combination of `1
with `2 norms (Zou and Hastie, 2005). Adding the quadratic term to the regularizer
makes the elastic net strictly convex, hence leading to a unique solution. The elastic
net regularization function is defined as:
Ω(β) := λ(α||β||1 + (1− α)||β||22). (3.23)
The ||.||2 encourages highly correlated features to shrink toward each other, while
the `1-norm induce a sparse solution over the coefficients of the shrunken features.
The elastic net regularizer make the trade-off between these two effects. The elastic
net penalty can be used with any loss function in the context of regression and clas-
sification.
Sparsity through `1/`q-norms
The standard `1 penalty does not assume any structure or dependencies between
input features, which limits its applicability to structured high dimensional data in
many real-world problems. In many situations, input features can be partitioned
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into groups of variables. This is typical when we are working with categorical vari-
ables, or we do have prior knowledge of group structures. It is desirable to simul-
taneously include or exclude all the variables forming a group. One can incorpo-
rate structured sparsity constraints by designing and applying a more complicated
sparsity-inducing penalty that induces a joint sparsity pattern over related groups.
It has been shown that regularization norms that explicitly exploit group struc-
tures improve the generalization performance and(or) interpretability of the models
(Huang and Zhang, 2010; Lounici et al., 2009; Obozinski, Taskar, and Jordan, 2010).




where G is the partition of features 1, ..., p, wg is the group specific weight, and βg ∈
R|g| denotes the coefficients of the features indexed by g in G. As defined in Eq.(3.24),
Ω behaves like an `1-norm at group level (||βg||2)g∈G in R|G|, and hence, Ω induces
group sparsity. In other words, each group βg, is encouraged to be set to zero by `1
penalization, but combined with the `2-norm, the mixed `1/`2-norm plays the role of
simultaneously setting all the weights within each group to zero or non-zero values.
More specifically, if estimated ||βg||2 6= 0, then all the β j for j ∈ g will be non-zero.
Hence the `1/`2-norm induces sparsity at group level, not within group sparsity. To
achieve within group sparsity in the context of mixed `1/`2-nrom, Friedman et al.
proposed to use additional `1 norm with Ω(β), which is known as the sparse group
lasso penalty (Friedman, Hastie, and Tibshirani, 2010b) and is defined as
Ω(β) := ||β||1 + ∑
g∈G
wg||βg||2. (3.25)
In practice, the `1/`2 and `1/`∞-norm is used. The grouped `1-norm is usually
used when we have the group structures as prior knowledge in multi-task learn-
ing (Obozinski, Taskar, and Jordan, 2010) and for multiple kernel learning (Xu et al.,
2010).
3.2.4 A geometrical intuition for the sparsity-inducing properties
We have described how we could use different structured sparsity-inducing norms
to incorporate our prior knowledge and learn a rich set of models with good gen-
eralization performance. The main question that arises here is how the geometry of
the regularizer is directly related to the minimizer β∗ of empirical regularized risk
minimization.
The regularized formulation that we considered in Eq. (3.21) is the Lagrangian re-
laxation of the following constrained optimization problem:
min
β∈Rp
`(β) such that Ω(β) ≤ µ, (3.26)
for some R+ . Under some weak assumption on the f (β) and Ω, from the La-
grangian multiplier theory, we can show that constrained formulation (Eq. 3.26) of
the regularized risk regression (Eq. 3.21) is equivalent to each other for µ > 0. This
means that the set of solutions for these two formulations is equivalent for different
values of µ and λ; however, there is no direct mapping between the corresponding
value of λ and µ (Borwein and Lewis, 2010). In machine learning, the Lagrangian
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form is preferred, since the solution is more robust to small changes in λ.
Now we focus on the constrained form of the `(β) to describe the behavior of the
sparsity-inducing norms.
The constraint Ω(β) < µ defines the set of feasible solutions B = {β ∈ Rd; Ω(β) ≤
µ}. At the optimum point, the gradient of f at any solution β to Equation 3.26 be-
longs to the normal cone of B. This means that the level set of f (β) is tangent to B.
Hence, depending on the Ω(β), the shape of the constraint will be different, and as
a consequence, the geometry of the Ω(β) is directly related to the properties of the
solution. For example, if Ω = ||.||2, then the resulting constraint will be a round ball
that does not prefer any specific direction in the model parameters space. On the
other hand, when Ω is taken to be `1-norm, then B is anisotropic (diamond shape
pattern in two dimensions), and due to the non-smoothness, it will present some
singular point on its surface. Furthermore, these non-smooth points are aligned in
the direction of the features axis, and hence if the level set of the objective function
`(β) happens to be the tangent to one of these singular points, it will lead to the
sparse solution (Figure 3.6).
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FIGURE 3.6: Geometry of different sparsity inducing norms. (a) shows the smooth
`2-norm ball. (b) `1-nrom. Singular points are not differentiable and usually are in
the direction of features axis, hence induce sparsity. (c) `1/`2 norm. This figure is
reproduced from (Bach et al., 2012)
3.2.5 Multi-task learning
The common practice in machine learning is to learn one task/model each time.
This methodology is sometimes sub-optimal because it does not leverage the rich
domain-specific source of information available in the training data of related tasks.
Multi-task learning is an approach in machine learning to simultaneously learn a
group of related tasks, partly using a shared representation. This creates a frame-
work to effectively transfer the information between related tasks by increasing the
amo t of data available per parameter and, hence, reduces the overfitting and im-
proves the generalization.
This is especially important in the context of constructi a biologic l r gulatory
network from high-throughput data because the n mber of the parameters to learn
is relatively way higher than the number of samples. Moreover, our model needs
to be rich enough to capture the considerable complexity of biological mechanisms,
which in turn requires reasonably sized training data. Hence, extensive data from
one task may be able to compensate for the sparse noisy data in other related tasks.
Many problems in computational biology can be formulated as multi-task learning
problems (Qi et al., 2010). Different tasks might correspond to different cell lines,
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tissues, pathways, or tumor subtypes (Widmer and Rätsch, 2012).
Recall that the regularized estimator for a single model is defined as
f (β) = `(y, 〈β j, X〉) + Ω(β). (3.27)
In multi-task learning, we are interested in simultaneously learning multiple models
parameterized by β1, . . . , βM, where the M is the number of tasks. We can easily
extend the single task learning formulation (Eq.3.27) to a multi-task formulation by
adding additional regularization terms that couple the model parameters as follows:








Ω(β j) + ΩMTL(β1, . . . , βM). (3.28)
The objective function for MTL (Eq.3.28) combines two main interrelated goals.
First, like other single task learning algorithms, the first term in Eq. 3.28 mini-
mizes the loss function for each task independently, while at the same time regu-
larizing each task’s parameters by Ω(β) avoids overfitting. Second, the regularizer
ΩMTL(β1, . . . , βM) shares the parameters across the tasks such that final parameters
are similar to each other (Evgeniou, Micchelli, and Pontil, 2005).
3.2.6 Cross-validation
One of the fundamental tasks in machine learning is model selection, and the bottom
line in model selection is generalization performance. In other words, the selected
model should have a low test error rate. We can compute the test error if designated
test data is available, which is usually not the case. In the absence of a large amount
of test datasets to estimate the test error rate, a number of algorithms have been de-
veloped to estimate it using training data.
Cross validation (Golub, Heath, and Wahba, 1979; Stone, 1974) is generally the
preferable method for approximating test error. In k-fold cross-validation, train-
ing data is randomly partitioned into k-disjoint subsets. In the ith cross-validation
fold, the ith subset is used to compute prediction performance, while the rest of k− 1
are used for training the model. The expectation of generalization performance in
k folds used as an approximation of the test error rate. One needs to be careful in
applying model selection approaches for tuning hyperparameters. Cawley et al. have
shown that hyperparameter selection via cross-validation is prone to over-fitting in
model-selection. Hence, in order to obtain an unbiased estimate of generalization per-
formance, more rigorous procedures like nested-cross validation are needed (Stone,
1974).
3.3 Gene expression modeling and regulatory network infer-
ence
A regulatory network describes the connections between regulators and their tar-
get genes. These networks are an abstraction of condition-specific gene regulation.
Inferring a condition-specific regulatory network is important because of their rel-
evance to cell identity, diseases, and development. Regulatory networks are often
represented as a directed graph, in which nodes represents regulators (TFs, miRNAs,
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RBPs, signaling proteins, and chromatin remodelers) and their targets. The edges
represent directed regulatory relationship between regulator and the target. The ex-
pression level of the target gene is the function of all the regulators that binds, the
activity level of regulators, as well as cis-regulatory elements features. The activity
of the regulator depends on its abundance, location, and possible post-translational
modifications of the regulator. The regulatory relationship can be direct or indirect.
For example, a miRNA can target a TF, which can regulate gene on the transcrip-
tional level. A regulatory network model has two main aspects: (I) structure or
topology of the network, which represents the regulators of a target gene, and (II)
the logic or regulatory function, which describes how combinations of different reg-
ulators specify a gene expression of targets. At a high level, methods for inferring
regulatory networks can be divided into (I) Experimental, and (II) Computational
approaches.
Experimental methods for inferring regulatory networks
The most widely used experimental approach for determining the transcriptional
regulatory network is ChIP-Seq and ChIP-chip technology. This measures the genome-
wide occupancy of a particular regulator. The main limitation of this technology is
the need for a TF-specific antibody. Another approach is to knock-out a specific
regulator and infer targets by measuring changes in gene expression. The limi-
tation of this approach is its inability to discern direct vs. indirect target of the
regulator. A more recent approach is the combination of chromatin accessibility
assays (ATAC/DNaseI-seq, etc.) with TF binding site models such as a position
weight matrix (PWM) to infer the genome-wide binding of the regulator. Over-
all the experimental approaches are accurate, expensive, time consuming, and less
high-throughput.
Computational methods for inferring regulatory network
Here, we briefly review computational methods for both inferring regulatory net-
work structure and regulatory functions.
Correlation-based approaches: Correlation is the most straightforward measure
for quantifying the degree of co-expression for two genes, such as Pearson or rank-
based correlation. The underlying assumption of correlation networks is that similar
regulators might regulate genes with similar expression pattern in different samples.
This idea led to the development of the concept of weighted gene coexpression net-
work analysis (WGCNA) (Zhang and Horvath, 2005), which has been widely used
and adapted. Correlation based-methods come with limitations however. First, they
do not have expression predictive power. Second, they are limited to discern the
indirect association from indirect association between a pair of genes, which can
lead to false positive associations. Partial correlation networks offer an alternative to
remove the indirect effects by other genes (Schäfer and Strimmer, 2004; Friedman,
Hastie, and Tibshirani, 2008).
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Information theory-based approaches: Another class of methods used to quan-
tify the dependency between two variables is mutual information. Mutual infor-
mation overcomes the limitation of correlation-based approaches in capturing non-
linear dependencies between two variables. In the context of gene regulatory net-
works, the use of mutual information is refered as relevance networks (Butte and Ko-
hane, 1999) which are widely used (Meyer et al., 2007).
Regression-based methods: The central idea behind this class of approaches is
to formulate a regression problem, where information of the regulators is used to
regress gene expression. The regression weight vector describes the direction and
magnitude of the regulation between the gene and the respective regulators. This
idea is the basis of several successful methods for network reconstruction (Haury
et al., 2012; Lebre et al., 2010; Irrthum, Wehenkel, and Geurts, 2010). The regression-
based methods are scalable and have predictive power of gene expression. Fur-
thermore, they can capture higher-order interactions between different regulators.
Moreover, one can incorporate different priors regarding the target genes or regula-
tors using various sparsity inducing norms.
Furthermore, several other methods including Markov networks, factor graphs,
and Bayesian networks are powerful paradigms for network inference. The readers
are referred to (Wang and Huang, 2014; Sanguinetti, 2019) for comprehensives re-
views of these methods.
The DREAM consortium (Marbach et al., 2012) assessed more than 35 different
gene regulatory network inference algorithms, which covered all commonly used
regulatory network inference algorithms in the field. However although most of the
methods showed a performance better than random on simulated and E.coli gene
expression data, overall the performance of these algorithms dropped significantly
for eukaryotic organisms, such as yeast. This implies that expression data alone is
not enough to infer a high quality regulatory network. One trend is to include aux-
iliary data sets, which are informative of the regulatory relationship between the
regulator and the target gene. All expression based network inference algorithm can
be categorized into per gene methods and per module methods.
Per gene methods consider genes as a random variable and estimate its regulators.
The main advantage of per gene methods is the ability to reason at the level of in-
dividual genes. On the other hand, module-based methods group genes based on
their co-expression pattern and they are learning the regulators for each module.
Since module-based methods summarize information at the level of each module,
they are more interpretable, but provide an approximation of the regulatory pro-
gram for each gene. A more recent effort by (Roy et al., 2013; Koch et al., 2017)
combines these two paradigms.
3.4 Network analysis
Here we describe some of the basic network analysis methods used in this thesis to
identify important regulators.
Definitions
Definition 3. (Graph). A graph G = (V, E) comprises an arbitrary, finite set of vertices
V(also called nodes) and set of edges E ⊆ V × V where each edge is assigned into two
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vertices. A graph G is undirected if there is no direction on the edges, i.e., for each edge
(υ, ν) ∈ E also (ν, υ) ∈ E holds.
Definition 4. (In- and out-degree). Given a graph G = (V, E), the in-degree d−υ of a node
υ is the number of the head ends to υ. Conversely, the out-degree d+υ of υ is the number of
the tail ends to υ.
In order to use the network to find the important nodes or edges based on their
connectivity patterns relative to the neighbors, we can use network centrality indices.
Centrality indices represent the relative importance of the nodes or edges by assign-
ing a real number to them concerning network characteristics. Depending on the
type of network, we can describe what importance means. Centrality indices can be
categorized into local and global centrality matrices. Local centrality indices, like de-
gree centrality, only consider the direct neighbor of the node of interest, whereas
global centrality measure (eigenvector centrality, page rank) take into account the
whole network (direct and indirect connections).
The simplest centrality measure is degree centrality, which is defined as follows:
Definition 5. (degree centrality). Given an undirected graph G = (V, E), the degree cen-
trality is defined as:
Cdeg(υ) := |{e | e ∈ E ∧ υ ∈ e}|.
Degree centrality counts the numbers of edges that are directly connected to each
node. For directed networks, we can extend the degree centrality definition for in-
degree and out-degree centrality. Degree centrality has been successfully applied to
identify essential proteins or genes for the survival of the organism in different bio-
logical networks (Jeong et al., 2001; Hahn and Kern, 2004; Bergmann, Ihmels, and
Barkai, 2003).
The eigenvector centrality idea, first proposed by Philip Bonacich (Bonacich, 1972),
states that the centrality value of a node directly depends on the centrality value of
the connected neighbors.
Definition 6. (eigenvector centrality) Given a strongly connected graph G = (V, E) and
A the adjacency matrix for G, the eigenvector centrality corresponds to the eignevector Ceiv
of the largest eigenvalue λmax of the following equation:
λCeiv = ACeiv.
In order to make the eigenvector centrality non-negative, we can select the eigen-
vector corresponding to principal component A high eigenvector value for node υi
means that it is connected to many nodes who themselves are connected to many
others. Hence, this centrality measure takes into account the direct and indirect
interactions between the nodes. This centrality score is very well suited for under-




Integrative analysis of miRNA and
protein-based post-transcriptional
regulation
This chapter presents an integrative analysis of transcriptome and miRNAome-dynamics
to elucidate the molecular function of IMP2, an RNA binding protein, and its con-
tribution to disease in the context of adult cellular metabolism. Our analysis shows
that IMP2 compete with miRNAs and alters the regulatory capacity of many miR-
NAs.
Contributions: I did the miRNA and IMP2 target prediction and the integra-
tive analysis of IMP2 and miRNA data. Moreover, I contributed to data analysis,
interpretation and writing of the manuscript. Finally, I supervised Pathmanaban
Ramasamy for miRNA expression quantification and differential expression analy-
sis. Marina Wierz prepared all sequence libraries and was involved in data inter-
pretation. Karl Nordström was involved in primary data generation. Sonja Kessler
prepared the mice and was invovled in data interpretation and paper writing. Mar-
tin Simon and Marcel Schulz were involved in data analysis and paper writing. The
content of this chapter has been published at the Molecular Basis of Disease jour-
nal (Dehghani Amirabad et al., 2018).
4.1 Introduction
The insulin-like growth factor (IGF) 2 mRNA binding protein 2 (IGF2BP2 or IMP2)
belongs to a conserved family of oncofetal proteins, which are usually expressed
dominantly during embryogenesis but are associated with cancer as well. Accord-
ing to their naming, this protein binds to the IGF2 mRNA, thus enhancing its trans-
lation efficiency (Dai et al., 2011). IGF2 itself has structural similarity to insulin thus
representing an important growth factor, whose overexpression was shown to be
associated with poor prognosis in several cancers [2]. Consequently, studying the
mechanisms of IMPs as a major control element for IGF2 and other genes may pro-
vide valuable insights into cancer development.
Although the naming of these IMPs implies specific binding to the IGF2 mRNA,
all IMP family members target many more transcripts (Bell et al., 2013) . Analyz-
ing IMP bound RNAs by PAR-CLIP revealed thousands of IMP2 targets in HEK
cells (Hafner et al., 2010) and glioblastoma cells (Degrauwe et al., 2016). However,
a clear picture of IMP targets in different cell types is missing as well as individual
regulatory mechanisms.
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Known IMP functions include effects on RNA stability, translational efficiency,
localization, and transport (Hansen et al., 2004; Runge et al., 2000; Nielsen et al.,
1999) by acting through three pairs of RNA-binding domains: RRM1–2, KH1–2, and
KH3–4. Furthermore, IMP2 was described to associate with other proteins, i.e. eIF-
4E, to initiate translation of its target RNAs (Bell et al., 2013). Interestingly, inter-
actions of IMP2 with other proteins independent of any RNA fate have been de-
scribed (Ren et al., 2015; Janiszewska et al., 2012).
An interesting mechanism linking miRNA function to IMPs was first shown in
colorectal cancer cell lines: the stabilizing effect of IMP1 to the BTRC mRNA was
absent in Dicer knockout cells (Noubissi et al., 2006). Elcheva et al. showed that
this is due to counteraction of IMP1 and miRNA-183 in the coding region of the
mRNA (Elcheva et al., 2009). In the same region TrCP1 mRNA associates only with
Ago2, which is the only slicing Argonaute in humans (Nielsen, Gloggnitzer, and
Martinez, 2009; Elcheva et al., 2009). More recently, another link between miRNAs
and IMPs was reported in glioblastoma cells, which express the let-7 miRNA family
apparently without inhibitory effect on their target genes, due to a transcriptome-
wide competition effect of IMP2 and let-7 miRNAs (Degrauwe et al., 2016). Inter-
estingly, IMP2 competition was not limited to let-7 targets, although these show the
highest fold changes in response to IMP2 overexpression. It remains to be discov-
ered to which extent such competition between miRNAs and IMPs contributes to
transcriptome-wide alterations and disease phenotypes in other systems and mod-
els. Enhanced CLIP suggested for instance that IMP2 binding sites are enriched in
3-UTRs of coding genes in pluripotent stem cells (Conway et al., 2016). However,
a complete omics point of view to mRNAs and miRNAs is missing for most IMP
models.
The IMP2 splice variant IGF2BP2-2/IMP2-2 (also called p62), was originally iden-
tified as an autoantigen overexpressed in hepatocellular carcinoma, HCC (Zhang
et al., 1999; Kessler et al., 2013; Kessler et al., 2015). IMP2-2 lacks exon 10 of the
IMP2 gene, which does not affect the six characteristic RNA binding motifs (Chris-
tiansen, Kolte, and Nielsen, 2009). Overexpression of IMP2-2 has been shown to
induce steatosis in mice (Tybl et al., 2011; Kessler et al., 2013; Laggai et al., 2014)
and to promote progression of non-alcoholic steatohepatitis (NASH) (Simon et al.,
2014). As IMP2-2 overexpression was also shown to promote hepatocarcinogene-
sis (Kessler et al., 2013; Kessler et al., 2015) the underlying molecular reasons for
steatosis and carcinogenesis remain unknown.
To get an insight into the molecular mechanisms of this important RNA bind-
ing protein, we follow the hypothesis, that IMP2 may not simply bind translated
transcripts but may moreover disturb miRNA function and thus RNA interference.
We therefore analyze IMP2-2 overexpressing mouse livers for their alterations in the
miRNAome and transcriptome. To allow for interpretation of functional associa-
tions, integrative analyses were carried out to compare the levels of miRNAs and
their targets in IMP2 and WT livers. The full transcriptome (mRNA and long non
coding RNA) in combination with the miRNAome of IMP2 induced steatosis gives





IMP2-2 transgenic mice were established as described by transgenic overexpression
of the specific IMP2-2 transcript variant (cDNA) (Tybl et al., 2011). Euthanization
of wild-type and IMP2-2 transgenic animals was carried out in week 5. Animal
procedures were in accordance with the local animal welfare committee. Mice were
kept with a 12h day/night rhythm and under stable humidity, temperature, and
food supply.
4.2.2 RNA extraction, cDNA library generation, and Illumina sequencing
Total RNA was isolated from snap frozen livers tissue by immediate lysis in TriReagent
(Sigma-Aldrich, Seelze, Germany). Because of the fatty composition of the tissue,
twice the amount of TriReagent was used. After additional purification with acid
phenol, the resulting RNA was additionally digested with DNAseI (Invitrogen, Karl-
sruhe, Germany) and again purified by acid phenol. After integrity check using the
Agilent Bioanalyzer 2100, directional cDNA libraries were prepared of poly-A en-
riched RNA using the NEB Next Poly(A) magnetic isolation module and the NEB-
Next Ultra directional RNA library Prep Kit using 10 PCR cycles. Small RNA li-
braries were prepared as described before (Götz et al., 2016) by extraction of small
RNAs (17˘30 nt) from denaturating PAGE and subsequent library preparation using
the NEB Next-small RNA library preparation Kit involving overnight ligation to the
3-preadenylated adapter and 5-monophosphate dependent 5-ligation. PCR amplifi-
cation was done using 10 PCR cycles and products were purified by gel extraction.
Sequencing was carried out on the Illumina HiSeq2500 using high output mode for
long RNA libraries (100 nt single end) and Rapid mode for miRNA libraries (30 nt,
single end). Reads were demultiplexed with bcl2fastq (v1.8.4) and long RNAs were
trimmed for adaptor contamination and low quality bases with the cutadapt (v1.4.1)
wrapper trim galore (v0.3.3).
4.2.3 Gene expression analyses
Transcript isoform expression levels for each individual library were quantified us-
ing Sailfish an alignment free quantification algorithm (version 0.9.2) (Patro, Mount,
and Kingsford, 2014). The transcript expression levels of the same gene are summa-
rized to give a gene expression estimate. Gene ontology (GO) enrichment was done
via Ontologizer (Bauer et al., 2008). Thereby, the differentially expressed genes were
categorized into different GO terms. Those are concepts to describe gene molecular
functions or biological processes. The GO annotation file was obtained from the
Gene Ontology Consortium webpage( http://geneontology.org). Gene enrich-
ment was determined for up- and down-regulated genes using the Parent-Child-
Union method (Bauer et al., 2008).
4.2.4 qPCR
Quantitative PCR was performed as described in detail previously (Laggai et al.,
2014)
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4.2.5 Prediction of IGF2BP2/p62 binding partners
We used the CatRapid omics webserver for the prediction of RNAs that are bound by
IGF2BP2-2/IMP2-2/p62 (Agostini et al., 2013). The mRNA sequence of the human
IMP2-2/p62 transcript (ID: ENST00000346192) was obtained from the ENSEMBL
database (version 88, assembly: GRCh38.p10) and used as input for CatRapid omics.
Mouse mRNAs with an IMP2-2 interaction score were obtained and summarized
at the gene level, taking the highest CatRapid score of all mRNAs for a gene. We
defined different categories of IMP2 binding using the Star rating score of CatRapid.
Using a score > 2.5 is denotated as IMP2+, a score > 2.75 is denotated as IMP2++.
In addition to the sequence based prediction of IMP2 target genes, we used
eCLIP RNA-binding data from the ENCODE consortium (Consortium, 2012) for
HepG2 liver cancer cells and K562 cells. eCLIP peaks were obtained from the EN-
CODE data portal ( https://www.encodeproject.org/). Each annotated human
gene in the Ensembl database, that had an eCLIP peak in at least one of the two
cell lines, was denoted as a IMP2 target gene. All IMP2 target genes in human de-
termined in this way were transferred to orthologous mouse genes according to En-
sembl version 87. In this way a mouse IMP2 target gene set was determined.
4.2.6 Inferring miRNA regulatory effects
In order to predict the global regulatory effect of miRNAs in WT and IMP2 livers,
we built linear models for individual samples to explain the expression levels of dif-
ferentially expressed genes using miRNA expression levels. The overall procedure
is illustrated in Figure 4.1.
In order to build the input feature matrix for the model, we retrieved sequence-
based predicted miRNA targets in 3-UTRs and CDS regions of genes from the Tar-
getScanMouse 7.1 (Agarwal et al., 2015a) and DIANA 5.0 (Paraskevopoulou et al.,
2013) databases. In order to decrease the amount of missing predictions (false neg-
atives), we merged predictions of these two databases for each gene. Then a fea-
ture matrix for each sample was built as follows: rows of the matrix denote DEGs,
columns denote miRNAs that have a predicted binding site in at least one DEG.
Every entry of the matrix represents the expression value of miRNAs that have a
predicted binding site in a gene. The input feature matrices were log2 transformed
and scaled before regression. We used the Elastic net algorithm (Zou and Hastie,
2005) from the glmnet package (Zhang and Heusdens, 2012) to learn linear regres-
sion models for each sample.
The objective function for Elastic net regression is defined as follow:
argminβ||y− βtX||2 + λ[(1− α)||β||22 + α||β||1] (4.1)
where y is the vector of DEG expression values. β is the miRNA regression co-
efficient vector and X is the input feature matrix. Model selection is done by 6-fold
nested-cross validation on hold out datasets. Mean value for miRNA regulatory in-
fluence of DEGs for WT and IMP2 livers was obtained by computing the mean value
for each miRNA over all regression vectors (Ws) obtained from the models built for
each set of samples, respectively. Then a t-test was conducted for each miRNA to
assess, whether a regression coefficient showed significant deviation between WT
and IMP2 livers (FDR≤ 0.05).
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FIGURE 4.1: Detailed comparison of differentially expressed lncRNAs (FDR≤
0.01). Scatterplot of mean expression values of lncRNAs in IMP2 overexpressing
livers (x-axis) and wild type (y-axis) samples. Color scaling of elements indicates
the number of expressed microRNAs that are predicted to target a gene (lightgrey:
target of few exp. miRNAs, black: target of many exp. miRNAs). The top lncR-
NAs with the largest fold changes are labeled in the plot. H19, RIAN, Meg3, MiRG,
Gm19705, Gm21980, Gm13834, 1700092C17RIK.
4.3 Results
4.3.1 Experimental setup
Five week-old wildtype (WT) and IMP2-2 transgenic (IMP2, p62) mice, which showed
liver-specific overexpression of IMP2-2, were used for all analyses. As previously
described, IMP2 mice developed a steatosis-like phenotype as indicated by Schar-
lach Red staining(Tybl et al., 2011; Simon et al., 2014) highlighting lipid droplets
(Figure 4.2 A). Expression of the transgene was confirmed in all six IMP2 mice (Fig-
ure 4.2B).
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FIGURE 4.2: Experimental setup (A) Wildtype (wt) and IMP2 transgenic (IMP2 tg)
mice were sacrificed at the age of 5 weeks. The figure shows a representative lipid
staining of wt and IMP2 tg livers. Lipids were stained with Scharlach Red on cryo
sections. Original magnification: 200 (left) and 500 (right). (B) IMP2 expression
in the livers of all animals shown as individual TPM values for the endogenous
mouse IMP2-2 (grey) and the transgenic human IMP2-2 (black). Note the different
scales.
4.3.2 Characterization of differential gene expression indicates discrete
differences
To characterize the different transcriptomes of WT and IMP2 induced fatty livers,
poly(A)-RNA was isolated and libraries for deep sequencing were prepared. Bioin-
formatics analysis revealed that from 32,360 unique genes of the mouse annotation,
9434 genes had no read count. Within the group of expressed genes, our anal-
ysis shows 1801 genes to be deferentially expressed using a false discovery rate
(FDR)≤ 0.01. Within those, we identified the majority to be up-regulated (1140
genes) and only 661 genes were significantly down-regulated. Individual genes
and lncRNAs have been validated by qPCR (Figure 4.3) supporting our bioinfor-
matics analysis. The MA-plot in Figure 4.4A illustrates that the latter genes showed
rather low fold-changes compared to WT, whereas the significantly up-regulated
genes show a higher degree of regulation.
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FIGURE 4.3: Comparison between gene expression determined by qPCR and by
TMP normalization of NGS data. Expression fold changes of IMP2-2, Igf2, H19,
Meg3, Pklr, and Ppara in IMP2 overexpressing livers normalized to wild type mice
determined by qPCR and RNA-Seq are shown. p-values were evaluated by Stu-
dent’s t-test or Mann-Whitney U test depending on normal distribution of the data.
Comparing the two groups of WT and IMP2 livers, PCA analysis of the gene ex-
pression data indicated a common response of the liver tissue to IMP2 overexpres-
sion. A separate grouping of sample 1 3 within the transgenic livers was apparent,
which correlates with a higher IMP2 expression level in these samples compared
to other fatty livers (Figure 4.2B). Figure 4.5 shows, that the different IMP2-2 levels
indeed have an effect on individual but not all Igf2 transcript isoforms.
4.3.3 IMP2 overexpression leads to stabilization of thousands of mRNAs
We sought to investigate the effect of IMP2 overexpression on the global gene expres-
sion program. It has been suggested that IMP2 binds to target mRNAs and leads to
increased stabilization (Bell et al., 2013). We predicted target mRNAs of IMP2 us-
ing the following strategy. First, we obtained from the CatRapidOmics webserver
human IMP2 (IMP2-2) binding predictions for 42,951 transcripts of 18,081 mouse
Ensembl genes. Many of these binding sites had low probability of binding, as in-
dicated by a low CatRapid score and were not considered for analysis. We noted
that higher mean expression of genes after IMP2 overexpression leads to higher
CatRapid scores suggesting an increased probability of IMP2 binding (Figure 4.4C).
Therefore, we asked if there is a change in expression of IMP2 targets after IMP2
overexpression. For this we included publically available IMP2 CLIP data from hu-
man HepG2 and K562 cells and transferred these to mouse genes (see Methods).
Then gene subgroups were dissected into genes with or without IMP2 binding, and
the total of all expressed genes. Figure 4.4D shows that genes bound by IMP2 show
significantly higher expression after IMP2 overexpression. Non-target genes (IMP2-
) showed lower fold changes than the gene average. Similar results can be seen in
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FIGURE 4.4: Differential gene expression in Wild Type and IMP2 induced fatty liv-
ers (A) MA plots of fold change expression levels (y-axis) against expression level
(x-axis). Each point represents a gene, significantly expressed genes (FDR≤ 0.01)
are indicated in red. (B) Principal component analysis using two components (PC1
and PC2). Each dot represents an individual liver sample. The legend is shown on
the right side. Difference in variance between the samples can be ascertained by
the physical difference between circles on the plot. (C) Genes with predicted IMP2
binding where partitioned into 4 quantiles based on mean expression in IMP2 sam-
ples (x-axis). Boxplots of CatRapid scores (y-axis) are shown for each quantile.
(D) Cumulative plot of gene expression (log2 fold change) in IMP2-2 overexpress-
ing livers. Gene subgroups were built according to IMP2 binding determined by
IMP2 CLIP data (see Methods) and representing all genes (black), IMP2 positive
genes (IMP2+, blue) and IMP2 negative genes (IMP2-, green). Significant differ-
ences according to a Kolmogorov-Smirnoff test (p-value ≤ 0.05) are marked with
(*). Numbers in brackets denote the number of genes in each category.
Suppl. Figure 4.6 analyzing altered gene expression of gene groups with positive
and negative IMP2 binding prediction according to CatRapid. These analyses sug-
gest that overexpressed IMP2 stabilizes thousands of mRNAs.
Since mRNA stability is regulated by miRNAs, we sought to investigate the ef-
fect of IMP2 overexpression on miRNAs and miRNA target genes. Figure 4.7 shows
a scatter plot of mean expression values of all DEGs as well as their IMP2 bind-
ing prediction in combination with the number of miRNAs targeting an individ-
ual transcript. The most up-regulated gene was IGF2, which is a known target of
IMP2. However, the fold change of IGF2 was much higher than the majority of
genes that are predicted IMP2 targets according to CatRapid. Interestingly, IGF2
mRNA is also a target of 96 expressed miRNAs, which suggests that the high degree
of up-regulation may not be solely due to IMP2 mediated stabilization (see below).
According to Figure 4.7, the transcript with the second highest fold change was IMP2
itself.































FIGURE 4.5: Scatter plot of TPM values for seven Igf2 isoforms and IMP2-2 (human
transgenic isoform) of the twelve individual samples. All wild type samples show
no or low expression and are summarized by the black circle. The individual IMP2-
2 transgenic lines are indicated on the right.
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FIGURE 4.6: Cumulative distributions of log2 fold changes (IMP2/WT) after IMP2
overexpression (x-axis) are compared for different subsets of the data: all genes
(black), genes with CatRapid score > 2.5 (IMP2+, blue) or > 2.75 (IMP2++, red)
or no CatRapid prediction (IMP2-, green). Significant differences according to
Kolmogorov-Smirnoff test (p-value≤ 0.05) are marked with (*). Numbers in brack-
ets denote the number of genes in each category.
described to be associated in HCC (including IMP2 and IGF2): the alpha-1 fetopro-
tein (AFP), which is expressed usually in the fetal liver as well as in cirrhosis and
HCC (Zucman-Rossi et al., 2015); member C18 of the aldo-keto reductase family 1
(AKR1C18), a component of the lipid metabolism, which was shown to be strongly
up-regulated in HCC (Ohrnberger et al., 2015), glypican-3 (GPC3) which controls cell
division being highly up-regulated in HCC (Suzuki et al., 2010), and serine protease
inhibitor Kazal-type 1, also known as tumor associated trypsin inhibitor, SPINK1,
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which is also overexpressed in HCC (Marshall et al., 2013). AFP is routinely used as
a diagnostic marker for HCC and a combined usage of AFP and GPC3 to improve
diagnosis has been suggested (Capurro et al., 2003).
Figure 3 
A
FIGURE 4.7: Detailed comparison of DEGs (FDR≤ 0.01). Scatterplot of mean
expression values of DEGs in IMP2 overexpressing livers (x-axis) and wild type
(y-axis) samples. Genes that are categorized as IMP2+ target genes according to
CatRapid are denoted with a triangle. Color scaling of elements indicates the num-
ber of expressed microRNAs that are predicted to target a gene (lightgrey: target
of few exp. miRNAs, black: target of many exp. miRNAs). The top 10 genes with
the largest fold changes are labeled in the plot. IGF2, IMP2, SPINK1 (serine pepti-
dase inhibitor, Kazal type1), AFP (alpha fetoprotein), AKR1C18 (Aldo-keto reduc-
tase family 1, member C18), GPC3 (Glypican 3), Gm12671 (predicted gene 12,671),
Gm10359 (predicted gene 10,359), Gm14303 (predicted gene 14,303).
4.3.4 GO enrichment indicates activation of immune processes and cell
cycle processes
To identify altered biological processes in IMP2 overexpressing livers, GO enrich-
ment of DEGs was carried out. Figure 4.8 shows a graphical visualization of signifi-
cantly altered biological processes in fatty livers (FDR≤ 0.01).
Figure 4.8A shows that GO terms enriched with up-regulated genes were domi-
nated by terms correlated with cell divisions: “cell cycle”, “cell cycle process”, “chro-
mosome segregation”, and “organelle fission”, thus indicating that mitotic divisions
could occur more frequently in fatty liver tissue. However, IMP2 transgenic livers
do usually not show increased weight compared to WT, but an increased liver to
body weight ratio (Tybl et al., 2011). Other reports observed an altered cell cycle in
steatosis models (Cui, Chen, and Hu, 2010). Interestingly, in pancreatic islet cells cell





FIGURE 4.8: GO-enrichment of up-regulated (A) and down-regulated (B) GO
terms. Plots are shown of GO representatives for biological processes generated
by the REVIGO tool which summarizes the list of GO terms derived from differ-
entially expressed genes (FDR≤ 0.01) by removing redundant terms. The distance
between circles (representing individual GO terms) indicates the relationship be-
tween terms: smaller distance means more similar relationships. Bubble color indi-
cates significance of differential expression of an individual GO term (red low and
blue high); the size (in log10 p-value) indicates the percentage of genes annotated
with a term in the reference database (UniProt) and thus indicates more general
terms (large) and more specific ones (small).
Also processes correlated to the immune system can be found among the up-
regulated genes and the GO terms “immune system process” and “immune re-
sponse” represented the second dominant group. As increased lipid content is often
accompanied by inflammatory events in NASH (Day, 2006), and IMP2 overexpress-
ing mice show a slightly inflammatory phenotype (Laggai et al., 2014), association
with these processes makes sense and is further supported by the autoantigenic char-
acter of the transgene.
Among the down-regulated DEGs, enriched GO terms were related to energy
metabolism and metabolism, such as “cellular metabolism”, “metabolism” and “oxidation-
reduction process” suggesting that the general energy turn-over and metabolic rate
is lower in fatty livers compared to WT-liver-samples (Figure 4.8B). Also the process
of “cellular lipid metabolism” was significantly down-regulated. In this context,
the IMP2 overexpression phenotype has been shown to include not only the accu-
mulation of lipids but also their different composition, as for instance the C18:C16
fatty acid ratio becomes significantly elevated(Laggai et al., 2013). This is in agree-
ment with altered lipid compositions in human NAFLD (Puri et al., 2009; Puri et al.,
2007). Still, down-regulated DEGs of the process “cellular lipid metabolism” mostly
included genes leading to a reduction of lipids, such as enzymes of the fatty acid
beta-oxidation or inhibitory enzymes of lipid synthesis, in turn resulting in hepatic
lipid accumulation.
4.3.5 Genome-wide miRNA analysis shows global dysregulation
In addition to the DEG analysis, we also extracted small RNA fractions of the same
RNA samples from which poly(A) RNA was prepared and subsequently analysed
miRNAs by deep sequencing. Figure 4.8 reveals the global analysis of differentially
regulated miRNAs. The MA-plot shows that only few miRNAs were significantly
differentially expressed between WT and IMP2 induced fatty livers (Figure 4.9A).
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Although the PCA analysis in Figure 4.9B shows that WT and IMP2 livers could
be clearly separated based on their miRNA expression, a higher divergence of the
samples becomes apparent as expected from the clustering of transcriptomes (Fig-
ure 4.4B).
Going into detail which miRNAs are significantly expressed, Figure 4.9C lists
up- and down-regulated miRNAs according to their significance indicated by the
adjusted p-value. The figure shows that of a total of 24 significantly regulated miR-
NAs (FDR≤ 0.01), 16 miRNAs are up-, and 8 miRNAs were down-regulated.
The two most significantly regulated miRNAs are miR151-5p and miR483-3p.
The latter is encoded by the IGF2 mRNA, which we know to be up-regulated by
IMP2 overexpression. We can consequently see that both strands of this miRNA
accumulated in the IMP2 samples (Figure 4.9C).
In the context of IGF2 and miR483 up-regulation, also miR675, which is pro-
cessed from the H19 RNA was significantly accumulated (Figure 4.9C). Both, the
H19 locus, encoding for a lncRNA, and the IGF2 locus are linked imprinted loci
showing reciprocal monoallelic expression: H19 from the maternal, IGF2 from the
paternal allele (Zemel, Bartolomei, and Tilghman, 1992). To clarify whether also
the miR675 up-regulation could be due to increased precursor levels, genome wide
lncRNA quantification was carried out comparing the IMP2 and the WT livers. Fig-
ure 4.1 shows that many lncRNAs are upregulated in IMP2-2 livers: these include
H19 as well as three lncRNAs belonging to the DLK1/DIO3 domain. Therefore, the
up-regulation of miR675, which is processed from the H19 transcript, is likely due to
increased template RNA. Figure 4.9C also reveals that 10 out of 16 up-regulated miR-
NAs are located on chromosome 12. It is noteworthy that all of them are located in
the DLK1/DIO3 domain, which contains a large and highly conserved miRNA clus-
ter (Seitz et al., 2004). In agreement with the upregulation of three of its lncRNAs
(Meg3, Rian, MiRG) we see nearly all of the encoded miRNAs enriched in IMP2-2
livers (Figure 4.10).
4.3.6 IMP2 alters miRNA regulation and stabilizes miRNA targeted tran-
scripts
Our paired miRNA expression data allowed us to conduct integrative analyses to
measure associations of miRNA expression and their potential target genes in WT
and IMP2 samples. We developed an analysis framework that allowed us to quan-
tify associations of miRNAs to DEGs. Briefly, we build a linear regression model for
each WT and IMP2 sample for the prediction of DEG expression (Figure 4.1). The
features for the regression are miRNA expression levels of miRNAs that target a gene
obtained from sequence-based miRNA target predictions, see methods. This anal-
ysis allowed us to investigate the regulation of DEGs through changes in miRNA
expression after IMP2 overexpression. For each sample we obtained a regression
(association) coefficient for each miRNA. Figure 4.11A shows the Top 100 miRNAs
with the largest change in mean regression coefficients between WT and IMP2 sam-
ples. We observed that miRNA regression coefficients are smaller (less influence on
DEG expression) in IMP2 samples compared to WT samples. In total 8 miRNAs
(t-test FDR≤ 0.05) showed a significant difference in their mean regression coeffi-
cients. This suggests that expressed miRNAs have reduced regulatory influence on
DEGs in IMP2 samples. We followed the possibility that IMP2 binding may interfere
with genome-wide miRNA binding to transcripts as observed by (Degrauwe et al.,
2016) in human glioblastoma stem cells. First, we arbitrarily partitioned all genes
into four groups according to the amount of expressed miRNAs that are targeting a
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miRBase ID Chromosome Overlapping transcript (s) Adjusted p-value Fold change (log2)
mmu-miR-151-5p 15 Ptk-2, protein tyrosine kinase 2 4.58E-35 4,50
mmu-miR-483-3p 7 IGF-2, insuline-like growth factor 2 1.47E-27 5,58
mmu-miR-300-3p 12 miR300-201 ncRNA 2.99E-05 2,47
mmu-miR-341-3p 12 RIAN-010 3.34E-05 3,14
mmu-miR-675-5p 7 H19 ncRNA 8.54E-05 5,02
mmu-miR-540-3p 12 miR540-201 ncRNA 1,27E-04 3,39
mmu-miR-1948-3p 18 TTC39C, tetratricopeptide repeat domain 39C 5,03E-04 2,33
mmu-miR-483-5p 7 IGF-2, insuline-like growth factor 2 5,58E-04 3,75
mmu-miR-543-3p 12 miR543-201 ncRNA 1,10E-03 2,22
mmu-miR-411-5p 12 miR411-201 ncRNA 1,47E-03 1,48
mmu-miR-434-5p 12 RTL1-201 retrotransposon-like 1 1,51E-03 1,69
mmu-miR-370-3p 12 RIAN-010 2,22E-03 2,76
mmu-miR-193a-3p 11 ncRNA 3,05E-03 2,37
mmu-miR-376b-3p 12 miR376c-201 ncRNA 3,20E-03 3,18
mmu-miR-127-5p 12 RTL1-201 & miR127-201 5,66E-03 1,98
mmu-miR-154-3p 12 MIRG 8,85E-03 3,04
 
mmu-miR-139-5p 7 PDE2A, phosphodiesterase 2A 6.60E-07 -1,65
mmu-miR-1981-3p 1 MARC2 mitochondrial amidoxime red. component 2 1,27E-04 -1,87
mmu-miR-25-3p 5 MCM7, minichromosome maintenance deficient 7 5,58E-04 -0,62
mmu-miR-704 6 PDIA4, protein disulfide isomerase associated 4 9,84E-04 -3,29
mmu-let-7a-5p 13 miRlet7a-1-201 ncRNA 3,03E-03 -1,31
mmu-let-7f-5p 13 GM24111-201 ncRNA 4,80E-03 -1,41
mmu-miR-222-3p X intergenic 5,95E-03 -1,15










FIGURE 4.9: GO-enrichment of up-regulated (A) and down-regulated (B) GO
terms. Plots are shown of GO representatives for biological processes generated
by the REVIGO tool which summarizes the list of GO terms derived from differ-
entially expressed genes (FDR≤ 0.01) by removing redundant terms. The distance
between circles (representing individual GO terms) indicates the relationship be-
tween terms: smaller distance means more similar relationships. Bubble color indi-
cates significance of differential expression of an individual GO term (red low and
blue high); the size (in log10 p-value) indicates the percentage of genes annotated
with a term in the reference database (UniProt) and thus indicates more general
terms (large) and more specific ones (small).
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Average in WT    
Average in IMP2-2
FIGURE 4.10: Regulation of miRNAs of the imprinted DLK1/DIO3 domain in
IMP2 overexpressing livers. The scheme shows the murine DLK1/DIO3 domain.
Maternally expressed loci are shown in blue, paternally expressed loci in green.
Please note that the scheme is not drawn to scale. DLK1: delta like 1 Homolog,
GTL2: glycosyltransferase-like2 (MEG3 in human), RTL1: Retrotransposon like,
RIAN: RNA imprinted and accumulated in the nucleus, MIRG: miRNA containing
gene, DIO3: Type III deionidase, DIO3-OS: Dio3 opposite strand. Below the scheme
the approximate position of miRNAs is demonstrated. The graph shows average
miRNA expression in WT (blue) and IMP2 livers. Expression of miRNAs with no





























































FIGURE 4.11: Integrative analysis of miRNA dysregulation and gene expression.
(A) Heatmap of regression coefficients of TOP100 miRNAs (rows) that show a dif-
ference in regulation of DEGs. The strength of the miRNA association with all
DEGs in a given sample (column) is indicated by a color coding (blue and red,
negative and positive association, respectively). (B) Cumulative distributions of
log2 fold changes (IMP2/WT) after IMP2 overexpression (x-axis) are compared for
different subsets of the data: all genes (black), genes with binding sites for 1–5 ex-
pressed miRNAs (blue), for 6–30 expressed miRNAs (red), for 31–100 expressed
miRNAs (green) and genes not targeted by any expressed miRNA (light blue). Sig-
nificant differences according to Kolmogorov-Smirnoff test (p-value ≤ 0.05) are
marked with (*). Numbers in brackets denote the number of genes in each cate-
gory.
gene based on TargetScanMouse 7.1 (Agarwal et al., 2015a). Figure 4.11B shows that
genes that are targeted by >5 expressed miRNAs (6–30miRNA+ and 31–100miRNA+
categories) show a significant up-regulation (KS-test p-value = 0.0091 and < 2.2e-16
respectively) compared to the whole set of genes. In addition, genes that had bind-
ing sites for >30 miRNAs showed a significantly stronger up-regulation (KS-test p
= 8.038e-14). In contrast, genes with no predicted binding site for an expressed
miRNA (miRNA-) showed the least up-regulation after IMP2 overexpression and
significantly less than the average over all genes (KS-test p < 2.2e− 16).
To include a potential effect of IMP2-2 to the miRNA attacked transcripts, we
combined the miRNA analyses with either the CatRapid IMP2 binding prediction
(Figure 4.12) or the IMP2 CLIP data (Figure 4.11A). We stratified genes into several
combinations of these two attributes (Figure 4.11C). We observed that genes that
are bound by IMP2 and >50 miRNAs (IMP2 + miRNA++) showed the strongest up-
regulation after IMP2 overexpression compared to all genes and to genes that are
only targeted by >1 miRNA (IMP2-miRNA+). For genes that are not bound by miR-
NAs we observed reduced fold-changes compared to the majority once IMP2 binds
them. To characterize the individual numbers of transcripts, which can be bound by
either miRNAs, IMP2 or both, we used set intersection plots (Figure 4.13B). We ob-
served that most of the genes that showed IMP2 binding also had miRNA binding
sites. Moreover, genes with binding sites for at least 30 miRNAs were more likely
bound by IMP2 (7,304 out of 12,327) suggesting that IMP2 binding and miRNA bind-
ing are not independent. These analyses strongly suggest that IMP2 competes with
miRNA binding and thus leads to genome-wide stabilization and up-regulation of
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FIGURE 4.12: Cumulative distributions of log2 fold changes (IMP2/WT) after IMP2
overexpression (x-axis) are compared for different subsets of the data: IMP2 targets
(IMP2+, CatRapid score > 2.5) or non-targets (IMP2, no CatRapid prediction), genes
that have binding sites for 30 or more miRNAs (miRNA+) or have no binding site
for an expressed miRNA (miRNA). All combinations of the four attributes are sep-
arated in the plot and compared to all genes (black). Significant differences accord-
ing to Kolmogorov-Smirnoff test (p-value ≤ 0.05) are marked with (*). Numbers in
brackets denote the number of genes in each category.
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mRNAs. The large number of genes which could be regulated by this competing
IMP2/miRNA system may suggest a co-evolution of binding sites.
4.4 Conclusion
It has been well documented that hepatocyte-specific overexpression of the RNA
binding protein IMP2 in murine livers leads to a steatosis like phenotype (Kessler
et al., 2015; Tybl et al., 2011; Laggai et al., 2014). To analyze the effect of IMP2 on
the liver transcriptome and miRNAs, we analysed whole liver tissue samples of five
week-old WT and transgenic mice. Although hepatocytes display the predominant
hepatic cell type, the analysed Seq-data contained data not only from hepatocytes,
but also from non-parenchymal cells such as Kupffer cells, stellate cells, and en-
dothelial cells. Differences in cell composition cannot be excluded.
4.4.1 Genome wide effects of miRNA and IMP2 competition: Just stabi-
lization?
We know several hundred RNA binding proteins in humans, but few of them have
been implicated in progression of certain diseases (Lukong et al., 2008). However,
precise mechanisms and genome-wide data are rare, especially for the growing un-
derstanding of RNA binding and miRNA competition. One exception is the RNA
binding protein LIN28, which supresses maturation of the let7 miRNA family by
binding to the precursor RNA thus blocking Drosha during development (Viswanathan
and Daley, 2010). This is interesting also for our analyses of IMP2 as recent evidence
that also IMP2 can prevent let7 silencing, not by inhibition of miRNA biogenesis but
by competition with target sites (Degrauwe et al., 2016). In our study, we overexpress
IMP2, thus mimicking aberrantly high expression of IMP2 as found in HCC (Zhang
et al., 1999; Kessler et al., 2013; Kessler et al., 2015).
In this work, we dissected individual groups of genes by different criteria: their
ability to bind miRNAs and their ability to bind IMP2. The latter argument was
predicted either by CatRAPID or by the integration of human IMP2 CLIP data.
Both analyses clearly show the same result: genes that are preferentially bound by
IMP2 and many miRNAs are upregulated in IMP-2 overexpressing livers. We there-
fore conclude that both, IMP2-2 and miRNAs, compete for transcripts. This means
that IMP2-2 overexpression tilts the balance towards IMP2: leading to widespread
miRNA inhibition thus lowering the extent of genes regulated by miRNAs.
Similar effects have been shown on glioblastoma cells expressing endogenous
up-regulated IMP2, only (Degrauwe et al., 2016). In addition, our data indicate a
general decrease of miRNA regulation in IMP2 livers and this occurs for miRNAs
with positive as well as negative effects on target abundance. For individual miR-
NAs, increasing knowledge shows the effect of individual RNA binding proteins
to formation and function of the target bound RNA silencing complex (RISC) (Van
Kouwenhove, Kedde, and Agami, 2011). Data for IMP2 are missing and our data
do not allow for decisions whether competition inhibits miRNA repression or RISC
and IMP2 interact to modulate translation. Likely, both happens which will have
to be verified individually for each transcript by Ribo-footprinting of IMP2 livers.
A non-exhaustive analysis of lipogenic enzymes in IMP2 overexpressing liver cells
did not reveal significant changes in their mRNA abundance, although some com-
ponents showed alterations of the protein expression levels in Western blots (Laggai
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FIGURE 4.13: Integrative analysis of the effects of miRNAs and IMP2-2 to gene
expression. (A) Cumulative plot of gene expression (log2 fold changes) in IMP2-2
overexpressing livers. Gene subgroups were dissected first according to IMP2 bind-
ing determined by IMP2 CLIP data with positive binding (+) and without () and
second for miRNA binding sites, >1 miRNAs binding (miRNA+), > 50 miRNAs
binding (miRNA++) and all other genes (miRNA-). All combinations of the five
attributes are separated in the plot and compared to all genes (black). Significant
differences according to a Kolmogorov-Smirnoff test (p-value ≤ 0.05) are marked
with (*). Numbers in brackets denote the number of genes in each category. (B) Set
intersection plot of four different gene groups. With positive IMP2 CLIP, with >30
miRNA predicted binding sites (miRNA30), with more than one predicted miRNA
binding site (miRNA1) and without (NOmiRNA).
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et al., 2014). This supports the drawn conclusions that translational alterations of
lipogenic genes contribute to the steatosis-like phenotype.
4.4.2 General characteristics of IMP2-2 induced transcriptome and miR-
NAome
With the identified GO enrichments, some aspects of the microsteatosis phenotype,
such as the inflammation and alterations of the lipid metabolism, can be attributed
to differential gene expression. Strikingly, the five highest elevated transcripts (IGF2,
AFP, GPC3, AKR1C18, SPINK1) in IMP2 overexpressing livers are characteristic
markers for HCC (Zucman-Rossi et al., 2015; Ohrnberger et al., 2015; Suzuki et al.,
2010; Capurro et al., 2003).
Also in the analysis of miRNAs, an interesting aspect of the genome-wide com-
parison is that our study of IMP2-induced microsteatosis did not reveal significant
changes in miRNAs, which have been previously described in NAFLD or NASH,
such as miRNAs 34a, 155, 200b, 214-5p, 221, 29c, 122, 192, 203, and 467b (Cecca-
relli et al., 2013). However, two miRNAs intensively studied in HCC, miR483 and
miR151 (Callegari et al., 2015), were significantly up-regulated.
Both miRNAs, miR438 and miR151, are processed from the coding mRNAs IGF2
and PTK2, respectively. Our data indicates an up-regulation for the miR483 mRNA
precursor only. The IGF2 mRNA becomes highly enriched in IMP2 overexpressing
livers in agreement with previous findings (Tybl et al., 2011). Consequently, both
strands of miR438 can be found to be enriched (Figure 4.9C). In contrast, the up-
regulation of miR151-5p cannot be easily explained by increased abundance of its
precursor mRNA (PTK2). Here, we can only speculate whether processing by the
RNAi machinery is different or whether the miRNA becomes stabilized to a higher
degree by increased occurrence of target sites in the altered transcriptome. In HCC,
increased expression of miR151 is either linked to a copy number gain (Ding et al.,
2010) or elevated levels of the hosting gene PTK2 (Luedde, 2010). Strikingly, the
five most elevated transcripts and most significant miRNAs in IMP2 livers are HCC
specific, which could explain the significantly increased risk to develop HCC after
exposure to carcinogens in this model (Kessler et al., 2015).
4.4.3 miRNA dysregulation in imprinted loci
Our data show that many up-regulated miRNAs derive from reciprocally imprinted
loci: IGF2, H19 and the DLK1/DIO3 domain (Figure 4.8D), raising the questions
whether this is due to allele-specific regulation or loss of imprinting. Concerning
the IGF2/H19 gene cluster, loss of imprinting was associated with developmental
disorders as well as many tumors such as HCC (Kim and Lee, 1997; Li et al., 1997;
Reik et al., 2000). However, loss of imprinting was not observed in IMP2-2-induced
steatosis by us, instead a common transcriptional regulator Aire may be responsible
for the concerted activation (Tybl et al., 2011).
The second imprinted region, which is affected by IMP2 overexpression, is the
DLK1/DIO3 domain. Although IMP2 mice were shown to have elevated levels of
the paternally expressed protein-coding gene DLK1 (Kessler et al., 2015) loss of im-
printing cannot be excluded. A possible connection between both loci could be the
H19 lncRNA, which was shown to be a central regulator of an imprinted gene net-
work by binding MDB1 (methyl-CpG binding domain protein 1) (Gabory et al., 2009;
Monnier et al., 2013). However, these pioneer studies clearly showed that H19 is
a negative regulator for DLK1 during development, which is the opposite in our
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studies in five week-old animals. Also, alterations in H19 levels did not alter the
entire DLK1/DIO3 domain as for instance expression of RIAN was not affected by
H19 (Gabory et al., 2009). Clearly, the molecular triggers for regulation of imprinted
loci are different in studies depleting H19 (Gabory et al., 2009; Monnier et al., 2013)
and overexpressing IMP2 and therefore future studies have to clarify the epigenetic
landscape of imprinted loci in IMP2 and H19 transgenic models.
4.4.4 Different aspects contribute to IGF2 mRNA accumulation
Still, the question remains open why exactly the IGF2 mRNA is highly accumu-
lated in IMP2 overexpression lines. One aspect is of course the direct stabilization
of the transcript by the RNA binding protein. Second, miR483 is processed from the
transcript and our data shows accumulation of its 5p and 3p strand. Especially the
increase of miR483-5p should lead to an additional increase of IGF2 transcriptional
activity as the nuclear fraction of this miRNA was shown to bind to the 5-UTR of the
IGF2 mRNA, thus increasing the transcriptional activity of the host gene by a feed-
forward regulatory loop (Liu et al., 2013). Here, this would result in two sequential
stabilizing effects i.e. (i) post-transcriptionally by IGF2 mRNA stabilization and (ii)
on the transcriptional level increasing IGF2 transcription. As a third aspect, our pre-
diction indicates that the IGF2 mRNA is target of 96 expressed miRNAs. Therefore,
competition between IMP2 and miRNAs as predicted by our data could have an
even stronger effect on this transcript.
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Chapter 5
Multi-task learning of transcript
isoform regulatory network
"Gene regulatory network" is a somewhat vague term. We use it to describe the con-
nection between regulators and the target gene. However, the term "gene" by itself
is virtual concept. This chapter introduces a new paradigm for gene regulatory net-
work inference. We challenge the concept of a gene regulatory network as a gene is
a virtual, but useful concept. We propose isoform regulatory network as an appro-
priate term for network inference.
Contributions: All method development and data analysis of this project was done
by me. This chapter is the extension of our manuscript published at Proceedings of
German Conference for Bioinformatics 2016 (Dehghani Amirabad and Schulz, 2016).
5.1 Introduction
The regulatory network describes the connection between regulators (TF, miRNA,
RBP, etc.) and the target genes. These networks specify condition-specific expression
of a gene. Inferring condition-specific regulatory network is important because of
their relevance to cell identity, diseases, and development.
Substantial progress has been made in reconstruction of the regulatory network
including regression models (Haury et al., 2012), graphical models (Schäfer and
Strimmer, 2005) and Bayesian networks (Friedman et al., 2000). The readers are
referred to (Wang and Huang, 2014; Sanguinetti, 2019) for comprehensives reviews
of the methods.
Despite considerable progress in the field, regulatory network inference and anal-
yses have yet been limited to inference from total gene expression levels in a sample
cohort. Gene expression denotes the summed activity of all isoforms of a gene, and
a gene may have a different number of isoforms due to alternative promoter usage,
alternative splicing, or alternative polyadenylation (Figures 5.1 and 5.2). Further-
more, alternative isoforms are the ultimate effectors of RBPs and miRNA, therefore,
isoform annotation should be taken into account.
Moreover, a regulator might only target a subset of isoforms of a gene, hence aggre-
gation of the isoform expression to gene level might lead to loss of isoform-specific
regulation, with possible false positive (FP) or false negative (FN) regulator target
association.
In a pioneering study by Deng et. al (Deng et. al, 2011), who used Mutu I cells that
overexpressed miR-155, it was shown that a simple transcript expression cut-off and
seed enrichment strategy revealed more true miR-155 targets than using a cut-off on
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gene expression only. They had used RNA-seq data of Mutu I cells to estimate tran-
script expression levels using an Expectation Maximization (EM) algorithm. Over
the last years, a number of EM-related approaches have been introduced which al-
low the quantification of transcript expression levels from RNA-seq data (Richard
et al., 2010; Li and Dewey, 2011; Patro, Mount, and Kingsford, 2014). Therefore, we
believe there is an opportunity to develop methods that allow regulatory model re-
construction on the level of individual isoforms, particularly in the light of a large
number of available paired transcriptomics and epigenomics data sets, e.g. from the
ENCODE(Sloan et al., 2015).
Here we propose a multitask learning (MTL) approach to fully exploit gene struc-
ture and cross isoforms commonalities. In this framework, as regulator binding site
can be shared between different isoforms of a gene (see Figure 5.1, grey triangle
miRNA), systematic information flows between different isoforms (tasks) of a gene,
leading to more accurate isoform expression prediction, thus, reducing the chances
of overfitting and improving model generalization performance. We investigate the
difficulties of regulator-target prioritization for isoforms using different simulation
studies and analysis of liver cancer RNA-seq data. We show that the new MTL ap-
proach is able to predict the expression level of target isoforms accurately than single
task learning approaches, and leads to the most accurate prediction of experimen-
tally validated miRNA targets (Dehghani Amirabad and Schulz, 2016).
Moreover, we extend our formulation to the joint inference of gene and iso-
form regulation, which allows to transfer the fine-grained biological variation at
the isoform level to the gene level. We explicitly demonstrate that this leads
to more accurate gene expression prediction in challenging scenarios (low sample
size, high dimensionality). We shows that transcript isoforms is one of the rich-
est sources of informative biological prior knowledge regarding transcriptional and
post-transcriptional activities of a gene and our algorithm is the first and the only
algorithm that fully exploit these priors.
In order to solve the multi-task regression for the entire human transcriptome,
we derive and implement an efficient solver.
We apply our algorithm to integrate epigenomics and transcriptomics data from
hepatocellular carcinoma (HCC), breast invasive cancer (BRCA), and prostate can-
cer. By analyzing the models, we highlight novel mechanisms of transcript isoform
regulations.
5.2 Method
Transcript isoform regulatory network inference
We formulate the network inference problem as learning a single linear regression
model for each transcript isoform using weighted linear combinations of TFs and
miRNA (Figure 5.3). To this end, we integrate different high-throughput data
including chromatin accessibility, paired transcriptomics (isoform and miRNA),
and isoform annotation (3P-seq) into learning framework. The goal is to learn per
isoform an interpretable model, and find sets of regulators for each isoform that
explain observed variance in their expression.
Here, we describe our general setting for modeling transcript isoform regula-
tion. Then, we describe a learning algorithm where we make full use of isoform



















FIGURE 5.1: Structured information at isoforms of a gene. Different isoforms of a
gene can share similar regulatory elements. Transcript isoforms 1, 2, and 4 have the
same 3’-UTR, hence they posses the same miRNA and RBP binding sites in the 3’-
UTR. Moreover, the transcript isoforms of 2 and 3 have the same promoter, hence
they posses the same TF binding profile at the proximal promoter.
learning problems (tasks), which lead to an accurate isoform, and gene regulation
inference. We evaluate the performance of models in terms of gene and isoform ex-
pression prediction accuracy and recovering the known underlying regulatory net-
work.
Modeling isoform regulatory network inference
We model the steady-state expression of transcript isoform k at condition j, ykj , as a










For each transcript isoform model, we want to find a sparse solution (β ∈ RP×1)
where non-zero elements of β indicate the contribution of each regulators in explain-
ing observed variance in transcript isoform expression. We infer the parameters (β)
of Eq. 5.1 in three different settings: single-task learning (STL), multi task learn-
ing (MTL) with isoforms of a gene, and multi-task learning of genes and the corre-
sponding isoforms (GMTL).
5.2.1 Lasso formulation of regulatory network inference
Lasso is a sparse linear regression model for inferring the regression coefficients, β,




f (βk) ≡ 1
2
||yk − Xkβk||2F + λ||βk||1 , (5.2)









FIGURE 5.2: Isoform expression in BRCA data. The pie chart shows the distribution
of the number of expressed isoforms per gene. Approximately 40% of genes express
more than one isoform with predicted miRNA binding sites in their 3’-UTR.
where yk ∈ RN×1 is the isoform expression level in N samples, Xk ∈ RN×P
is the input feature matrix, || · ||F denotes the Frobenius norm, and || · ||1 is the
`1-norm. λ is the regularizer parameters, which controls the sparsity in β. We call
this single-task learning, because parameters of each model are estimated separately.
5.2.2 Multi-task regression formulation of isoform regulatory network
inference
Different isoforms of a gene may share regulatory elements, hence they can share
similar regulators (Figure 5.1). For example, isoforms from the same gene may share
miRNA binding sites because they have similar 3’-UTRs. In the case of Lasso esti-
mation (Eq. 5.2), we optimize the parameter of individual models (tasks) indepen-
dently (Eq. 5.2). This may lead to suboptimal inference and instability in regulator
feature selection, especially in a low sample size setting or high dimensional data.
We aim to improve the generalization performance of individual isoform models
by exploiting the shared and complementary information (structred sparsity pat-
tern) between them. To this end, we formulate isoform expression level prediction
as a multi-task regression problem as follows:






||yk − Xkβk||2F + Ω(B) (5.3)
Where K, Xk ∈ RP×N , and βk ∈ RP×1 are the number of isoforms of a gene (tasks),
isoform specific input feature matrix, and isoform specific regression coefficient vec-
tor respectively. The first term, is the fitting term and fits the parameters of the model
independently. The second term Ω(B) is the sparse group lasso, which couples the
models parameters by simultaneously shrinking the weights of the shared regulator
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FIGURE 5.3: Isoform regulatory network inference workflow. Our network infer-
ence algorithm takes as input an isoform expression matrix, chromatin accessibil-
ity data, and priors for miRNA and TF target interactions. It returns a distinct
regulation model for each isoform. Step I: Using priors and isoform expression
data, we estimate TF activities in different samples. Subsequently, we expand our
isoform-specific input features matrix by adding miRNA expression according to
miRNA-isoform interaction priors. Step II: We learn a distinct linear model for
each isoform as a function of TF activities and miRNA expression data. In this step,
our algorithm incorporates isoform annotations (alternative promoter and 3’-UTR
structure) to the model for effectively sharing regulatory information and a robust
estimate of the isoform regulatory network. Step III: We construct the regulatory
network of the entire transcriptome. Each model gives us the adjacency list of tar-
get node (isoform) and the input feature nodes (miRNA and TF). After statistical
test corrections, we pool all the adjacency lists together and construct a directed
regulatory network of the entire transcriptome. Weights of the individual edges
correspond to the feature weight in the corresponding model. Morever, using our
models, we predict the expression level of the isoforms in hold out data set
between isoforms ( 5.4). Its sparse multi-task group lasso is defined as:





Where B = [β1, . . . , βK] ∈ RP×K is the regression coefficien matrix for isforms of a
gene. gp is group-specific weight, which is defined as the square root of group size.
Gp is the non-overlapping group lasso penalty and translates into the regression
coefficient vector for the regulator p that has binding sites at subsets of isoforms of
a gene (Figure 5.4).
One of our biological motivations behind this formulation is that a regulator with
similar binding sites in different isoforms of a gene may also have similar regulatory
effects. To this end, we use the non-overlapping group lasso to encourage the joint
selection of regulators that have similar binding sites across different isoforms of a
gene. This is achieved by structured sparsity-inducing property of the group lasso,
which shrinks the coefficients within each group toward to a small value. Hence, if
a group is selected by group lasso, then all entries of the group will have non-zero
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minimize f(w)



















































































































































































































||yk    kXk||2 + ⌦(B) (4)
Where k, Xk 2 RP⇥N and  k 2 RP are the number of tasks, task specific input fea-
ture matrix, and task specific regression coefficient vector respectively. The first term,
square loss, is the fitting term and fits the para eters of the model independently. The
second term ⌦(B) is the sparse group lasso penalty that couples the models parameters
by simultaneously shrinking the weights of each regulator between different isoforms
that have predicted binding sites (See figure X). Sparse multi-task group lasso is de-
fined as:
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Gp is the group lasso penalty and translates into the regression coefficient vector
for the regulat r p that has binding sites at subsets of isoforms of a gene. Different
to Equation 3, we define a structured sparsity-inducing penalty, ⌦(B), for regulator
binding sites that are shared between two or ore transcripts of a gene. In our setting
it translates into non-overlapping group lasso penalty (l2,1 norm). More specifically
Gm is the group of regression coefficients for regulator m that has shared binding sites
across isoforms of a gene (ref to picture). Non-overlapping group lasso encourages the
joint selection of the regulators that have similar binding sites at different isoforms of a
gene and encodes similarities for regression coefficients of regulator among isoforms.
Another hand, different isoforms of a gene might have different regulatory program
despite having similar binding sites (because of miRNA binding site accessibility or
combinatorial binding of TFs). Thus, this could be a very strong assumption that all
isoforms of a gene are regulated by similar regulators. A more realistic assumption
would be that specific regulator only regulate subsets of isoforms. To this end, we add
an additional l1 norm penalty to induce within group sparsity.
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FIGURE 5.4: Comparison of single-task learning vs. multi-task learning. (A) In
single-task learning, the output variable is the expression vector of is form i mea-
sured in N samples. The input f ture matrix consists of estimated TF ctivities
and miRNA expression. By fitting lasso regression, we learn weig vector β,
which represents the contribution a d direction of each regulator t explaining he
observed variance in isoform expression. We learn a single model per isoform. In
single-task learning, we do not encode any grou inform ti over inpu feature
(B) In multi-task learning, the output variable is a matrix, where the rows are the
samples, and the columns are the isoforms of a gene. Different to single-task learn-
ing, we have multiple input feature matrices ( one matrix for each isoform). We
infer a weight matrix B, where the columns are the isoforms, and the rows corre-
spond to the regulators. Non-zero entries in the weight matrix correspond to the di-
rection and magnitude of the regulators in explaining the observed variance in the
corresponding isoform expression data. The black rectangles are the group struc-
tures that we define to incorporate isoform annotation into the model. Each regu-
lator with similar binding sites in different isoforms of a gene forms a group (i.e.,
group 1 is the regression coefficient of the read TF in the isoform models 2, and
4). Structured sparsity-inducing penalty Ω(B) encourages the joint selection of the
coefficient within each group.
values. In our context, this means that a regulator with similar binding sites in iso-
forms of a gene should have a similar regulatory effect. This might not be a realistic
assumption for different reasons. For example, a binding site might be occluded de-
pending on the secondary structure of the isoform. To relax this assumption, we add
`1−norm to induce within group sparsity. This increases the power of our model to
capture these subtle events as well.
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would be that specific regulator only regulate subsets of isoforms. To this end, we add
an additional l1 norm penalty to induce within group sparsity.
8
problem [?].







||yk    kXk||2 + ⌦(B) (4)
Where k, Xk 2 RP⇥N and  k 2 RP are the number of tasks, task specific input fea-
ture matrix, and task specific regression coefficient vector respectively. The first term,
squar loss, is the fitting term and fits the parameters of the model indep ndently. The
second term ⌦(B) is the sp r e group lasso pena ty at c up es the models parameters
by simultaneously shrinking the weights of each regulator between different isoforms
that have predicted binding sites (See figure X). Sparse m lti-task group lasso is de-
fined as:
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Gp is the group lasso penalty and translates into the regression coefficient vector
for the regulator p that has binding sites at subsets of isoforms of a gene. Different
to Equation 3, we define a structured sparsity-inducing penalty, ⌦(B), for regulator
binding sites that are shared between two or more transcripts of a gene. In our setting
it translates into non-overlapping group lasso penalty (l2,1 norm). More specifically
Gm is the group of regression coefficients for regulator m that has shared binding sites
across isoforms of a gene (ref to picture). Non-overlapping group lasso encourages the
joint selection of the regulators that have similar binding sites at different isoforms of a
gene and encodes similarities for regression coefficients of regulator among isoforms.
Another hand, different isoforms of a gene might have different regulatory program
despite having similar binding sites (because of miRNA binding site accessibility or
combinatorial binding of TFs). Thus, this could be a very strong assumption that all
isoforms of a gene are regulated by similar regulators. A more realistic assumption
would be that specific regulator only regulate subsets of isoforms. To this end, we add
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FIGURE 5.5: Simultane us inference f gene and isoform r gulation. Different to
the previous formulation (Figure 5.4B), we incorporate gene expression as an ex-
tra task to the formulation. W p oject binding sites at isoform level to the gene
level; hence group structur r each regulator includes the regression coefficients
of the corresponding regulator at the gene level as well (See group 1, 2, and group
p). Ω(B) encourages t e joint selection of the coe ficients within each group, which
can lead to biologically m aningful regulator selection at the gene level, and subse-
quently accurate gene expression prediction.
5.2.3 Multi-task regression formulation for simultaneous inference of
gene and isoform regulation
Another novel aspect we developed is to model gene expression by jointly learning
gene and associated isoform expression level. This helps to transfer fine-grained bi-
ological knowledge at the isoform level to gene level, hence improving gene expres-
sion prediction accuracy. To this end, we add gene as an extra task to the previous







||yk − Xkβk||2F + Ω(B) (5.4)
Where K is the number of isoforms of a gene and +1 denotes gene as an extra task.
To construct the input feature matrix for the gene task, we project predicted binding
sites (miRNA and TFs) in isoforms to the gene level, and use activity of them as
the input feature for training (i.e. isoform-specific task features are the subset of the
gene task feature matrix). Moreover, we expand the definition of group structure for
regulators. First, we project all the binding site information at isoform level to the
gene level. Second, the size of each regulator group is increased by one to include
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the corresponding regression coefficient at gene level (Figure 5.5). This formulation
enables us not only to learn an accurate model of gene and corresponding isoform
regulations, but also highlight isoform specific regulators that may drive specific
physiological function.
5.2.4 Model selection
In order to select the best model, we choose the optimal combination of hyper pa-
rameters (λ, γ) that minimizes sixfold cross-validation errors as estimated on vali-
dation set using a fixed parameter grid applied to the training samples.
5.2.5 Optimization and implementation
Although Eq. 5.3 defines a convex function, in which a globally optimal solu-
tion to β is attainable, the main challenge arises from the non-smooth penalty
term. Widely used algorithm to solve regression problems with structured sparsity-
inducing penalty is based on Nesterov’s smoothing technique, which provides a
smooth approximation of non-smooth structured sparsity term (Chen et al., 2012).
Here, using accelerated proximal gradient descent algorithm, one can solve Eq. 5.3
for large-scale problems with convergence rate of O( 1K2 ) . The idea is that we de-
compose Eq. 5.3 into a sum of two convex functions as follows:









Both `(B) and g(B) are optimized iteratively (Algorithm 1). Algorithm 1 consists of
two main steps.
The first step is to compute the task-specific gradient descent using the following
equation:
Bt[k]← βkt − sk∇l(βkt ) for k = 1, . . . , K. (5.6)
where K and sk are the number of isoforms (tasks) and task-specific step size.
Since `(B) is Lipschitz continuous, the step size can be obtained from sk = 1Lk , where
Lk = λmax is the maximum eigenvalue of (XK)T × Xk.
The second step is to optimize g(B). Once we moved in the direction of gradient
with step size sk, we optimize non-smooth g(B) at Bt using proximal operator as
follows:
Bt+1 ← arg minW(g(W) +
1
2
||W − Bt||2F). (5.7)
Eq. 5.6 and Eq. 5.7 iterate until the algorithm converges.
By solving Eq. 5.7, we want to find a matrix W which minimizes g(W) and it is
as close as possible to the solution that we get from the gradient step (Bt). The
damping factor 12 ||W − Bt||2F enforces this closeness. Solving Eq. (5.7) is equivalent
to solving another optimization problem. Here, we show that optimality of Eq. (5.7)
is attainable using a closed formula solution.
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Algorithm 1 Accelerated proximal gradient descent for multi-task regression with
structured sparsity over input feature
Input: X ← [X1, . . . , XK], Y, βk0, Lipschitz constants L ← [L1, . . . , LK], desired accu-
racy ε
Initialization: βk0 = random, s
k = 1Lk
for t = 0, 1, . . . , until convergences of βkt do
Bt ← [β1t , ..., βkt ]
#Compute task specific gradient
for k= 1, . . . , K do
Bt[k]← βkt − sk∇l(βkt )
#Compute the proximal mapping using Eq. (5.13)
Wt+1 ← argminW(g(W) + 12 ||W − Bt||2F .
#Compute momentum
Bt+1 ←Wt+1 + tt+3 (Wt+1 −Wt). .
Output: B̂←Wt+1.
To this end, we can write it as follows:











Since Eq. 5.9 is the element-wise l1-norm, it can be decomposed either by columns













||Wp∗ − Bp∗||2F. (5.10)
Hence, we can optimize P functions independently. As this deals exclusively with
vectors, u = Bp∗ corresponds to the p−th row’s of B and f (w) = h(Wp∗), then each
of P equations can written as:
f (w) = λ||w||1 + γgp||Gp||2 +
1
2
||w− u||2F . (5.11)
It is easy to show that (proof in the appendix A) the minimizer of f (w) can be com-
puted using the following closed formula solution:
Qp = argminw f (w) =
{
(1− λ||so f t(u;λ)|| )(so f t(u; λ) ||so f t(u; λ)||2 ≥ γgp
0 ||so f t(u; λ)||2 < γgp,
(5.12)
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where
so f t(u; λ)
{
0 i f |ui| ≤ λ
ui − λsign(ui) i f |ui| > λ ,









5.2.6 Estimating regulatory network confidence score
Since different isoform models has different number of the features, the direct com-
parison of the regression coefficients between different isoforom models is not pos-
sible. Hence, we need a score to prioritize the predicted interactions comming from






where RSS1 is the residual sum of squared (RSS) errors produced by isoform model
i, excluding feature j, and subsequently, the RSS2 is the error from isoform model
i, including all the selected features. p1 and p2 are the number of the parameters of
the models (number of regulators + intercept), and N is the number of data point
is used to learn the model. Our null hypothesis is that removing feature j from
the model does not significantly increase the RSS error. F will have F-distribution,
with (p2 − p1, N − p2) degrees of freedom. The p-value was calculated by P[X >
F(1, N − p2)] and adjusted for multiple hypotheses testing over the regulators of an
isoform using Benjamini-Hocherberg method (Benjamini and Hochberg, 1995a).
5.2.7 Expression data and preprocessing
Potential miRNA-isoform interactions are retrieved from TargetScan (v. 7.2) (Agar-
wal et. al, 2015). We used miRTarBase release 7.0 (Chou et al., 2017) to obtain experi-
mentally validated miRNA target interactions.
We downloaded Sailfish-quantified gene, isoform, and miRNA expression val-
ues (TPM) (Patro, Mount, and Kingsford, 2014)for liver, breast, and prostate cancer
from UCSC Xena (Vivian et al., 2016).
Differential expression of isoform in liver cancer determined with the DESeq2 algo-
rithm version 3.3 (Love, Huber, and Anders, 2014) using un-normalized read counts
per isoform. After performing multiple testing correction, isoforms with a false dis-
covery rate (FDR) of ≤ 0.01 were considered differentially expressed isoforms.
The expression levels of gene, transcript isoforms, and miRNAs are log2 scaled.
We filtered all miRNAs, transcripts, and genes if their expression was ≤ 0.5 RPKM
in 90% of all samples. Moreover, we obtained DNaseI peak for HepG2, MCF-7, and
PC-3 cell lines from Encode (https://www.encodeproject.org/).
Building TFs prior network from open chromatin data and sequence motifs
We defined the proximal promoter for each transcript isoform as a window of size
1.5 kb centered at each TSS.
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In order to obtain an accessible promoter region for each transcript isoform, we
intersected DNase1 peaks with core promoter regions of each transcript isoform us-
ing tools beetool (Quinlan and Hall, 2010). We used TEPIC to annotate and compute
the binding affinities of TFs at open promoter regions (Schmidt et al., 2016).
Estimating the regulators activities
Transcription factor expression level is a not good proxy of their abundance in the
cell (Arrieta-Ortiz et al., 2015). Instead of using TF expression level as the input
feature, we do estimate their activities in different samples using RNA-seq, DNase-1
peak, and TF binding affinities as follows (Arrieta-Ortiz et al., 2015).
Let Y be the expression matrix of the isoforms, where rows are the isoforms and
the columns represent samples. Moreover, P denotes a matrix of prior regulatory
relationships between TFs (columns) and isoforms. The entries of the prior network
are derived from scaled TF-binding affinities at open chromatin regions. In order
to estimate the activities of TFs at each sample, we assume that we can write the
expression level of isoform i in sample j as a linear combination of TFs activities A,




We have more equations than number of variables (TFs), so it is an over-
determined system, hence there is no solution A. However, we can approximate
activities by finding Â that minimizes ||PÂ−Y||2 . Hence, using the pseudo inverse
of P∗ = (PTP)−1PT, the solution is obtained by Â = P∗Y.
5.2.8 Simulation
The main assumption for creating the synthetic data is that there is a linear relation-
ship between regulators and a target transcript:
yk = Xkβk + εk .
Moreover, regulator (TFs and miRNAs) binding sites in different isoforms of the
same gene, have a similar (not necessarily the same) regulatory strength. We sim-
ulated regulator activity levels (X) for 50 regulators by sampling from a univariate
Gaussian distribution for each regulator. Mean and standard deviation of the reg-
ulator activity distribution is sampled from µ ∼ N (0.1, 2) and σ ∼ N (0.01, 1),
respectively. Moreover, we sampled the ground truth regulatory effect vector (β∗)
from β ∼ N (−0.5, 0.5). Then we created sparse regulator transcript binding pri-
ors such that isoforms of the gene share at least 50% of regulator binding sites with
each other. For the simulation for every task (transcript) we defined 6 true regulator
binding events (cf. Fig. 5.6A) and 42 regulators as false positive associations. Unless
otherwise stated we simulated 35 samples in each setup.
We simulated transcript expression levles using the following linear model:
yk = Xkβk + εk, ∀k = 1, . . . , 16 (5.16)
where βk is the vector of coefficient for regulators that have binding sites at tran-
script k. For each transcript, and ε ∼ N (0, 0.5) is the added random guassian noise.
Both transcript and miRNA expression level scaled and considered model without
intercept. We simulated synthetic data for three different setups with the above
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setting
(I): We created 5 different simulation setups with 2, 6, 8, 10, and 16 isoforms using
Eq. 5.16 with noise distribution ε ∼ N(0, 0.5).
(II): We created 6 simulations with different noise levels using 16 isoforms with
Eq. 5.16 and noise levels with µ = 0 and σ = 0.15, 0.5, 0.75, 1.0, 1.5, and 2.0
respectively.
Given the simulated expression level yk we measure the root mean square error







(yi − ŷi)2 , (5.17)
where N is the number of test data samples (N=500).
Given true positive and true negative regulator binding events from simulated
data, we normalized the estimated coefficients to the interval [0,1]. Then we used R
package pROC (version 1.8., (Robin et al., 2011)) to compute Area Under the Curve
(AUC) values for ROC curves of the models for each simulation setup.
5.3 Results
5.3.1 Evaluation of synthetic data
In order to assess the problem of transcript expression based inference of miRNA
regulation we created a set of simulated datasets that allow us to explore the per-
formance of the different approaches, see methods. In particular we are interested
to test our hypothesis that the MTL approach can outcompete the disjoint model by
borrowing information from several isoforms.
Effect of different number of transcripts on model performance
In the first setup we vary the number of transcripts (2,6,8,10,16) using the ground
truth miRNA interaction matrix as shown in Fig. 5.6A, by taking different subsets of
this matrix (columns from right to left). 8 miRNAs with different interaction strength
are simulated, such that the interaction coefficient is the same among all regulated
transcripts. 4 of the miRNAs are shared among all 16 transcripts and the other 4 are
shared between 10 and 6 transcripts, respectively.
In Fig. 5.6B we show the normalized coefficient matrix for estimation with all 16
transcripts. Both the MTL and the disjoint model recover most of the true miRNA
interactions, but select a number of false positive interactions. In this simulation
∼ 80% of the interactions in the ground truth set are FP interactions, which makes
it a challenging problem, resembling the amount of FP interactions when relying
on static sequencing based prediction methods. We noticed that the MTL method
shows overall more low intensity FP coefficients compared to the disjoint model,
albeit at higher frequency. We believe that this is an advantage as these low intensity
coefficients are easy to filter. However, the disjoint model has a number of non-zero
interactions that are false positives, but have equally high values compared to TP
interactions.
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FIGURE 5.6: Comparison of recovering sparsity pattern for the 16 transcript simu-
lation. (A) Ground truth values of regulator binding association for the complete
set of 16 transcripts. Out of 50 regulatrors (rows) each transcript (columns) has 6
regulators that are associated with it, visible as a colored spot in the heatmap. The
rows of the heatmap are clustered using hierarchical clustering and group regu-
lators that show similar associations in the simulation. (B) Estimated regression
coefficients with the single-task and multi-task methods on the simulation dataset
with N = 100 for transcript expression levels. (C) Same as (B) with N = 200. All
absolute values of simulated and estimated coefficients are normalized to [0,1].
FIGURE 5.7: Comparison of the STL and MTL learning on different simulated
datasets. Comparison of test RMSE (y-axis) obtained for an increasing number of
transcripts per gene (A) or increasing dimensionality of the problem (ratio of fea-
tures to samples) (B). (C) Distribution of AUC values for all simulations in setup
(III), see Methods. The higher the number of transcripts that share a binding site,
the more the MTL method outperforms the disjoint model
Figure 5.9A shows the RMSE (Equation 5.17) on test samples for all setups and
compares the disjoint with the MTL model. Generally, the higher the number of cou-
pled transcripts per miRNA binding site, the smaller the error for the MTL method.
The error for MTL converges at 10 transcripts with no further improvement with
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16 transcripts. In contrast, the disjoint model shows increased error with more than
10 transcripts. This is due to our simulation setup, where the 10 and 16 transcript
problems have more miRNAs with smaller true binding coefficients, that are harder
to estimate correctly (cf. Fig.5.9A).
Learning performance in a high dimensionality setting
Another important aspect of learning sparse models is the dimensionality (p/n) of
the problem, where p denotes the number of parameters and n denotes the number
of samples. Then if p  n the problem is called high dimensional. We conducted
additional simulations for learning with increased dimensionality (simulation setup
III), as occurs often in practice when a limited number of paired miRNA and gene
expression samples are available. In Fig. 5.9B we show the obtained error for the
disjoint and MTL model. With higher dimensionality the error for both models in-
creases as expected. For all values tested the MTL model shows smaller errors com-
pared to the disjoint model. The disjoint model is more prone to overfitting in high
dimensions.
While smaller RMSE values show, that the MTL model predicts true expression
levels better, we used a ROC analysis in addition to evaluate the performance of
true miRNA binding predictions (see Methods). In Figure 5.9C we show the dis-
tribution of AUC values for different ranges of problem dimensionality, stratified
by the number of transcripts. Overall, we observed that for the MTL model, when
the number of tasks increases the AUC values increases, with values up to 0.85 for
16 transcripts. Also the MTL model always shows higher AUC values and lower
variance in the AUC compared to the disjoint model.
We further investigated the variance in the coefficient estimates in Fig. 5.8, study-
ing all simulations (setup III). All 7 simulated miRNAs (features) that were consis-
tently selected as non-zero by both models are shown. Note that the disjoint method
failed to select one of the miRNA features most of the time and therefore we ex-
cluded it from this analysis. Over all feature values the variance of the MTL method
is much smaller compared to the disjoint method. Features that are shared between
all 16 transcripts show the largest reduction in variance.
Thus, if the assumption of shared miRNA binding strength for transcripts with
the same site is true, then using MTL leads to better performance and can be trained
with fewer samples.
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FIGURE 5.8: Variance in regulator binding strength estimation. Variance of esti-
mated feature coefficients compared to the ground truth value from simulations
(y-axis) over all simulation setups and for each miRNA feature and method (x-
axis), same colors as in Fig. 3. MTL shows consistently smaller variance among all
simulation setups.






























































































FIGURE 5.9: Comparison of the STL and MTL learning on different simulated
datasets. Comparison of test RMSE (y-axis) obtained for an increasing number of
transcripts per gene (A) or increasing dimensionality of the problem (ratio of fea-
tures to samples) (B). (C) Distribution of AUC values for all simulations in setup
(III), see Methods. The higher the number of transcripts that share a binding site,
the more the MTL method outperforms the disjoint model.
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Multiple transcripts of a gene may share very similar exonic structures. This can
potentially make it hard to discern the origin of the read and lead to noisy estimation
of transcript expression levels from RNA-seq data (Teng et al., 2016). In order to
prioritize miRNA target at transcript level, the algorithm should be robust to high
noise levels in transcript expression data.

















































































FIGURE 5.10: Comparison of gene and isoform expression prediction accuracy.
Boxplot of Spearman correlation between the predicted and held-out genes (red)
and transcript (blue) expression in sixfold cross-validation (CV). The All uses all
input features (TF and miRNA) and is compared to the models exclusively trained
using only one type of input variable (TF or miRNA). For each gene and respective
isoforms, the optimum models are selected. The Box-plot shows the distribution
of the correlation for all the models. The higher the reduction in correlation by
excluding a specific variable, the more power that regulator has in explaining the
variance in the expression data. Excluding TF from the models leads to a higher
reduction in the model’s performance relative to the full model; hence TFs provide
more power in terms of explaining the variance in mRNA expression level.
In light of a large amount of throughput RNA-seq data, we aimed to learn pre-
dictive models of isoform expression in liver cancer. It remains to be determined
whether we can predict isoform expression level with remarkable precision using
miRNA expression level and TF binding profile at the core promoter region. Fig-
ure 5.10 shows the generalization performance measured as the correlation between
predicted and hold-out isoform expression data for 14,000 isoform-specific models
in liver cancer. On average, specific models explain the variance in the expression
level to a large extent. Moreover, it highlights the contribution of the core promoter
and 3’-UTR in controlling gene expression level. As expected, TF is a strong predic-
tor of isoform expression compared to miRNA, which mainly inhibit translation of
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the mRNA or fine-tune the expression level. As a result, they are not strong features
in explaining observed variance in the expression data.
Another interesting aspect is the relative accuracy of the gene vs. isoform level ex-
pression prediction. Models trained at gene levels shows relatively better general-
ization performance compared to isoform-level models (Fig 5.10).
5.3.3 Multi-task learning improves miRNA target prioritization
16








































FIGURE 5.11: Comparison of the STL and MTL approach for prediction of miRNA-
transcript target interactions in liver cancer RNA-seq data. Predicted interactions
are ranked based on their adjusted p-value(x-axis) and at each interval the number
of detected experimentally validated interactions is shown (y-axis). MTL consis-
tently shows superior performance compared to the Lasso.
In order to test the ability of the methods to prioritize true miRNA interactions,
we used Hits-Rank plots, using experimentally validated miRNA interactions from
the miRTarBase database (Chou et al., 2017). We compared the MTL and disjoint
methods in their ability to rank validated miRNA interactions. After fitting mod-
els to isoforms, all predicted miRNA-isoform interactions were pooled together and
ranked by their p-value. Then, at each interval, the number of experimentally val-
idated interactions (hits) was computed. As shown in Fig. 5.11, the MTL method
is able to rank more true miRNA interactions in the top ranks, and also detects a
higher number of true interactions among all non-zero coefficients.
5.3.4 Joint learning of gene and isoform models leads to accurate isoform
expression prediction
We asked whether we can we improve isoform expression prediction accuracy in a
low sample size setting through sharing regulatory information between transcripts.
We compared the performance of MTL and the lasso method for isoform expression
level prediction for a LumA liver cancer subtype dataset for 4,200 isoform models.
Figure 5.12 shows the generalization performance obtained on test samples with












































































FIGURE 5.12: Comparison of isoform expression prediction accuracy. Sparse re-
gression models predict transcript isoform expression level on holdout data for the
LumA breast cancer subtype. ST and MTL represent lasso and multi-task regres-
sion, respectively. GMTL (Eq. 5.4) denotes the multi-task learning model, where
the gene is added as an additional task in the formulation. Y-axis is the correla-
tion between predicted and holdout expression data. (A) Models trained using
expressed miRNA as input features. (B) Models trained using miRNAs and TFs as
input feature.
both approaches. We observed that MTL outperforms lasso for most of the tran-
scripts, as it does in the simulated data examples. Irrespective of the input features
used (miRNAs or TFs), MTL models capture more of the observed expression be-
havior of individual transcripts in liver cancer. Moreover, lasso models are prone to
overfitting when they are trained exclusively, using miRNAs input features.
Finally, we investigated the possibility of further improving the isoform expression
level prediction by incorporating gene expression as an extra task to the formula-
tion (GMTL in Fig 5.12). As in figure 5.12, the transcript models do not benefit re-
markably from the gene as an auxiliary task in the multi-task learning setting.
5.3.5 Incorporating isoform-level estimates leads to more accurate gene
expression prediction
As we mentioned, using gene expression for predictive modeling can mask
transcript-level dynamics and lead to suboptimal regulatory network inference.
Conversely, gene abundance estimates are more accurate, and downstream analysis
at the gene level may be more interpretable than at the transcript level. A straight-
forward way to reconcile gene-centric vs. transcript-centric views is to construct a
model at the isoform level, then aggregate that to the gene level. This approach may
be able to capture biological variability at the isoform level, but does not leverage
gene expression estimates in the learning procedure.
Keeping in mind that aggregating isoform expression levels cancels out the up and
down regulation of isoform, we tried to address it to a large extent in network recon-
struction. We hypothesized that, if isoforms of a gene show up and down regulation
due to deregulation of regulators, then corresponding isoform tasks will more likely
pick up the respective regulators in the learning procedure. Hence, if we add gene
as an extra task to the formulation, the group lasso penalty will encourage the joint
selection of the respective regulators at gene level as well. This might lead to a
robust and accurate gene expression prediction, since captures the fine-grained bi-
ological variation at isoform level and shares it with gene level. To investigate this,
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FIGURE 5.13: Comparison of gene expression prediction accuracy with and with-
out incorporating isoform annotation and expression into the model.(A) STL is the
lasso regression on gene expression across different samples. MTL is the joint mod-
eling of gene and associated isoform expression values (Eq. 5.4). Models are trained
using only miRNAs as input features and performance is separated by the number
of expressed isoforms per gene (x-axis). (B) The same as A, but models are trained
using TFs and miRNAs. In both cases, incorporating isoforms into the formula-
tion boosts gene expression prediction accuracy, especially for genes with man y
isoforms expressed.
two different settings. We trained the gene level models using the lasso, and multi-
task regression in two different settings; (I) Only expressed miRNA used as input
feature (II) miRNA and TF used as an input feature. We assess accuracy of the pre-
diction as a Spearman correlation between predicted and hold-out gene expression
data sets. As figure 5.13 shows, incorporating isoform annotation and expression
level improves the prediction accuracy of the gene expression in both settings.















































































































































































































































FIGURE 5.14: Association of 3’-UTR and model performance in explaining the vari-
ance in isoform expression level. (A) There is a positive association between the
ability of the model to explain the isoform expression level with the number of
miRNA binding sites at 3’-UTR. (B) This is similar to the trend with the length of
3’-UTR.
To get insights regarding the length of 3’-UTR and miRNA-mediated gene regu-
lation, we investigated the connection between isoform expression level prediction
accuracy and 3’-UTR length. We hypothesized that longer 3’-UTRs may mediate
more regulatory functions, since they often harbor more regulatory elements, which
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may lead to more flexibility in combinatorial binding events. We categorized the
performance of isoform models (I) by the number of miRNA binding sites in 3’-
UTRs ( Figure 5.14 A), or (II) the length of 3’-UTRs (Figure 5.14 B). Our analysis
suggests that the accuracy of isoform expression prediction using miRNAs strongly
depends on both the number of miRNA binding sites in the 3’-UTR and the length
of 3’-UTRs (Figure 5.14).
5.3.7 3’-UTR is a major driver of tissue specific expression for many iso-
forms
As shown previously, 3’-UTRs can play a major role in driving of tissue-specific iso-
form expression (Merritt et al., 2008; Spies, Burge, and Bartel, 2013). We investigated
whether we can find a subset of isoforms, where regulation heavily relies on the
3’-UTR region whereas the promoter shows a more constant gene expression pheno-
type. To this end, we partitioned models based on generalization performance into:
(I) only post-transcriptional regulation (PTR) models, and (II) both transcriptional
and post-transcriptional regulation (TR-PTR) models.
PTR corresponds to the isoforms, where TF-based models fail to predict expression
level reliably (correlation <0.1 on holdout data), but miRNA-based models predict
expression more accurately. The rest of the isoform models refer to TR-PTR, where
both TF-based and miRNA-based models work given the correlation threshold
We asked if there is any subset of isoforms, where TF-based models (transcriptional
models) fail to explain the observed variance in expression values. Surprisingly, we
found 2,300 expressed isoforms in the liver cancer dataset, where the corresponding
core promoter was accessible, but TF-based models failed to predict their expres-
sion level. This suggests that the core promoter of these isoforms are only permis-
sive of transcription. Moreover, when we looked at the performance of miRNA-
based (PTR) models, these were able to predict expression accurately, compared to
the miRNA-based models for the rest of isoforms (TR-PTR) models (Figure 5.15 A).
This suggests that the 3’-UTR sequence is the major driver of expression variation
for these isoforms (PTR) compared to the rest of the expressed isoforms in the data.
When we compare the expression level of PTR isoforms with TR-PTR isoforms, PTR
isoforms tend to have a low expression level (Figure 5.15 B). Moreover, the gap be-
tween the expression prediction accuracy for TPR and TR-PTR increases with the
increase in the length of the 3’-UTR (Figure 5.15 A). This evidence supports the idea
that the 3’-UTR sequence is the major driver of expression variation for PTR iso-
forms. Furthermore, recent reports (Wang et al., 2012) indirectly support our find-
ings. It was shown that isoforms with longer 3’-UTRs are generally unstable, have a
low expression level, and harbor high density of conserved miRNA binding sites.
5.3.8 On the tissue specificity of transcriptional and post-transcriptional
regulation
Many computational methods model the expression level of individual genes from
genomics and epigenomics data. One interesting aspect is whether models, trained
in a particular tissue, can accurately predict the expression values of individual
genes in other tissues. When we train a linear model for one individual isoform
based on chromatin accessibility of the regulatory elements and miRNA expression,
we are estimating a model of regulation for each isoform. How transferable is this
information? Can we predict isoform expression in a different tissue? In other




























































































































FIGURE 5.15: 3’-UTR as major driver of isoform expression level. Correlation be-
tween predicted hold-out expression (y-axis) is compared for different bins of 3’
UTR length (y-axis,log). (A) There is a positive association between the ability of
the model to explain isoform expression with the number of miRNA binding sites
at 3’-UTRs. (B) A similar trend is observed with the length of 3’-UTRs.
tissue-specific?
We investigated this for both TF-based and miRNA-based models. More specif-
ically, we trained isoform-specific models in one tissue (5.16 A and B) and used
pre-trained models to predict the expression level of the corresponding isoform
in other tissues (here referred to as target tissues). We did this experiment for
the isoforms expressed in both tissues, with an accessible corresponding proximal
promoter. Surprisingly, on average isoform models show very poor generalization
performance to other tissues ( 5.16). More interestingly, the relative performance of































































































































































































































FIGURE 5.16: Isoform-specifc model generalization performance across tissues. (A)
Two sets of isoform-specific models (TF and miRNA) are trained on prostate cancer,
and pre-trained models are used to predict the expression level of the isoforms
in liver and BRCA. Y-axis shows the correlation between predicted and holdout
expression data. Every point in the distribution is the performance of an individual
model. Both TF and miRNA based models show high reduction in their expression
prediction performance in the target tissues (Liver and BRCA). (B) Similar to A, but
models are trained using the BRCA data set and applied to predict the expression
level of isoforms for liver and prostate cancer data. Relative reduction in TF based
models is higher than for miRNA based models.
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Regulator Centrality Node degree Regulator Centrality Node degree
TFDP1 0.4 205 hsa-miR-5589-5p 0.3 159
TCFL5 0.37 193 hsa-miR-153-5p 0.28 157
TEAD2 0.36 187 hsa-miR-766-3p 0.27 153
NRF1 0.34 177 hsa-miR-590-3p 0.28 143
GMEB1 0.33 170 hsa-miR-340-5p 0.26 141
ZBTB14 0.33 169 hsa-miR-335-3p 0.25 141
KLF6 0.33 166 hsa-miR-576-5p 0.24 132
ETV5 0.32 165 hsa-miR-3074-5p 0.23 130
SP2 0.31 156 hsa-miR-629-3p 0.25 129
KLF7 0.3 153 hsa-miR-423-5p 0.22 129
TABLE 5.1: Top TFs and miRNA that are associated with differentially expressed
isoforms in liver cancer. They are ranked according to eigenvector centrality.
5.3.9 Regulatory network analysis of differentially expressed isoforms in
hepatocarcinoma
After demonstrating that POSTIT outperforms gene-centric methods in the priori-
tization of miRNA target interactions in liver cancer, we proceeded with network
analysis to find important regulators that target many of the differentially expressed
isoforms in liver cancer. Therefore, after FDR correction of the predicted interac-
tions, we computed both TF-isoform and miRNA-isoform networks. In these net-
works we computed the eigenvector centrality and node degree for all the regula-
tors. Table 5.1 shows the top TFs and miRNAs that regulate most of the differentially
expressed isoforms in liver. To further examine the functional implication of the top
regulators identified in the isoform regulatory network in hepatocarcinoma, we per-
formed an in-depth literature survey. Interestingly, the top regulators prioritized by
POSTIT are enriched in cancer-related TFs and miRNAs. To name a few by order
of eigenvector score, the TFDP1 TF regulates the activity of genes involved in cell
cycle progression from G1 to the S phase. Overexpression of TFDP1 is associated
with progression of hepatocellular carcinomas (Yasui et al., 2003). TEAD2 (Liu et al.,
2016) controls the tumor initiation and progression by regulating tumor progression-
inducing genes such as CTGF, Cyr61, Myc, and Gli2. KLF6 (Sirach et al., 2007) regu-
lates the cell cycle in the liver and it has been reported that inhibition of KLF6 helps
hepatocellular carcinoma (HCC) cells to evade from apoptosis. It has been reported
that overexpression of hsa-miR-153-5p promotes β-catenin transcriptional activity,
which leads to cell cycle progression and colony formation in HCC cells (Wu et al.,
2016). Furthermore, miR-153-5p anti-miR suppressed hepatocellular carcinogenesis
in a murine liver cancer model. (Hua et al., 2015). Further, hsa-miR-766-3p (You et
al., 2018) acts as tumor suppressor miRNA by targeting Wnt3a in HCC. Additionally,
hsa-miR-590-3p (Dong and Qiu, 2017) is overexpressed in HCC and promotes cell
proliferation, tumor growth, and metastasis. Finally, hsa-miR-423-5p (Stiuso et al.,
2015) has been reported to promote autophagy in cancer cells and was increased in
the blood serum of the HCC patients. This highlights that our isoform specific anal-
ysis, was able to prioritize many known important regulators of hepatocarcinoma.




We have introduced a new paradigm for regulatory network inference that works
on the level of individual isoforms instead of the (virtual) gene. We have introduced
three sparse learning setups that allow inference of isoform regulation from paired
transcriptomic and epigenomics data. The MTL approach in particular makes full
use of available isoform expression data and annotations to estimate regulator
interaction coefficients by borrowing information from all isoforms of the same
gene that share this binding site. If no binding sites are shared between isoforms
of a gene, then the MTL approach reduces to the lasso and, therefore, there is no
limitation in practice.
We conclude that the reduced variance on coefficients with the MTL approach leads
to lower errors in simulated and real data. However, we note that our simulations
are oversimplified, disregarding many other relevant aspects of regulator target
prediction, for example, RNA secondary structure, and assuming that expression
levels follow a Gaussian distribution. Further, one could explore more complex
simulation setups with a varying sparsity pattern and number of regulators, for
instance.
In real data, although most of the genes we tested only had two expressed isoforms,
the MTL approach showed a clear advantage, as sharing between more isoforms
reduces the variance of coefficient estimates due to the group lasso norm.
It has been reported that isoform expression estimation from RNA-seq data
can be noisy, which is a hard learning problem. Therefore, we evaluated the
robustness of our method on different noise levels on synthetic data and showed
that the MTL formulation increases robustness to noisy transcript expression
estimation. Studying how biases in transcript expression estimation impact regu-
latory network inference further would be helpful to understand the limits of the
suggested approach when applied to commonly available protocols for RNA-seq
data sets (Griebel et al., 2012). However, more recent technologies like PacBio or
Oxford Nanopore often allow for complete sequencing of the transcript, therefore
mitigating the above mentioned biases in transcript expression estimation.
Gene vs. isoform expression prediction accuracy
Another interesting aspect is the relative accuracy of the gene vs. isoform level
expression prediction. Models trained for gene expression show relatively better
generalization performance compared to isoform-level models (Fig 5.10). This may
be due to the difference in the total number of features used for training the models.
More specifically, depending on the annotation of the 3’-UTR and core promoter
of isoforms, different isoforms of a gene can have different input features, and
the union of these feature sets are used as input for training the respective gene
model. Hence, gene models have more input features compared to most isoform
models. Therefore, gene models have more explanatory variables compared to
isoform models, which may contribute to the difference in the prediction accuracy
compared to isoform models. Another reason might be that the variance for isoform
expression is higher than that observed at the gene level, since up and down
regulation of isoforms may cancel out at the gene level. This averaging in the gene
expression level, may contribute to the robustness of the gene model.
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Isoform annotation and expression are informative biological priors for
gene regulation modeling and expression prediction
Accurate gene regulation inference from high-throughput data is a big challenge
in systems biology, for which many existing algorithms reach limited accuracy.
This is mainly because of the dimensionality of the data, low sample size, inher-
ent noise, and sparsity in high-throughput biological assays. Exploiting other
sources of prior knowledge is one of the ways to address these issues (Ghanbari,
Lasserre, and Vingron, 2015; Schäfer and Strimmer, 2005; Friedman et al., 2000).
Here, we demonstrate that isoform expression level and annotation is a rich
source of prior knowledge regarding transcriptional and post-transcriptional activ-
ities of a gene. Our new approach is the first one to make full use of this information.
POSTIT fully exploits isoform level priors, consequently addressing the dimen-
sionality and sample size problem to a large extent and leading to more accurate
gene expression prediction in challenging settings. To this end, it integrates gene
expression, isoform expression, and annotation into a single learning framework for
accurate gene regulation modeling and expression prediction (Eq. 5.4). Depending
on the application, it provides an opportunity to conduct the downstream analysis
at the gene level, transcript level, or both. This is important for two reasons. First,
it leads to more accurate and robust gene expression prediction in a low sample
size setting by incorporating informative biological priors, thus increasing the
practical applicability of our algorithm. Second, it combines and leverages two
complementary views (gene vs. isoform centric analysis) in an elegant way, and
increases the interpretability and resolution of regulatory network analysis.
Association of 3’-UTR and expression prediction accuracy
The power of 3’-UTR as a driver of tissue-specific gene expression may be under-
valued. We showed that there is a strong connection between isoform expression
level prediction accuracy and 3’-UTR length (Figure 5.14). One possible explanation
is that the transcripts with longer 3’-UTRs harbor a high density of miRNA binding
sites, and are hence under tight regulation. Moreover, a recent study by (Wang
et al., 2012) shows that unstable isoforms usually have longer 3’-UTRs and harbor
a high density of miRNA and RBP binding sites. To our knowledge, this is the
first systematic study to reveal the connection between 3’-UTR length and isoform
expression prediction accuracy using miRNAs. We speculate that a similar trend
might exist for isoform expression regulation through RBPs.
However, this trend might not hold for all the isoforms with long 3’-UTRs.
It has been found that miRNA binding sites located in the middle of 3’-UTRs
are less responsive to miRNA regulation (Kim, Kim, and Baek, 2014), since the
secondary structure of the 3’-UTR might occlude the accessibility of the binding
sites and decrease the regulation by miRNA. However, conversely, having multi-
ple binding sites in a long 3’-UTR can have a synergistic effect on isoform regulation.
Moreover, we found 2,300 isoforms in liver cancer, whose expression level is
predictable from miRNA seeds in the 3-UTR sequence, but not using TF binding in
its promoter sequence (Figure 5.15). It has been reported that, for most genes in C.
elegans, 3’-UTRs are sufficient for regulation, and promoters are just permissive for
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expression (Merritt et al., 2008). It would be interesting to understand how these
dynamics are controlled in disease and cell development. Multiple methods have
been developed to annotate or quantify 3’-UTRs in different tissues (Jan et al., 2011).
Hence, our method can make full use of 3’-UTR data, and provide an opportunity
to elucidate novel regulatory functions of 3’-UTRs in controlling transcriptome and
proteome dynamics.
Regulatory connections are more tissue-specific than trans acting regula-
tory factors and target isoforms
Another novel aspect that we investigated is predictive power of the models across
different cancers. Isoform-specific models which are trained in one cancer do
not generalize well to other cancer (Figure 5.16). We demonstrated this for the
transcriptional and miRNA-mediated post-transcriptional models. We observed
significant reduction in their generalization performance (Figure 5.16). This in-
dicates that although the regulators are shared between different cancers that
compared, the regulatory connections are more tissue-specific than regulators and
target isoforms. A recent coexpression-based network analysis, which integrated
GTEx RNA-seq data across 38 different tissues and protein-protein interaction
indirectly confirms our finding (Sonawane et al., 2017). We showed that pre-trained
linear models reach limited accuracy in the corresponding isoform expression
level in other cancers. Among them, the miRNA-based model demonstrated
relatively better performance as compared to TF-based model. Many factors might
contribute to the poor generalization of the pre-trained models. Regarding the
transcriptional models, our modeling approach only considers TF binding profile at
the proximal promoter region of each isoform. However, it is possible to accurately
predict isoform expression level using accessible proximal promoter within a
cancer, but it does not generalize to cross cancers. Transcriptional gene regulation
are controlled at multiple levels, and our modeling approach does not consider
epigenetic modification at core promoters. DNA methylation and histone marks
also influence TF binding preferences to core promoter and enhancer region, thus
contributing to the gene expression changes. Moreover, distal regulatory elements
such as enhancers show very tissue-specific activities. Thus they modulate gene
expression in a very tissue-specific manner. We speculate that the generalization
performance of pre-trained transcriptional models might improve if these factors
could be integrated into the model.
Regarding miRNA mediated post-transcriptional model, we also observe a high
reduction in generalization performance; however the models we considered, at
least 80% of their associated miRNAs were expressed between two tissues. We can
think of many reasons including the unknown complexity of the miRNA target
regulation, transitivity effect of TFs, and tissue-specific distribution of the miRNA.
It is possible that the underlying distribution that generates miRNAs expression
level is very tissue-specific as well, hence pre-trained models fail to explain isoform
expression level using miRNA because they are trained on tissue-specific input data
distribution.
MiRNA-based models explain the variance in the isoform expression level to
large extent (Figure 5.16). Although this might initially look surprising, most of the
transcriptome is coexpressed. Hence, it is more likely that the same set of TFs coreg-
ulates miRNA and its associated targets. Moreover, this coregulation might also be
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very tissue-specific, and pre-trained models are already overfitted to these coregula-
tion effects, which could lead to poor generalization performance. Currently, we do
not remove transitivity effects (indirect regulations) from our modeling approach.
We expect that some part of the isoform prediction accuracy by miRNA is due to
transitivity effects by TFs. We speculate that, if we correct our predictive models
for these confounding factors, maybe the cross-cancer generalization performance
of miRNA-based model will improve.
Nevertheless, the generalization performance of the miRNA-based models
is higher than transcriptional models. Nevertheless, this might means suggest
that transcriptional regulation is more tissue-specific than miRNA-mediated post-
transcriptional regulation.
5.5 Conclusion and outlook
POSTIT is a fast and scalable algorithm for modeling and predicting gene and
associated isoforms expression level. It fully exploits the gene and transcript iso-
form structure and expression level and shares the regulatory information between
different tasks, thus leading to to more accurate gene and isoform regulation
inference. The POSTIT approach is successful when the annotation of isoforms is
neither too similar nor too different. If they are too different, it might be difficult
transfer knowledge between them, and it reduces to single-task learning. On the
other hand, if isoforms have the same annotations (same alternative 3’-UTR and
promoter), then it might be a good idea to combine the training data and learn a
single model for these isoforms.
Another critical factor is the difficulty of learning the isoform model concerning the
number of parameters and available training data. More specifically, if the problem
is hard to learn, then sharing regulatory information between transcripts of a gene
helps. One way to test this is to compute the expression prediction accuracy as a
function of a number of the training data point. If the performance of the isoform
models saturates very fast, means that the problem is easy to learn. Therefore,
exploiting cross isoform commonalities will not help much. A similar idea can be
applied to check the similarity of regulation between the two isoforms. Accordingly,
we can train an isoform-specific model and test on the data from another isoform
of the gene. Subsequently, we can plot the expression prediction saturation curve
for each isoform. This can give us a useful measure to test whether transferring
regulatory information between two isoforms is beneficial.
Our approach proposed approach can be extended in multiple directions. First,
from the algorithmics perspective, one can try to infer the task similarities from data
and, hence, enforce the similarity of the cross task parameters accordingly. More-
over, it is easy to modify our optimization framework to learn whole regularization
path, which can speed up hyper-parameters selection.
Second, from modeling perspective, it is not really clear which aspects of isoform
expression level is controlled by proximal promoter, distal enhancers, and 3’-UTR.
In oue anlysis, we showed that there are 2300 transcript isoforms in human liver
whose expression is mainly regulated by 3’-UTR. To what extent these isoforms are
tissue-specific and their distrubtion in other tissues yet to be understood.
Although gene is a useful concept, it is an abstraction of the underlying bio-
logical processes because regulatory mechanism works at the level of isoform and
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not the gene. Different isoforms of a gene might have various functions, which are
even sometimes oppose to each other. We believe that reconstruction and analysis
of the regulatory network at isoform level will provide an enhanced picture of gene
regulation in different tissues, diseases, development, etc. There are many regula-
tory mechanisms that can not be identified if the analysis is conducted gene level.
To mention a few, recent reports have demonstrated that, many diseases-associated
variants change the ratio of the isoforms of a gene (Li et al., 2013b) rather than
gene expression. Moreover, alternative transcript isoform usage might alter the
gene function in different tissue, but might not significantly change the associated
gene expression level, hence it is more likely that we will miss these regulatory
mechanisms at the gene level.
We presented an algorithm that reconstructs the transcript isoform regulatory
network by integrating different high-throughput assay, but unlike gene regulatory
network, isoform regulatory network faces a unique challenge: the lack of functional
annotation for isoforms. Currently available resources such as gene ontology and
pathway annotation, provide only gene level function annotation, and hence lose
the fine-grained functional information at the isoform level. Second, the annotation
of the transcript isoforms is also far from perfect, and different transcript assembly
algorithms output might not agree to a large extent with each other. Nevertheless,
future researches will fill in the gaps (Li et al., 2013b; Li, Omenn, and Guan, 2015),
thus facilitating the functional analysis of isoform regulatory network at transcript
isoform and hopefully will further our understanding of regulatory mechanisms




Large-scale inference of competing
endogeneous RNA networks with
sparse partial correlation
The main contributions in this chapter are the following:
• We propose a scalable algorithm for inference of competing endogenous
RNA (ceRNA) network from transcriptomics data.
• We derive a theory for null distribution simulation for quantifying miRNA
mediated correlation.
• We present an easy to use Bioconductor package for ceRNA network inference.
Contributions: I had a major contribution to the design and development of
the algorithm. I made all the derivations for the null model simulation and im-
plemented the first working version of the algorithm and designed the simulation
experiments. Furthermore, I contributed to data analysis, interpretation and writing
the manuscript. Dennis Kostka suggested the idea of using the Schur complement
for covariance matrix simulation. Moreover, he helped to derive the null model sim-
ulation for the case microRNA = 1. Markus List led the data analysis, wrote the
Bioconductor package, and contributed to writing the manuscript. Marcel Schulz
supervised the project and contributed to writing the manuscript. This chapter will
appear at ISMB-ECCB Proceedings 2019.
6.1 Introduction
In the previous chapter, we introduced an algorithm for modeling and analysis of
transcriptional and post-transcriptional isoform regulation. We showed how we
could improve condition specific miRNA target prediction, and how regulatory ele-
ments in 3’-UTR play roles in miRNA mediated regulation. In this chapter, we will
build on top of that to study another mode of RNA regulation.
However, the common belief is that miRNA regulates the target transcript expres-
sion; the relationship between transcript and miRNA could be reciprocal. This
means the level of one transcript can control the level of other transcripts through
shared miRNA. More specifically, RNA transcripts with miRNA recognition ele-
ments (MREs) compete for shared miRNA for binding, hence create transcriptome-
wide RNA cross-talk.
Notably, genes sharing binding sites for the same miRNA(s) compete over a lim-
ited pool of miRNA molecules, giving rise to a complex gene-regulatory network of
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FIGURE 6.1: ceRNA interaction between two genes that have the same miRNA
binding sites. (A) both green and red genes have the same expression level; hence
they are regulated by miRNA by a similar amount. (B) Green gene is overexpressed,
therefore binds more miRNAs and protects red transcript from translational repres-
sion, hence protein output of red transcript increases.
competing endogenous RNAs (ceRNAs) (Tsang, Ebert, and Oudenaarden, 2010). A
number of cancer-associated genes have been shown to act as ceRNAs (Arvey et al.,
2010b; Salmena et al., 2011; Tay, Rinn, and Pandolfi, 2014), including PTEN (Poliseno
et al., 2010), CD44 (Jeyapalan et al., 2011), ESR1 (Chiu et al., 2015), BRAF (Karreth et
al., 2015), KRAS (Poliseno et al., 2010), MYCN (Powers et al., 2016) and HULC (Wang
et al., 2010). This evidence has sparked interest in developing systematic methods
for inferring ceRNA interactions from gene and miRNA expression data, reviewed
in (Le et al., 2016).
The different methods can be broadly categorized into methods that use (i) only
static information, such as the number of miRNA binding sites or binding energy or
(ii) methods that use condition-specific information in addition such as expression
or Clip-data. One of the most commonly used methods in category (i) is based on
the idea to assess the probability that two mRNAs share miRNAs and their binding
sites, and to then highlight cases where this probability is much higher than expected
by chance, for example by using the hypergeometric test (Li et al., 2013a).
With the emergence of large-scale studies providing gene and miRNA expression
data for hundreds of samples, a number of methods of category (ii) have been devel-
oped (Le et al., 2016). (Sumazin et al., 2011) proposed the use of conditional mutual
information (CMI) for estimating the effect of a miRNA on a gene-gene interaction
in their method HERMES. The advantage of this approach is that it measures non-
linear associations, but estimation of significance is done using permutations, later
implemented as part of the CUPID software (CUPID step III) (Chiu et al., 2015).
Recently the JAMI software has improved the runtime of the extensive CMI compu-
tation compared to CUPID (Hornakova et al., 2018), but runtime is still a limiting
factor for this approach in applications to very large datasets.
This issue has motivated the use of conceptually simpler and fast linear
correlation-based methods, for instance, restricting to only gene-gene correlation
values (Du et al., 2016; Xu et al., 2015), gene-miRNA correlation (Zhang et al., 2017)
or correlations within triplets of two genes and one miRNA (Wang et al., 2015; Liu
et al., 2017). However, in contrast to CUPID, these approaches do not quantify the
contribution of the miRNA to the ceRNA interaction in a unified model.
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(Paci, Colombo, and Farina, 2014) overcame this issue with the definition of sen-
sitivity correlation (scor), which has similarities to the CMI-based approach. Linear
partial correlation can be used to quantify the remaining correlation between two
genes after accounting for the effect of one miRNA. scor is then defined as the dif-
ference between gene-gene correlation and partial correlation and thus quantifies
the contribution of the miRNA in the regulation of two genes. Similar to CMI, scor
considers the impact of miRNA regulation on both genes in a single mathematical
model and is thus more powerful than the methods proposed in (Wang et al., 2015;
Zhang et al., 2017; Du et al., 2016; Xu et al., 2015; Liu et al., 2017). Unlike CMI,
however, scor computation is based on efficient estimators of covariance matrices
for computing partial correlation and thus allows large-scale ceRNA network infer-
ence as demonstrated by (Zhang et al., 2016), who inferred lncRNA-mRNA related
ceRNA networks for 12 different cancer types.
While the estimation of the scor coefficients is efficient, no theory for the compu-
tation of the null distribution of these values exists. Therefore, previous work relied
on ad hoc approaches. (Paci, Colombo, and Farina, 2014) selected the top 5% of scor
coefficients for downstream analysis, disregarding significance testing. (Zhang et
al., 2016) addressed this issue by generating a null distribution using permutations
based on randomly selected lncRNA-miRNA-mRNA triplets. This null distribution
was then used to obtain empirical p-values.
We have identified a number of issues with the current approaches that use scor.
First, current correlation-based approaches assume independence between scor val-
ues and the gene-gene correlation. However, as we show in this work, the distribu-
tion of scor coefficients is strongly affected by gene-gene correlation (Fig. 6.2A and
Supp. Fig. 1). Thus, previous studies that have used scor values have been biased.
Second, we note that many ceRNAs are regulated by several miRNAs. Neglect-
ing joint contributions, many significant ceRNA interactions may be missed. The
CUPID approach considers that ceRNA interactions may be mediated by several
miRNAs in conjunction. To accommodate this, CUPID pools p-values obtained from
individual ceRNA triplets (Chiu et al., 2015). We propose that the contributions of
multiple miRNAs should be part of the ceRNA inference model to optimally account
for miRNA covariance effects.
Here we present a unified mathematical approach that addresses the above issues.
We have developed a Bioconductor/R package called Sparse Partial correlation ON
Gene Expression (SPONGE). At the core of SPONGE is a new mathematical frame-
work that is a generalization of scor values for more than one miRNA, which we call
multiple miRNA sensitivity correlation (mscor). Assessing the significance of mscor
coefficients is difficult due to biases of gene-gene correlation, number of samples,
and the number of miRNAs. Therefore, we have developed a novel strategy for
simulating background distributions that accommodate the aforementioned factors
and for inferring p-values for mscor coefficients efficiently. Due to SPONGE’s effi-
ciency, we were able to perform an analysis of the complete human transcriptome
across 31 different cancer types combining over 10,000 paired gene and miRNA ex-
pression samples using data from The Cancer Genome Atlas (TCGA). Our analysis
highlights the potential of ceRNA network inference for hypothesis generation by
revealing extensive ceRNA cross-talk. Some of the key regulators have already been
reported as ceRNAs while others potentially represent novel biomarkers and drug
target candidates.
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FIGURE 6.2: Overview of the SPONGE workflow. (A) Predicted and/or experimen-
tally validated gene-miRNA interactions are subjected to regularized regression on
gene and miRNA expression data. Interactions with negative coefficients are re-
tained since they indicate miRNA induced inhibition of gene expression. (B) We
compute sensitivity correlation coefficients for gene pairs based on shared miRNAs
identified in (A). (C) Given the sample number, we compute empirical null models
for various gene-gene correlation coefficients (k) and number of miRNAs (m). Sen-
sitivity correlations coefficients are assigned to the best matching null model and a
p-value is inferred. (D) After multiple testing correction, significant ceRNA inter-




The objective of SPONGE is to infer a ceRNA interaction network from gene and
miRNA expression data of paired samples. In theory, inferring a genome-wide
ceRNA network with n genes entails considering (n2) interactions for all pairwise
combinations. In practice, only gene pairs with shared miRNAs need to be consid-
ered. First, SPONGE identifies for each gene those miRNAs that are likely to have
a regulatory effect (Fig. 6.2A). Second, we filter for gene pairs with shared miRNAs
and determine their ceRNA interaction scores (Fig. 6.2B). Third, we assess the sig-
nificance of each ceRNA interaction using a series of null models (Fig. 6.2C) adjust-
ing for confounders. Finally, significant interactions are retained for constructing a
ceRNA interaction network (Fig. 6.2D). In the following, we describe each of these
steps in detail.
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Step 1: Identifying relevant miRNA-gene interactions
SPONGE identifies relevant gene-miRNA interactions in two stages. First, we re-
tain only miRNA-gene pairs for which we have general evidence from external pre-
dictive or experimental sources. SPONGE allows for an arbitrary number of data
sources to be combined.
Second, we test if the gene and miRNA expression data provides support for
these interactions, since we expect many of the putative miRNA-gene interactions in
particular to be false positives (Pinzón et al., 2017). Negative correlation of gene and
miRNA expression can provide evidence for a miRNA-gene regulation. However,
many miRNAs might target a single gene. To take this into account, and to identify
the most likely miRNA regulators of each gene, we use regularized regression.
We build an Elastic net regularized linear regression model with the expression
of gene g as the dependent variable and the expression of miRNAs Z′ ∈ Z as ex-
planatory variables, where Z′ are miRNAs predicted or experimentally shown to
target g. Elastic net balances lasso (L1) and ridge (L2) penalties using a linear combi-
nation of both denoted as a weight factor α. We build a range of Elastic net models to
optimize the parameters for α = 0.1, 0.2, ..., 1.0 and the optimal shrinkage parameter
λ via 10-fold cross validation using the glmnet package (Friedman, Hastie, and Tib-
shirani, 2010a). We select the best model based on the residual sum of squares. Since
miRNAs with positive coefficients are likely caused by effects other than miRNA re-
pression, we retain only miRNAs with negative coefficients, which was previously
shown to work well (Muniategui et al., 2012; Schulz et al., 2013). Moreover, SPONGE
offers a user-definable coefficient threshold for discarding miRNAs with negligible
impact on gene expression (default < -0.05).
In summary, we identify for each gene condition-specific miRNA regulators.
This leads to a dramatic reduction of gene pairs that share miRNAs (Fig. 6.2B) com-
pared to using all predicted miRNA-gene interactions and reduces the runtime of
SPONGE. In the next step, we determine the effect strength of ceRNA interactions.
Step 2: Computing miRNA induced correlation coefficients
In order to compute ceRNA interaction between gene 1 and gene 2, we are interested
to quantify how of much observed correlation between them are induced by shared
miRNA between these two genes. To quantify miRNA induced correlation (miRNA
effect), we use the different of observed correlation with partial correlation between
these gene 1, and gene 2 as follows(Paci, Colombo, and Farina, 2014):
scor(g1, g2, m) = cor(g1, g2)− pcor(g1, g2|m) . (6.1)
pcor(g1, g2|m) explains away the effect of miRNA m in explaining the observed
correlation between g1 and g2. Hence, different of correlation and partial correlation
quantify the miRNA contoribution in inducing correlation between g1 and g2.
Note that this approach does not account for a combinatorial effect of several
miRNAs. Consequently, strong ceRNA interactions mediated by several moderate
miRNA regulators can not be detected.
We thus propose to extend the definition of sensitivity correlation considering the
effect of multiple miRNAs M for the computation of the partial correlation. In this
way, we implicitly incorporate the effect of miRNA-miRNA cross-correlation. We
call this multiple miRNAs sensitivity correlation (mscor):
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mscor(g1, g2, M) = cor(g1, g2)− pcor(g1, g2|M) , (6.2)
where M = m1, ..., mi and i is the number of shared miRNAs between g1 and g2.
We compute mscor coefficients efficiently using the R package ppcor (Kim, 2015). In
the next step, we establish the significance of each mscor coefficient.
Step 3: Sampling from the mscor null distribution with respect to impor-
tant parameters
(Zhang et al., 2016) proposed to establish the significance of scor coefficients by
means of sampling a background distribution from random triplets. This approach,
however, disregards that correlation coefficients have smaller variance when the
coefficient is high (Fisher, 1915). Moreover, it can be expected that the significance
of sensitivity correlation values is linked to the number of samples and the number
of miRNAs involved.
To accommodate these biases, we propose a novel algorithm to study the null
distribution of mscor coefficients.
6.3 A null model for sparse partial correlation
SPONGE systematically computes the difference between the correlation of two
genes g1 and g2 and the partial correlation of those genes after accounting for the ex-
pression of miRNAs that potentially regulate both genes. This measure, also called
multiple miRNA sensitivity correlation (mscor), serves to quantify the strength of
the ceRNA relationship between two genes, i.e.,
mscor = cor(g1, g2)− pcor(g1, g2|mir1, ..., mirm)
Our null hypothesis is that the miRNAs have no effect on the correlation of the
two genes, i.e. mscor = 0 and thus we are interested in the significance of observing
mscor > 0. Here, we illustrate how numerical simulations can be used to model
the expected distribution of mscor under this null hypothesis for varying numbers
of miRNAs m, varying numbers of samples n and different correlations of g1 and
g2. We will demonstrate that all of these parameter influence the null distribution
and thus have to be taken into account. The result of the simulations are used in
SPONGE to compute p-values for mscor coefficients given the number of samples in
the data set and given the number of miRNAs considered for each pair of genes.
6.3.1 Computing conditional covariance matrix using Schur complement
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is the correlation matrix between the first two entries of Z. In order to com-
pute the conditional co-variance between the first two entries (g1, g2) of Z given
(mir1, ..., mirm) ∈ Z, we compute the Schur complement of R/R22 as follows:
R/R22 = R11 − R12R−122 RT12 =
(
1− a r12 − b
r12 − b 1− c
)
where
a = vT1 R
−1
22 v1
b = vT1 R
−1
22 v2
c = vT2 R
−1
22 v2 (6.3)
We define the vectors v1 and v2 as correlation vector of g1 and g2 with
[mir1, ..., mirm], respectively. Hence (R/R22)−1 gives us partial correlation as follows:
r12.m = (r12 − b)(1− a)−1/2(1− c)−1/2 (6.4)
For the null model, we need to show that partial correlation is equal to correla-
tion. In other words, we need to solve:
r12.m = r12
Our strategy to achieve this is to first sample K = r12 and R22 with −1 ≤ K ≤ 1 and
∀x ∈ R22 : −1 ≤ x ≤ 1. We then look for sensible values for v1 and v2 such that
sensitivity correlation (r12 − r12.m) is equal to zero. Replacing r12.m with r12 yields
r12 = (r12 − b)(1− a)−1/2(1− c)−1/2 (6.5)
6.3.2 Sampling Correlation Matrices
In the following, we consider two sampling strategies, one for the case of m = 1 and
one for the case of m > 1:
The case of m = 1:





Substituting a, b and c from (6.3) yields
r12 − r13r23 = r12
√
(1− r213)(1− r223) (6.7)
We further substitute K = r12 as well as Z = r13:
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K2 − 2KZr23 + Z2r223 = K2 − K2r223 − Z2K2 + K2Z2r223
Z2r223 + K
2r223 − K2Z2r223 − 2KZr23 + K2 − Z2K2 = 0
(Z2 + K2 − K2Z2)r223 − (2KZ)r23 + Z2K2 = 0 (6.8)
We can fix Z by uniform sampling from [−1, 1] and solve above quadratic equa-
tion:
A = K2 + Z2 − K2Z2
B = −2KZ
C = Z2K2 (6.9)







and to construct valid examples of correlation matrices R in which mscor = 0.
The case of m > 1:
When considering several miRNAs obtaining valid instances of R is considerably
more complex. Instead of considering individual values r13, r23 and r12 we have
much more degrees of freedom. As before, we sample K = r12 from [−1, 1]. More-
over, we sample a positive semi-definite correlation matrix R22 that expresses the
correlation between different miRNAs. Diagonal elements of R22 are 1 and off-
diagonal elements are −1 ≤ rij ≤ 1. More importantly R22 should be positive
definite which means that:
xtR22x > 0
∀x ∈ Rm
To obtain sensible values for v1 and v2 we modify our problem. Let the vectors
u1 and u2 be defined as
u1 = R−1/222 v1
u2 = R−1/222 v2 (6.11)
This allows us to rewrite a, b and c from (6.3) as
a = ||u1||2





c = ||u2||2 (6.12)
We also define λ = cos θ and substitute a, b, and c in (6.3) in the form of :
[(K2 + λ2)||u1||2 − K2]||u2||2 + (2λK||u1||)||u2|| − K2||u1||2 = 0 (6.13)
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where K, λ are scalars. Our strategy is the following: we sample u1 ∈ Rm, which
allows us to compute ||u1||. This allows us to determine ||u2|| since, knowing that
||u1||2 = ut1u1 = constant, we can simplify (6.13) and solve a quadratic function w.r.t
the ||u2||.
We define:
A = [(K2 − λ2)||u1||2 − K2]
B = 2λK||u1||
C = −K2||u1||2 (6.14)
Then we can rewrite equation (6.13) as :
A||u2||2 + B||u2||+ C = 0 . (6.15)







Suppose F is one of solutions to above equation. To construct a valid instance of
R, we now have to sample a vector u2 that respects the norm we just determined and
has the correct angle to u1. Finally, since elements of v2 are correlations, we have to
make sure to impose the following constraint on u2
− R−1/222 1 ≤ u2 ≤ R−1/222 1 (6.17)
To test if our chosen u2 has the correct angle, we can use the two alternative











We can now obtain a valid solution of u2 by randomly sampling m− 1 elements
of u2 to obtain u2\m . The last elements of u1 and u2 are defined as u1m and u2m ,
respectively.
To compute a valid element u2m , we rewrite (6.18) as follows
u2m =
λ||u1||||u2|| −∑m−1i=1 u1i u2i
u1m
(6.19)


























u1i u2i u1m (6.22)
and rewrite (6.21) as





2 = 0 (6.23)
This quadratic equation can be solved as before with
A = u21m − λ2||u1||2 (6.24)














We now can construct a vector u′2 with the desired angle to u1. However, it does
not have the correct norm yet. We thus need to scale u2 to the norm of F we have






Finally, we have to check if the final vector u2 is still compatible with R with































Should u2 violate these constraints, we need to repeat the sampling procedure.
The same is true if no solutions can be obtained for the quadratic equations in (6.10)
or (6.16) as well as (6.27).
Our sampling procedure for the case m > 1 can be summarized in the following
steps
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1. Fix v1, R22 and λ by random sampling.
2. Compute a valid solution for F = ||u2|| via (6.16).
3. If the previous step does not yield F, go to step 1.
4. Randomly select m − 1 components of vector u2 and compute a solution for
u2m via (6.27).
5. If u2m is without valid solution go to step 1.
6. Construct u′2m and scale it to F to obtain u2.
7. Test if u2 fulfills the constraints in (6.29).
8. Construct and return R.
6.4 Simulation Results
We used the above algorithm to sample sets of covariance matrices for all combina-
tions of the parameters gene-gene correlation (0.2 - 0.9 in steps of 0.1) and number of
shared miRNAs (1 to 8). These are incorporated in the SPONGE R package and can
be used to construct null models for a given number of samples. Here, we generated
null models for varying numbers of samples to study how the three parameters,
gene-gene correlation, number of shared miRNAs and number of samples affect the
random distribution of mscor coefficients. The results are depicted in 6.3.
Our null hypothesis is that the shared miRNAs M do not affect the correlation of
two genes g1 and g2. Hence,
We have devised sampling strategies that enable us to find values a, b and c
such that these conditions are fulfilled, allowing us to construct random covariance
matrices under the null.
Most importantly, we can control the gene-gene correlation r12 and the number of
miRNAs (via the dimensions of R22) to construct a series of covariance matrices with
respect to these important parameters. SPONGE uses these covariance matrices to
draw random samples which are subsequently used to estimate empirical p-values
for mscor values computed on experimental data. The details of this approach and
of our sampling strategy can be found in the Supplemental Material.
The SPONGE R package provides precomputed covariance matrices for a range
of gene-gene correlations and number of miRNAs. Given the number of samples in
the expression data, SPONGE can efficiently construct a series of null distributions
from these covariance matrices. Next, we assign each mscor coefficient to the closest
matching null model and infer its p-value via its rank in the random distribution
(Fig. 6.2D). The number of data points sampled for the null distribution determines
the maximal precision of this p-value (p > 1e6 by default). Finally, p-values are ad-
justed for multiple testing within each null model using the method by (Benjamini
and Hochberg, 1995b).
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Number of samples 50 100 200 400 800
FIGURE 6.3: Density plots of mscor values randomly sampled in the process of
generating null models for SPONGE. Different panels show that the distribution
depends strongly on the number of shared miRNAs (1-8) and gene-gene correlation
(0.2 - 0.9 in steps of 0.1) as well as on the sample number (50, 100, 200, 400 and 800).
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Step 4: Constructing a ceRNA network
We filter ceRNA interactions returned by SPONGE by a user-defined significance
threshold (FDR < 0.01 by default) and subsequently construct a ceRNA interaction
network N = (V, E), where nodes V correspond to genes participating in signif-
icant ceRNA interactions and edges correspond to significant ceRNA interactions
between two genes.
Using SPONGE to construct a pan-cancer ceRNA network
We downloaded reprocessed TCGA pan-cancer data from the TOIL project (Vivian
et al., 2017) via the UCSC Xena Browser (Goldman et al., 2018). We identified 10,019
samples for which both gene and miRNA expression data were available. Next, we
performed log2 transformation and discarded genes and miRNAs not expressed in
more than 80% of samples as well as genes and miRNAs with expression variance
< 0.5.
To consider both coding and non-coding miRNA-gene interactions, we down-
loaded sequence-based predictions of two methods, namely TargetScan (Agarwal et
al., 2015b) (v.7.1, downloaded 10/03/2017) and miRcode (Jeggari, Marks, and Lars-
son, 2012) (v.11, downloaded 10/03/2017). We included the latter since it also con-
siders non-coding RNAs which have been shown to act as ceRNAs.
TargetScan and miRcode predict target genes for miRNA families. We thus
downloaded suitable miRNA family definitions for both data sets (available at the
TargetScan website http://www.TargetScan.org/). Note that miRcode uses the
miRNA family definitions corresponding to TargetScan v.6. After mapping fam-
ily ids to miRBase mature miRNA ids (MIMATs) we generated integer matrices in
which genes are listed as rows and miRNAs are listed as columns. Each entry of the
matrix represents the number of binding sites for the corresponding interaction.
To consider experimental evidence for miRNA-gene interactions, we obtained
data sets from miRTarBase (v.6, downloaded 13/03/2017) (Chou et al., 2016) for
coding and lncBase (v.2, downloaded 13/03/2017) (Paraskevopoulou et al., 2016)
for non-coding genes and generated input matrices as described above.
Matrices, for gene and miRNA expression and miRNA-gene interactions were
analyzed with SPONGE. Significant ceRNA interactions were used to construct the
pan-cancer ceRNA network.
Runtime Analysis
In order to compare against the runtime of the CMI-based approach of CUPID (Chiu
et al., 2015), which similarly uses paired gene and miRNA expression to estimate
gene-miRNA-gene triplets, we used the JAMI software (Hornakova et al., 2018).
JAMI is a fast reimplementation of CUPID step III that leverages parallelization.
We compared the runtime of JAMI to that of SPONGE (without step1: the regres-
sion filter) for a fair comparison. We used a subset of the pan-cancer dataset with
200 genes, which form ca. 80,000 gene-miRNA-gene triplets. We ran both tools with
default parameters in parallel mode with 16 cores with varying number of samples
and genes.
Survival Analysis
For assessing the impact of gene or miRNA expression on the survival probabil-
ity, we downloaded right-censored TCGA survival data of TCGA patients from the
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UCSC Xena Browser (Goldman et al., 2018). We divided patients into two groups
based on the 50% quantile of the expression vector. Survival probability was com-
puted in R using the survfit function in the R package survival (Therneau, 2015).
p-values were computed using the function survdiff in the same package. survdiff
tests for significant differences of survival curves using the χ2 statistic. Kaplan Meier
plots were generated using the ggsurv function of package survminer.
To test for the enrichment of survival genes in a list of top candidates ranked
by degree, we used the following strategy. First, we computed survival p-values
based on expression data for all genes as outlined above using the survdiff function.
Second, we classified genes into survival-associated and -unassociated (background)
genes (FDR < 0.001, (Benjamini and Hochberg, 1995b) for the purpose of enrichment
analysis. Third, we computed enrichment of the candidate gene set in survival-
associated compared to background using the hypergeometric test in R.
6.5 Results
We have devised a method for the statistical evaluation of condition-specific ceRNA
interactions from paired miRNA and gene expression data considering contribu-
tions for multiple miRNAs: called multiple miRNA sensitivity correlation (mscor).
mscor is a generalization of scor previously defined for one miRNA by (Paci,
Colombo, and Farina, 2014) (see Methods for details).
Simulated data reveals dependency of sensitivity correlation on several
factors
As mentioned above, no theory existed to describe the distribution of sensitivity
correlation values (Paci, Colombo, and Farina, 2014). However, we wanted to un-
derstand how the mscor measure is influenced by confounding factors present in
ceRNA relationships: (i) the correlation of two genes, (ii) the number of miRNAs
involved in the ceRNA interaction and (iii) the number of samples that are available
for estimation. We developed an efficient simulation approach to explore null mod-
els in which miRNAs have no effect on the correlation of two genes, hence mscor is
zero (see Methods and Supplemental Material for details). Our method is able to
compute random covariance matrices that fulfill this null hypothesis. This allowed
us to simulate data sets for a range of gene-gene correlation coefficients (0.2 - 0.9
in steps of 0.1), shared miRNAs (1 to 8) and number of samples (50, 200, 800) and
thus to approximate the random distribution of the mscor coefficients under the null
hypothesis that mscor is zero.
Fig. 6.2 and Supp. Fig. 1 show our simulation results, which reveal that the
null distribution is strongly affected by all three tested parameters. Our findings
indicate that large mscor coefficients are more likely to occur by chance when the
gene-gene correlation is low and when the number of miRNAs increases. As ex-
pected, it is more difficult to obtain significant mscor coefficients with few samples
as higher mscor values are obtained with smaller samples sizes by chance. Thus,
comparing mscor values without proper adjustment for these parameters would pri-
oritize low gene-gene correlation pairs, interactions with many miRNAs and lead to
a bias when tests between studies with different sample numbers are compared.
The above insights led us to develop SPONGE, an R/Bioconductor package to
infer ceRNA interactions between pairs of genes. We briefly outline how SPONGE
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facilitates this in two steps (see Methods and Fig. 6.2). First, we estimate condition-
specific miRNA-gene associations from a large set of putative miRNA-gene interac-
tions. This is done using sparse regression of paired gene and miRNA expression
data obtained from many samples. Second, ceRNA interactions are predicted using
mscor values estimated for all gene-gene pairs that share at least one miRNA from
the first step. Statistical significance of mscor values is efficiently computed using the
simulation approach described above.
Considering multiple miRNAs leads to information gain
To demonstrate the advantages of mscor measure over scor, we selected a subset of
the TCGA data with 364 liver cancer samples and 1,000 randomly selected genes.
mscor allows us to incorporate multiple miRNAs in the model and thus to detect
ceRNA interactions that only become significant when several miRNAs act in con-
cert. Fig. 6.4A shows that considering all miRNAs lead in most but not all cases
to a higher mscor coefficient compared to the individual miRNA with highest scor.
However, when also considering significance (FDR < 0.01), the signal to noise ratio
increased and led to a clear gain in information, namely consistently higher mscor
coefficients for multiple miRNAs. Consequently, SPONGE is able to assess the joint
regulatory effect of several miRNAs in a ceRNA relationship in a condition-specific
way.
Our approach correctly adjusts the p-value to the number of miRNAs involved
(see Fig. 6.2C). As CUPID uses a meta analysis strategy on individual gene-miRNA-
gene triplets (Chiu et al., 2015) to obtains one p-value for a set of miRNAs per gene-
gene interaction, we sought to compare to such an approach for our measure. We
used Fisher’s popular meta analysis approach to combine p-values (Fischer, 1925) of
individual miRNA triplets. Fig. 6.4B shows that aggregated p-values tend to be con-
siderably higher in meta analysis, illustrating the loss of information and sensitivity
compared to assessing significance in a joint model via mscor.
Our simulation suggested that ranking ceRNA interactions by the scor or mscor val-
ues would introduce a bias towards interactions with low gene-gene correlation (see
Fig. 6.2C). In Fig. 6.4C, we compared the gene-gene correlation values of the top 5%
ceRNA interactions sorted according to mscor with our FDR corrected set of ceRNA
interactions. (Paci, Colombo, and Farina, 2014) used 5% as an arbitrary cutoff. We
observed that SPONGE selected ceRNA interactions showed significantly higher
gene-gene correlation values on average (t-test p-value < 2.2e−16) underlining that
sorting without proper correction leads to a bias.
Runtime comparison with a conditional mutual information-based ap-
proach
CMI is an alternative to partial correlation for estimating the effect and significance
of a gene-miRNA-gene interaction. We compared the performance of JAMI (Hor-
nakova et al., 2018), a fast implementation of the CMI-based approach of CU-
PID (Chiu et al., 2015), and SPONGE on a subset of the pan-cancer dataset. Fig. 6.5
illustrates that the SPONGE workflow can be computed fast even for large sample
numbers and large number of triplets, while the runtime of JAMI increases dramati-
cally due to the need to rank expression values and due to computationally intensive
permutations that are needed for assessing the significance of CMI values. In addi-
tion, SPONGE does normally not evaluate each triplet individually, but considers
all shared miRNAs in a joint model, giving rise to an additional speedup. SPONGE
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is thus uniquely suited to infer a genome-wide ceRNA network even on large-scale
datasets such as the TCGA pan-cancer data.
The empirical null model allows strict control over the false positive rate
To study ceRNA interactions in a pan-cancer setting, we applied SPONGE to paired
miRNA and gene expression data for 10,019 samples from TCGA (see Methods)
combining data from 31 cancer types. A comprehensive set of putative miRNA-
gene interactions was obtained by combining several sources: sequence-based pre-
dictions from TargetScan (Agarwal et al., 2015b) and miRcode (Jeggari, Marks, and
Larsson, 2012) as well as experimentally validated miRNA-gene interactions from
mirTarBase (Chou et al., 2016) and LncBase (Paraskevopoulou et al., 2016).
Considering all possible pairwise combinations of genes, ca. 109 putative ceRNA
interactions can be formed. Fig. 6.6 shows how the three-step approach of SPONGE
reduces this large set of putative interactions. In the first step, condition-specific
gene-miRNA interactions are inferred, which reduces the set of considered ceRNA
interactions to 108. However, many of these denote spurious ceRNA interactions
that do not pass our selected significance threshold (FDR < 1e − 5) in the second
filter step. Finally, ca. 106 significant ceRNA interactions are predicted by SPONGE
and used to construct a pan-cancer ceRNA interaction network.
SPONGE estimates ceRNA interaction significance based on simulated null dis-
tributions. To determine if this estimation is accurate when applied to real data, we
devised a random scenario in which SPONGE should not be able to find significant
interactions. We devised a true-negative setting by using only miRNAs as features
for a particular gene, which do not have a predicted miRNA binding site in the tar-
get gene in any of our considered databases, i.e. miRNAs that have no seed match in
the gene (blue bars, Fig. 6.6). Here only 66 interactions remained significant. Thus,
our assumed FDR < 1e− 5 appears conservative, which demonstrates the efficacy
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FIGURE 6.4: Comparison of sensitivity correlation and SPONGE FDR control on
liver cancer data. (A) mscor values (y-axis) compared to maximal scor values (x-
axis) for the same gene-gene interaction. (B) mscor p-values obtained from sam-
pling compared to p-value summarization of scor values using Fisher’s method.
(C) Boxplot of gene-gene correlations for gene-miRNA-gene triplets obtained after
selecting the top 5% ceRNA interactions according to the raw scor values (orange)
or based on FDR corrected p-values from SPONGE (blue). t-test p-value between










































FIGURE 6.5: Runtime comparison between SPONGE and JAMI, a fast method for
computing ceRNA interactions based on CMI. (A) Runtime for varying number of
samples on a fixed set of ca. 80,000 triplets. (B) Runtime for varying number of
triplets on a fixed number of samples. Time was measured in CPU hours (y-axis).








TABLE 6.1: Number of genes participating in significant ceRNA pan-cancer inter-
actions (FDR < 1e-5) divided by Ensembl gene type.
Pan-cancer ceRNA network analysis
After demonstrating that most of the ceRNA interactions in the pan-cancer network
are statistically sound, we proceeded with a more detailed analysis. After process-
ing expression data from 60,498 genes and 2,463 mature miRNAs, SPONGE reported
95,541,095 gene-gene interactions after step one from which we retained 914,165 at
an FDR threshold of 1e-5 (Fig. 6.6). 16,935 genes participated in ceRNA cross-talk
with a median of 29 interactions per gene and a median of six miRNAs per ceRNA
interaction with a maximum of 36 miRNAs per interaction. Table 6.1 shows the num-
ber of genes in different Ensembl gene categories, highlighting that ceRNA interac-
tion is not limited to protein-coding genes with a 3’ UTR. Interestingly, we found a
large number of pseudogenes in this pan-cancer analysis, including the two previ-
ously reported pseudogenes PTENP1 and BRAFP1 (Sanchez-Mejias and Tay, 2015).
We further investigated which microRNAs facilitate ceRNA cross-talk by count-
ing how many interactions they participate in. These results are shown in Supp. Fig.
2. Our results highlight that a few miRNAs mediate most of the ceRNA interactions
in the network. We observe that these miRNAs have comparably high expression
levels, which is in line with what we would expect since ceRNA competition only
plays a role if sufficient miRNA copies are present in a cell.
The ceRNA network is based on the pan-cancer TCGA dataset which contains
cancer as well as tumor-adjacent samples. To identify which of the key ceRNA reg-
ulators are associated with cancer, we filtered for genes which showed high mean
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Method miRNA(s) w/ seed match miRNA(s) w/o seed match
FIGURE 6.6: Analysis of SPONGE ceRNA interactions on the pan-cancer dataset.
Barplots show the number of interactions (y-axis) that are initially analyzed (grey),
obtained after the regression filter (Step 1) and after computing mscor values and
FDR correction of empirical p-values (Step 3). The analysis is shown for miRNA-
gene relationships for which miRNA binding sites (seeds) have been predicted (or-
ange bars) and for a large set of true-negative miRNA-gene relationships, investi-
gating miRNAs without seed matches in a given gene (blue bars).
expression levels (TPM > 100) and were differentially expressed between cancer and
tumor-adjacent samples (t-test, FDR < 0.01 (Benjamini and Hochberg, 1995b) and
log2 fold change > 1). Our rationale was to determine genes that are present at suffi-
cient copy numbers to exert cell-relevant ceRNA effects concentrated on genes that
are overexpressed in the pan-cancer samples, thus likely mediating oncogenic ef-
fects. A total of 141 unique genes were obtained using these criteria (Supp. Table 1).
The 10 genes with the highest number of interactions are shown in Table 6.2 and in
Fig. 6.7.
The gene with the largest number of significant ceRNA interactions is VCAN,
which is an established ceRNA (Tay, Rinn, and Pandolfi, 2014; Sanchez-Mejias and
Tay, 2015). In fact, previous work has shown that overexpression of the VCAN
3’UTR sequence alone is able to induce cancer growth in liver cancer cells (Fang
et al., 2013). Similarly FN1 is a known ceRNA (Sanchez-Mejias and Tay, 2015).
We used clinical data from TCGA to assess if the expression of the genes iden-
tified here is significantly associated with survival probability. Fig. 6.7B shows that
among the top 10 genes, 8 are significant (p < 0.05, see Methods). Among all 141
genes in this analysis (Supp. Table 1) we find a significant enrichment for survival
related genes according to a hypergeometric test (p = 3.75e-10) comparing against
the background of other genes.
An intriguing candidate in this list is the linc-RNA LINC00511, which has the
highest expression of all non-coding genes in this set and is associated with survival
(Fig. 6.7C). Interestingly, a recent paper has shown that LINC00511 is an oncogenic
ceRNA and regulates VEGFA gene expression in pancreatic adenocarcinoma (Zhao
et al., 2018). Further, it was found that LINC00511 is a ceRNA for E2F1 and is in-
volved in breast cancer tumourigenesis (Lu et al., 2018). Also, it was found that
LINC00511 drives tumourigenesis in non-small-cell lung cancer (Sun et al., 2016).















































































































FIGURE 6.7: (A) Degree of ceRNA genes with mean expression (TPM > 100) and
differential expression between cancer and tumor-adjacent samples (FDR < 0.01
and log fold change > 1). Number of ceRNA interactions (y-axis) is compared to
mean expression (x-axis). Differential expression magnitude is shown as color code
in the plot. (B) The 10 genes with highest degree ranked by their survival analysis
p-value. (C) Kaplan Meier survival plot of the non-coding RNA LINC00511.
in diverse cancer types, as experimental evidence for LINC00511 mediated ceRNA
regulation in two cancers already exists. Thus, LINC00511 qualifies as an interesting
pan-cancer drug target.
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ensembl gene id HGNC gene symbol degree
1 ENSG00000038427 VCAN 1135
2 ENSG00000113810 SMC4 923
3 ENSG00000166851 PLK1 812
4 ENSG00000115414 FN1 698
5 ENSG00000142945 KIF2C 519
6 ENSG00000134013 LOXL2 513
7 ENSG00000141756 FKBP10 481
8 ENSG00000227036 LINC00511 478
9 ENSG00000258947 TUBB3 433
10 ENSG00000106089 STX1A 391
TABLE 6.2: Top 10 ceRNA regulating genes with highest node degree among genes
differentially expressed between cancer and tumor-adjacent samples. The full table
with 141 differentially expressed genes is shown in Supp. Table 1.
6.6 Discussion
We identified two major obstacles that prevent the efficient inference of a compre-
hensive genome-wide ceRNA interaction network. One of the first approaches, CU-
PID (Sumazin et al., 2011; Chiu et al., 2015; Hornakova et al., 2018), does not scale to
the genome-wide level (see Fig.6.5) due to the use of permutation-based empirical
p-value computation for establishing significance and the complexity of estimating
CMI. Partial correlation-based approaches employing scor (Paci, Colombo, and Fa-
rina, 2014), on the other hand, are fast but do not accurately determine significance
of the estimated effects.
To overcome these two issues, we designed an efficient empirical p-value compu-
tation approach by sampling from null models that describe the random distribution
of mscor values. Moreover, this approach enabled us to accommodate possible biases
introduced by several parameters, namely the number of samples, the gene-gene
correlation and the number of shared miRNAs. Our results highlight that the current
practice of ranking ceRNA interactions by scor coefficients introduces a bias towards
gene pairs with low correlation, which are also more abundant. Furthermore, it be-
came evident that scor can not be directly compared across datasets with different
sample numbers, suggesting that previous studies on unbalanced data sets, where
ceRNA network comparisons between cancer and related normal samples were con-
ducted, have likely been biased. We note that null model-based significance analysis
is fast, which entails that SPONGE can compute p-values at high numerical preci-
sion (p > 1e6) compared to permutation-based approaches that often limit precision
(p > 1e3) due to excessive runtime.
In this work we have presented a statistical approach to jointly estimate the sig-
nificance of multiple miRNAs in a ceRNA interaction between two genes. Most
genes are regulated by several miRNAs and it can thus be expected that poten-
tial ceRNA interaction partners share more than one miRNA between them. This
suggests that there is an advantage in considering joint effects of several miRNAs.
As far as we are aware only CUPID considers such combinatorial effects when us-
ing paired expression data. However, CUPID integrates these effects at the level of
triplets, where p-values of triplets involving the same genes are pooled (Chiu et al.,
2015), which, as we have shown, results in a loss of sensitivity (Fig. 6.4B). In contrast,
our approach captures the contribution of several miRNAs and their co-expression
in a single mathematical model. To this end, we extended the concept of sensitivity
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correlation to multiple miRNA sensitivity correlation (mscor).
To make this approach broadly available, we developed SPONGE, a
R/Bioconductor package which provides a general framework for analyzing sen-
sitivity correlation beyond its current application in ceRNA network inference.
SPONGE enabled us to construct the first pan-cancer ceRNA network that system-
atically infers interactions between all genes within a few days on a typical compute
cluster. Notably, close to 16,000 genes are involved in ceRNA regulation. Roughly
12,000 of these are protein-coding genes highlighting that this is a genome-wide phe-
nomenon as proposed by (Salmena et al., 2011) and not limited to non-coding RNAs.
However, association may not be confused with causation. We can not rule out that
some of the effects we observe are caused by the activity of the proteins encoded by
the tested ceRNA genes. For instance, transcription factors or RNA binding proteins
may affect the expression of ceRNA interaction partners directly or indirectly.
To further investigate to what extend our results are biased by non-miRNA-
mediated regulatory effects, we conducted an in silico control experiment where we
observed that almost no significant ceRNA interactions remained when miRNAs
were tested for which an actual regulation is unlikely as they have no seed match
in either of the genes. This suggests that the majority of SPONGE reported ceRNA
interactions can be attributed to miRNA-based association.
Network analysis in which we focused on genes that show moderate to high av-
erage expression and that are differentially expressed between cancer and tumor-
adjacent samples revealed ceRNA genes with hundreds of interactions, many of
which also show a significant association with survival probability. Our findings
suggest that many protein-coding genes auch as VCAN and FN1 have an additional
regulatory function as a ceRNA. Moreover, SPONGE suggests ceRNA regulation as
a potential mechanism to explain why non-coding RNAs such as LINC00511 have
a significant impact on survival. This straight-forward analysis thus illustrates the
potential of ceRNA networks for hypothesis generation and biomarker discovery.
We note that results might vary depending on the choice and quality of miRNA
target interaction databases. To alleviate this issue, we selected datasets based on
sequence-based predictions as well as experimentally validated miRNA target in-
teractions. Most of the sequence-based prediction methods focus exclusively on the
3’ UTR of protein-coding genes for detecting miRNA binding sites. Our results in-
dicate that non-coding RNAs make a substantial contribution to miRNA cross-talk
such that future miRNA-target annotations should be adapted.
It is important to emphasize that statistical significance does not equal biological
relevance. While we have ensured that the pan-cancer ceRNA interactions predicted
in this work are likely true associations with respect to our model and its assump-
tions, understanding which of those individual interactions are of physiological rel-
evance, is another important problem. Large-scale validation of ceRNA interactions
is challenging and new methods are needed. One interesting approach is the work
by Rzepiela et al., in which miRNA target sensitivity values were estimated using
mathematical modelling of miRNA overexpression coupled to single cell expression
analyses and may provide a way to prioritize ceRNA targets of functional biological
relevance (Rzepiela et al., 2018).
6.7 Conclusion and Outlook
The TCGA pan-cancer analysis performed here provides unique insights into global
ceRNA cross-talk in cancer. However, cancer-specific networks will be needed to
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draw a more comprehensive map of ceRNA regulation where sophisticated network
alignment methods are employed to reveal commonalities and differences between
cancer types. Generating paired gene and miRNA expression data for healthy tis-
sues in databases like GTEx (Lonsdale et al., 2013) will become crucial for gaining
an understanding of tissue-specific ceRNA cross-talk which will in turn present a
baseline for detecting cancer-specific aberrations in the network presented here. Re-
cently, single cell protocols that facilitate measurements of multi-omics have become
available (Macaulay, Ponting, and Voet, 2017). We envision that a protocol support-
ing parallel measurement of microRNA and gene expression will particularly bene-
fit from fast correlation-based approaches like SPONGE for celltype-specific ceRNA
network inference.
Note that, to our knowledge, we have devised the first generalized algorithm
for sampling covariance matrices in which the partial correlation is equal to the cor-
relation. We envision that this might be relevant beyond the inference of ceRNA
interaction networks with possible applications in other scientific disciplines.
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7.1 Future directions
In this section we talk about the extension of our work.
7.1.1 POSTIT
In the model we presented, we have the parameter γ Eq. (5.3), which controls the
similarity of regression coefficients for a regulator between different isoforms. An-
other alternative would be to define a kernel function and learn the task similarity
from the data directly. This might lead to a more accurate estimation of regression
coefficients but would make the computational algorithm more involved. More-
over, one could use the Bayesian sparse group lasso, where we could incorporate
our priors regarding regulators and epigenomics priors of the regulator binding
site. This may be a more tractable formulation and elegant solution to learn the
fine-grained complexity of gene regulatory mechanisms.
POSTIT reconstructs a transcript isoform regulatory network by integrating dif-
ferent high-throughput assays. Unlike a gene regulatory network, an isoform reg-
ulatory network faces a unique challenge: the lack of functional annotation for iso-
forms. Currently available resources such as the gene ontology or pathway anno-
tations, provide only annotation on the level of genes. Hence, these resources lose
the fine-grained functional information at the isoform level. There is a big need
for resources that curate functional annotation on the isoform level of transcripts,
acknowledging the complexity of human transcription and post-transcriptional reg-
ulation. If more of these resources are being developed, downstream analyses of
prediction of POSTIT will become easier and will be more revealing.
7.1.2 SPONGE
In many genes, alternative splicing gives rise to a large number of transcripts, many
of which differ strongly in their expression. Some of these transcripts are not trans-
lated and vary in the miRNA binding sites they carry. Thus, similar to transcripts
originating from non-coding genes, they have no apparent biological role but may
potentially contribute to ceRNA cross-talk. Considering transcript-level expression
data will improve the quality of ceRNA network inference and allow for identifying
disease-relevant changes in alternative splicing that act through ceRNA effects.
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7.1.3 Modeling competition between miRNAs and RBPs
In Chapter 4 we showed that over expression of IMP2 alters the regulatory capacity
of miRNAs by competing for binding sites. As a result, IMP2 induces a steatosis-
like phenotype and enhances the risk of developing hepatocellular carcinoma (De-
hghani Amirabad et al., 2018). Currently, there is no computational method that
integrates transcriptomics and par-clip data to prioritize RBPs that control the regu-
latory capacity of miRNA in biological systems and diseases. Moreover it is poorly
understood to what extent RBPs interfere with miRNA mediated regulation.
Game theoretic approach: In this approach, self-interested agents (RBPs and
miRNAs) compete to bind to limited resources (transcripts). We can define the
strategy profiles and pay-off functions of players from sequence motifs and bind-
ing affinities of the regulators. The goal is to solve the game and find the Nash
equilibrium that represents the optimum allocation of regulatory elements between
regulators.
Probabilistic graphical model: In this approach, we can integrate miRNAs,
RBPs and isoform expression as observed nodes. Furthermore, competition is en-
coded as a binary latent variables. The goal is to compute the posterior probability
distribution for a latent variable given noisy priors of RBP and microRNA motif
overlaps on the transcripts
These kinds of computational models have the potential to prioritize RPBs
that add another layer of complexity to post- transcriptional gene regulation and,
hence, might contribute to disease mechanisms. Both of these models can be easily
extended to simultaneously model both cooperative and competitive modes of
regulation. Furthermore, these modeling approaches can applicable to modeling





A.1 Proximal operator of sparse group lasso for multi-task
regression
Since Eq. 5.9 is the element-wise `1-norm, it can be decomposed either by columns












||Wp∗ − Bp∗||2F. (A.1)
Hence, we can optimize P functions independently. Because we are dealing with
vectors exclusively, u = Bp∗ corresponds to the pth row’s of B and f (w) = h(Wp∗),
then each of P equations can written as:
f (w) = λ||w||1 + γgp||Gp||2 +
1
2
||w− u||2F . (A.2)
In order to find the optimality condition for the Eq. A.2, we derive∇ f (w), which
leads to the following:
0 ∈ λ∂||w||1 + γgp∂||Gp||2 + w− u . (A.3)
Using dual-norm theory of vectors we can write the subdifferential of the norms
as follows:
∂||w||1 = {D1 s.t ||D||∞ ≤ 1, 〈D, w〉 = ||w||1} (A.4)
∂||Gp||2 = {D2 s.t. ||D||2 ≤ 1, 〈D, w〉 = ||w||2} . (A.5)
Now Equation A.3 can be written as:
0 ∈ λD1 + γgpD2 + w− u (A.6)
w∗ ∈ u− λD1 − γ gpD2 , (A.7)
where w∗ denotes the optimal solution. First we will simplify u − λD1 in the next
Lemma.
Lemma A.1.1. u− λD1 is equal to so f t(u; λ), known as soft-thresholding:
so f t(u; λ)
{
0 i f |ui| ≤ λ
ui − λsign(ui) i f |ui| > λ ,
where ui denotes the i-th element of u.
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Proof. We define s(u) = λ||u||1, proximal of s is defined as follows:
proxs(u) = argminz(λ||z||1 +
1
2
||z− u||22) . (A.8)
We can then write the optimality condition as:
0 ∈ ∇(||z− u||22) + ∂(λ||z||1) (A.9)
0 ∈ z− u + λ∂||z||1 ⇒ z∗ = u− λ∂||z||1 (A.10)
Thus u− λ∂||z||1 is the proximal operator of l1 norm at point u. We can derive
the solution for Equation A.10 by considering each component separately, due to
separability of l1 norm:
• Case I:
zi 6= 0⇒ ∂||zi|| = sign(zi),
then
0 = zi − ui + λsign(zi)
zi = ui − λsign(zi)
zi 6= 0
{
i f zi < 0 ⇒ ui − λsign(zi) < 0⇒ ui < −λ
i f zi > 0 ⇒ ui − λsign(zi) > 0⇒ ui > λ
We can conclude that |ui| ≥ λ.
• Case II:
zi = 0⇒ ∂||zi||1 ∈ [−1, 1],
then we can write A.10 as follow:
0 ∈ 0− ui + λ[−1, 1]
ui ∈ [−λ, λ]⇒ |ui| < λ.
Putting case I and II together, we have:
[proxs(ui)] = z∗i =
{
0 i f |ui| ≤ λ
ui − λsign(zi) i f |ui| > λ
Above equation is called soft-thresholding. So we can conclude that:
u− λ∂||z||1 = u− λD1 = so f t(u; λ).
Lemma 1 reduces optimality condition for A.7 to:
w∗ ∈ so f t(u; λ)− γgpDp. (A.11)
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Lemma A.1.2. Equation A.11 is equivalent to evaluating the proximal sum of `2-norm at
point so f t(u; λ).
Proof. let’s define A = so f t(u, λ) and k(A) = γA. Proximal operator of k(A) is
defined as follow:




We can write optimality condition for equation A.12 as follow:
0 ∈ γ∂||w||2 + w− A (A.13)
then
w∗ ∈ A− γD2 = so f t(u, λ)− γgpD2. (A.14)
Lemma 2 reduces optimality condition for A.7 to:
γgpD2 + w ∈ so f t(u; λ)⇒ w∗ ∈ so f t(u; λ)− γgpD2. (A.15)
Since D2 is a point in the inner product of dual space of `2-norm (which is again
the `2-norm), we can apply Moreau’s decomposition theorem to the `2-norm to solve
Equation A.15.
Theorem A.1.3. Moreau’s decomposition theorem: Given a function g(x), the following
holds regarding proximal of g




where g∗ is convex conjugate of g(x).
So, for any g = ||.|| and B is unit ball of dual norm, then
proxλg(x) = x− λ ∏
B
(x/λ). (A.17)






||x||2 ||x||2 > 1
x ||x||2 ≤ 1,
which helps us to rewrite the proximal operator of `2-norm in the following form:
proxλg(x) =
{
(1− λ||x||2 )x ||x||2 ≥ λ
0 ||x||2 < λ
We already showed that the optimum value for w∗ is given by
w∗ ∈ so f t(u; λ)− γgpD2. (A.18)
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Which is equivalent to proximal for sum of `2-norms at so f t(u; λ) point. Thus we
conclude for group p is defined as:
Qp =
{
(1− λ||so f t(u;λ)◦Ii ||2 )(so f t(u; λ)) ||so f t(u; λ)||2 ≥ γgi
0 ||so f t(u; λ)||2 < γgi
Thus we conclude that:
argminw f (w) = Qp. (A.19)
This concludes the proof.
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